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Abstract 
This thesis explores the role of psychological factors and co-morbid affective disorders 
involved in chronic pain outcomes, in particular, treatment adherence. Study One was a 
systematic review examining the predictive nature of various pain-related beliefs on 
treatment adherence during and after multidisciplinary intervention. The review found ten 
eligible papers and highlighted various cognitions as predictors of treatment adherence 
outcomes. Pain self-efficacy was found to be the most commonly researched predictor of 
treatment adherence. The reviewed literature also showed support for other cognitions such 
as fear-avoidance beliefs, perceived disability, catastrophizing, and perceived benefits and 
barriers. Based on the findings of the review, further research with more refined and 
standardized methodologies is encouraged to better understand the contribution of pain-
related cognitions on adherence behaviour.  
 
In light of this review, Study Two utilized a retrospective design to investigate the role of 
pain-related cognitions and their associations with pain and affective disorders using an 
innovative analytic technique (network analysis). The participants were 169 chronic pain 
patients aged 22-80 years old who had attended a multidisciplinary pain management 
program. Participants completed a battery of questionnaires at the beginning of their allocated 
program. Network analysis identified pain self-efficacy, fear-avoidance beliefs, and 
perceived disability as important constructs in the relationship between chronic pain and 
affective disorders, albeit in different ways. That is, whereas, pain self-efficacy was found to 
have direct links to other constructs in the network model, fear avoidance and perceived 
disability seemed to function more as mediators, linking other constructs in the model. 
Perceived control and anxiety were found to be less influential in the model. This study was 
exploratory and showed that various pain-related cognitions play a significant role in the 
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experience of pain and co-morbid psychopathology. However, due to the limitation of cross 
sectional research, replication of these findings using a longitudinal design is needed to 
strengthen these results.  
 
As an extension of the systematic review and Study Two, Study Three utilised a longitudinal 
prospective design to evaluate how the measurement timing and change in a combination of 
pain-related cognitions and psychological factors predict adherence post-treatment. 
Participants were 61 chronic pain patients aged 31-72 years old who had completed a 
multidisciplinary pain management program between 2014 and 2016. Self-report measures 
were collected at pre-program, program discharge, and 3-6 months post-program. 
Correlation, moderation and hierarchical regression were used to statistically analyse the 
data. Study Three results revealed pain self-efficacy (at both pre- and post-program) to be the 
only predictor variable to positively correlate with treatment adherence. Moderation analysis 
revealed that change in anxiety was the only variable to moderate the main effects of a 
proposed risk factor on treatment adherence. Finally, hierarchical regression showed that 
depression and fear-avoidance beliefs (both at post-intervention) were unique positive 
predictors of treatment adherence maintenance. Based on these longitudinal findings, 
depression and fear-avoidance were shown to be important for post-program adherence to 
treatment recommendations. However, larger samples of participants and more objective 
measures of treatment adherence are recommended for future research to better clarify the 
predictive value of these variables for self-maintenance behaviour following intervention.  
Together, these three studies highlight that various specific psychological factors contribute 
to the experience of chronic pain and treatment adherence. This research has important 
clinical implications, highlighting the importance of psychological factors on chronic pain 
outcomes and the need for patients to be more thoroughly screened for at-risk levels of these 
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factors pre- and post-intervention. Based on the collective findings of these studies, 
psychological interventions based on reducing fear-avoidance, depression and anxiety whilst 
also strengthening pain self-efficacy would be helpful to chronic pain patients and may 
improve treatment outcomes in Australia. 
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Chapter 1 
 
Introduction 
 
Chronic pain is a highly prevalent and debilitating health problem, affecting millions 
of people around the world (Goldberg & McGee, 2011). The concept of chronic pain is 
complex, consisting of a heterogeneous group of pain states with varying degrees of severity, 
physiological distribution, and functional impact (McBeth & Jones, 2007). Disability 
associated with chronic pain can influence all aspects of a person’s functioning, including 
emotional, interpersonal, vocational, as well as physical functioning (Plesh, Adams & 
Gansky, 2011). These aspects of functional impairment may be measured in terms of an 
individual’s ability to work, level of mobility and independence, emotional distress and 
degree of social isolation, among other measures (Plesh et al., 2011). Therefore, successfully 
treating pain patients requires attention not only to the biological basis of the symptoms but 
also to the range of psychosocial factors that moderate the pain experience and related 
disability (Gatchel, Peng, Peters, Fuchs & Turk, 2007). For these reasons, the 
biopsychosocial model has become the most widely used theoretical model to understand the 
complexity of risk and protective factors associated with chronic pain and related disability 
(Kamper et al., 2015; Gatchel, McGeary, McGeary & Lippe, 2014). Early identification of 
biopsychosocial factors not only reveals chronic pain patients at risk of poorer outcomes, but 
also point to the areas in which such interventions may be employed. 
The development of a more holistic approach to chronic pain management has seen 
psychosocial factors, including emotions, beliefs, attitudes, and expectations become 
increasingly recognised for their impact on chronic pain outcomes. As such, interventions 
based on a biopsychosocial model of chronic pain have largely become best practice for 
effective chronic pain management (Kamper et al., 2015). For example, Multidisciplinary 
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Pain Rehabilitation Programs (MPRPs), have gained considerable momentum in the past 
decade. MPRPs aim to reduce distress and disability in patients with chronic pain by 
improving functional capacity whilst concomitantly attempting to reduce the impact of 
psychosocial factors (Kaiser, Arnold, Pfingsten, Nagel, Lutz & Sabatowski, 2013). Several 
studies reflect the success of MPRPs (Fedoroff, Blackwell & Speed, 2014; Oslund et al., 
2009). However, more randomised controlled trials are needed to further establish the 
effectiveness of multidisciplinary methods of pain management (Kamper et al., 2015). With 
the addition of more evidence-based research, MPRPs provide a promising and 
comprehensive treatment approach for chronic pain sufferers. 
 The role of psychosocial factors (such as cognitive and psychological factors) in 
predicting poor outcomes among chronic pain patients is well documented (Jensen, Moore, 
Bockow, Ehde & Engel, 2011; Gatchel et al., 2007). Pain-related cognitions that have been 
found to impede chronic pain and recovery include low pain self-efficacy (Costa, Maher, 
McAuley, Hancock & Smeets, 2011), fear-avoidance beliefs (Crombez, Eccleston, Van 
Damme, Vlaeyen & Karoly, 2012), high catastrophising (Richardson et al., 2009), 
expectation of solicitousness (Cano, Barterian & Heller, 2008), belief in medical cure 
(Nicklas, Dunbar & Wild., 2010), low control beliefs (Baker, Buchanan & Corson, 2008), 
and perceived disability (Alschuler, Theisen-Goodvich, Haig & Geisser, 2008). 
Psychological disorders such as depression and anxiety are also frequently associated with 
poorer treatment outcomes (Gormsen, Rosenberg, Bach & Jensen, 2010). However, unlike 
other predictors (e.g., demographic variables) of pain-related disability that have been 
considered in previous research, psychosocial factors are amenable to change (Yazdi-Ravandi 
et al., 2013). Therefore, research in this area may assist in the development of psychological 
and cognitive interventions for chronic pain populations as a whole, as well as targeted 
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interventions for chronic pain populations with a higher risk of poor disability and treatment 
outcomes.  
Various measures of pain-related disability (e.g., return to work, pain intensity) have 
received considerable attention throughout the literature over the past decade (Wicksell, 
Lekander, Sorjonen & Olsson, 2010; Boonstra, Preuper, Reneman, Posthumus & Stewart, 
2008). However, certain treatment-related outcomes, particularly treatment adherence, have 
received less focus. There exists ample research examining pain-related outcomes at the 
discharge (i.e., completion of a pain management programme) phase of pain management 
(Pereira et al., 2014; Kristjánsdóttir et al., 2013). However, exploration of the factors 
impacting adherence behaviour post-treatment (i.e., 3months+) remains under investigated. 
Adherence to treatment recommendations is important to reduce pain-related disability 
(Nicholas et al., 2012). In order to maintain and, in some cases, further improve pain 
symptoms following intervention, individuals are required to adopt prescribed self-
management behaviours. However, as illustrated in the broader literature, post-treatment non-
adherence to strategies recommended for effective pain management is not uncommon 
(Coppack, Kristensen & Karaheorghis, 2012; Jack McLean, Moffett & Gardiner, 2010). 
Consequently, non-adherent individuals are often faced with the re-emergence and, in some 
cases, exacerbation of pain symptoms, resulting in pain program re-admissions and 
associated healthcare burden (Nicholas et al., 2012). Further research examining what 
specific factors predict post-treatment non-adherence are important for preventing relapse and 
ongoing disability. 
On top of this is the added complexity that the interrelationships between 
psychosocial factors may have on post-treatment adherence behaviour (Roditi & Robinson, 
2011). There are several unhelpful cognitions and psychological disorders that can interact in 
different ways among individuals with chronic pain, potentially worsening pain and disability 
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making it more difficult for individuals to maintain self-management strategies (Dobkin et 
al., 2010). Research suggests that the more maladaptive cognitions and psychological 
disorders that exist among chronic pain patients (and the greater the interactions between 
them), the less likely that individuals will successfully adhere to recommended strategies 
post-treatment (Kamper et al., 2015). However, past research that has considered the impact 
of psychosocial aspects on post-treatment adherence among chronic pain patients has been 
narrowly focused; with adherence to pharmacological treatment receiving much of the 
literary attention (Nicklas et al., 2010; Manchikanti, Atluri, Trescot & Giordano, 2008). For 
these reasons, it is suggested that a more integrated investigation of the multiple influencing 
factors and their interactions will enable for further improvements in multidisciplinary 
chronic pain intervention and post-treatment outcomes.  
This review will discuss the problem of chronic pain, including its prevalence, causes, 
and pain locations, as well as the sequelae of unhelpful pain-related cognitions and 
psychopathology on treatment adherence outcomes. There will be a specific focus on 
psychosocial problems, including pain-related cognitions and co-morbid psychopathology on 
chronic pain outcomes, particularly post-treatment adherence. Research that has examined the 
role of psychological and cognitive variables in explaining treatment adherence among 
chronic pain patients will be discussed. Finally, a research approach is proposed that aims to 
investigate the role of multiple factors, including various pain-related cognitions and co-
morbid psychopathology in predicting post-treatment adherence among a sample of 
Australian chronic pain patients. 
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1.1 Chronic Pain: An Overview 
1.1.1 Definitions 
Many definitions have been proposed to explain the subjective experience of pain. 
The most commonly cited definition, from the International Association for the Study of 
Pain, explains pain as “an unpleasant sensory and emotional experience associated with 
actual or perceived tissue damage” (Merskey & Bogduk, 1994, pg.1). Pain can be usefully 
divided into two subtypes; acute pain and chronic pain (Neville, Peleg, Singer, Sherf & 
Shvartzman, 2008). Acute pain begins suddenly and is usually sharp in quality. It is often 
experienced after trauma or surgery and produces a normal response to tissue damage. In 
most cases, acute pain is short-lived (i.e. days to weeks), and is likely to disappear when the 
underlying cause of pain has healed or been treated (Harris, 2011). However, if acute pain 
remains unrelieved, progressive and long-lasting (i.e. months or years) chronic pain may 
develop. Chronic pain is defined as pain with duration of greater than three months (Loeser & 
Treede, 2008) in which continuous and recurrent pain experiences commonly persist beyond 
normally expected healing (Neville et al., 2008). In these cases, ‘pain signals’ remain active 
in the nervous system for long periods of time causing severe disability. A further distinction 
involves nociceptive and neuropathic pain. Nociceptive pain is usually time-limited, meaning 
that when the tissue damage heals, the pain typically resolves (with the exception of arthritis; 
Loeser & Treede, 2008). Examples of nociceptive pain include sprains, bone fractures and 
inflammation obstructions such as arthritis. Neuropathic pain, on the other hand, is caused by 
a lesion or dysfunction of the peripheral or central nervous system (e.g., phantom limb pain). 
It is generally chronic and disabling, and is among the most challenging to treat (Jensen et al., 
2011).   
Despite the general acceptance of the above definitions, they contain several aspects 
that complicate the study of the epidemiology of pain (Casey, Greenberg, Nicassio, Harpin & 
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Hubbard, 2008).  Referring to ‘actual or perceived tissue damage’, excludes the possibility of 
a decisive and objective test to clarify the existence of pain. Similarly, ‘unpleasant sensory 
and emotional experiences’ emphasise the subjectivity associated with pain. In addition to 
these ambiguities are the complications associated with the classification of acute and chronic 
pain. Both acute and chronic pain involve a combination of physiological, psychological and 
behavioural mechanisms (Gatchel et al., 2014). The complexity of pain is illustrated by 
Loeser’s (1982) model of the components of pain (see Figure 1).   
 
                                             
 
Figure 1. Loeser’s Model of the Components of Pain 
 
In this model, the physical origin of pain is considered to be at the core and the pain 
experience, suffering, and pain behaviour are considered to be the surrounding layers. These 
layers are determined not only by the pain experience, but also by other factors such as 
cultural values and reinforcing factors. In line with this model, acute pain has a directive link 
between nociception, pain, suffering, and pain behaviour. However, in chronic pain a 
directive link with a nociceptive substrate is not always present. That is, chronic pain often 
occurs in the absence of tissue damage and develops long after a noxious stimulus has 
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stopped exerting an effect (Casey et al. 2008). In the absence of such a link, chronic benign 
pain (i.e. also known as idiopathic or somatoform pain) is determined (Neville et al., 2008). 
Both idiopathic and somatoform pain are considered psychiatric categories in the third edition 
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III; Fishbain, Goldberg, 
Meagher, Steele & Rosomoff, 1986). In the fourth edition (DSM-IV), chronic pain without an 
organic explanation is categorised as Chronic Pain Disorder Associated with Psychological 
Factors (Hiller, Heuser & Fichter, 2000). With the development of a new edition, the DSM-V 
adopts a more biopsychosocial perspective of chronic pain, replacing previous criteria for 
Somatic Symptom Disorder (Dimsdale et al., 2013). In line with Loeser’s (1982) multiple 
components of pain, new research is aimed at identifying the integrated biological, 
psychological, and social causes of and contributors to chronic pain problems.      
1.1.2 Prevalence 
Population studies have revealed the prevalence of chronic pain to be a worldwide 
physical and mental health care problem (Elzahaf, Tashani, Unsworth & Johnson, 2012). 
Although there are few estimates of the incidence of global chronic pain, the World Health 
Organisation (WHO) has estimated that as many as 1 in 10 adults are newly diagnosed with 
chronic pain each year (Goldberg & McGee, 2011). Moreover, a recent review of 
epidemiological studies identified chronic pain to occur in 30% (±11.7%) of adults, 
worldwide (Elzahaf et al., 2012). Based on the 2012 National Health Interview Survey 
(NHIS), 25 million adults in the United States reported chronic pain. Of even greater concern, 
Fayaz, Croft, Langford, Donaldson and Jones (2015) found the prevalence of chronic pain in 
the United Kingdom to range from 35% to 51.3% (19 population studies, N = 139,933). 
Chronic pain is also considered to be a significant healthcare problem within Australia, 
however, significantly fewer Australian research data on chronic pain appear to exist 
compared to other developed countries such as the US and UK (Azevedo, Pereira, Mendonca, 
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Dias & Castro-Lopes, 2012; Schopflocher, Taenzer & Jovey, 2011). Upon review of the 
literature, the most recent large Australian population study was conducted nearly two 
decades ago (Blyth, March, Brnabic, Jorm, Williamson & Cousins, 2001). At which time, 
chronic pain was found to occur in one in five Australians; affecting 17.1% of males and 20% 
of females (N = 17,543; Blyth et al., 2001). Another more recent (although, considerably 
smaller) study found chronic pain to occur in 19.2% of Australian general practice patients 
(N = 1,113; Henderson, Harrison, Britt, Bayram & Miller, 2013). The need for current and 
sizeable epidemiological studies identifying the prevalence of chronic pain within Australian 
populations is clearly apparent. Based on more recent data, the global pain market has been 
valued between $560 and $635 billion annually in health care costs and lost productivity 
(Gaskin & Richard, 2012). As these statistics attest, the prevalence and cost of chronic pain is 
a major health care problem; one which is expected to increase over the coming years due to 
an ageing population (Goldberg & McGee, 2011).  
Estimates of gender prevalence have also fuelled a great deal of research on chronic 
pain. There is clear consensus throughout the literature that women report chronic pain more 
frequently than men (Nahin, 2015; van Hecke, Torrance & Smith, 2013; Johannes, Le, Zhou, 
Johnston & Dworkin, 2010), reporting more severe levels of pain (Gatchel et al., 2007), and 
pain of longer duration in comparison to men (van Hecke, Torrance & Smith, 2013). These 
statistics are similar among children, with female paediatric patients more likely to suffer 
chronic pain conditions than males (Goldberg & McGee, 2011). Age is another important 
predictor of poor outcome for sufferers of chronic pain. Although variable, research suggests 
that the prevalence of chronic pain increases after the age of 50 years. This was shown in 
Blyth et al.’s (2001) study which found age prevalence to be highest in the 55-69 year age 
group for males and 80-84 year age group for females. However, as previously stated, 
Australian populations estimates are outdated and in need of revision. Generally speaking, 
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research shows that older adults are often at greater risk of accidental injury and that the 
incidence of injury (e.g., osteoarthritic fractures) is likely to increase with age (Deandrea, 
Lucenteforte, Bravi, Foschi, La Vecchia & Negri, 2010). Based on an accumulation of 
research, older female pain patients and younger male pain patients may be at greater risk of 
pain-related disability. In which case, prevention and treatment intervention targeted 
specifically at these populations are required. 
1.1.3 Summary 
Prevalence estimates have highlighted the significance of chronic pain internationally 
(Elzahaf et al., 2012) and within Australia (Henderson et al., 2013). Although females have 
been shown to experience chronic pain to a greater extent than males (Nahin, 2015), statistics 
of age reveal that males and females may be at greater risk of chronic pain at different 
lifespan stages (Blyth et al., 2001). Awareness of these population trends have contributed to 
an increased concern about chronic pain problems, and suggest that the prevalence of chronic 
pain is at significant risk of escalating unless more effective preventative strategies are 
employed (Goldberg & McGee, 2011). More population-based data, particularly within 
Australia, are needed to more reliably define this burden and the requirements for optimal 
health care planning.  
 
1.2 Chronic Pain Localisations 
Factors such as the location in the body and distribution of chronic pain may help to 
assist in understanding pain-related disability and treatment outcomes (Johannes et al., 2010). 
Chronic pain can present in numerous locations of the body, all of which have a combination 
of general and unique characteristics. The most common types of chronic pain by location are 
musculoskeletal in nature (Dieppe, 2012). Other types of chronic pain include chronic 
migraine (Leistad, Nilsen, Stovner, Westgaard, Rø & Sand, 2008), Complex Regional Pain 
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Syndrome (CRPS; Bruehl, 2015), and chronic abdominal pain (Kaiser, 2012). Each of these 
pain conditions as well as the impact of multiple pain locations and pain intensity will be 
discussed in the following sections.  
1.2.1 Musculoskeletal pain  
Much of the research focus on chronic pain problems has related to musculoskeletal 
pain and the burden it produces (Gore, Sadosky, Stacey, Tai & Leslie, 2012; Juniper, Le & 
Mladsi, 2009). Musculoskeletal conditions are the most common cause of pain in many 
countries. In Australia, there are an estimated 6.1 million (26.9%) cases of chronic 
musculoskeletal pain conditions (Arthritis and Osteoporosis Victoria, 2013). Musculoskeletal 
pain conditions are different in terms of pathophysiology but linked anatomically and by their 
association with pain and impaired physical function (Dieppe, 2012). They include 
inflammatory diseases such as rheumatoid arthritis, osteoporosis, and osteoarthritis as well as 
conditions of uncertain aetiology such as fibromyalgia (i.e., diffuse and widespread pain; 
Ablin, Buskila, Van Houdenhove, Luyten Atzeni, & Sarzi-Puttini, 2012). A large proportion 
of the literature also considers musculoskeletal pain conditions to be commonly related to 
conditions of traumatic injury (Harris, Young, Rae, Jalaludin & Solomon, 2007). These 
include traumatic injuries such as fractures, sprains, strains, dislocations, or lacerations (e.g., 
whiplash injury). And cumulative trauma disorders such as repetitive motion injuries or 
disorders associated with repeated trauma (e.g., Carpal Tunnel Syndrome; Dieppe, 2012). 
One chronic musculoskeletal pain condition that has received considerable research regarding 
its association with traumatic injury is chronic low back pain (CLBP; Juniper et al., 2009; 
Cohen, Argoff & Carragee, 2008). The Global Burden of Disease (Vos et al., 2012) study 
identified CLBP to be more prevalent than any other condition, including major depression, 
diabetes and heart disease. According to previous studies comparing the frequency of 
musculoskeletal impairment in the USA, CLBP was found to be the most frequently reported 
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pain as a result of occupational injury (Franklin, Rahman, Turner, Daniell & Fulton-Kehoe, 
2009). These results suggest considerable pain severity and impairment to be associated with 
CLBP, and that those with worse CLBP associated function are less likely to adhere to 
treatment; making this population at higher risk of poor outcome.     
1.2.2 Migraine 
Persistent migraine is another common cause of chronic pain (Leistad et al., 2008), 
however prevalence estimates vary considerably. The most recent population-based study 
(N=257,339) found chronic migraine prevalence to range between .48% to 1.29% among 
adults, with middle aged women most affected (Buse et al., 2012). It is typically characterised 
by recurrent and extended periods of pulsating pain that occurs for 15 days or more per 
month (Natoli et al., 2009). Chronic migraines are commonly experienced among disabled 
workers and victims of traumatic brain injury (Elbers, Hulst, Cuijpers, Akkermans, & 
Bruinvels, 2012). Chronic migraines often occur in conjunction with or lead to the 
development of other chronic conditions such as musculoskeletal pain (Buse et al., 2012). 
However, the direction of the relationship between migraine and other chronic conditions is 
unclear and is likely to vary according to severity of pain. In these cases, chronic migraine 
may be a risk factor for the development of other chronic pain conditions (Lipton, 2009). 
Perhaps chronic migraine sufferers exhibit more psychosocial features (e.g., depression, 
catastrophising), exacerbating migraine symptoms and thereby, increasing the risk of 
developing other chronic pain conditions. Mental stress has been related to the development 
and maintenance of chronic migraine (Pompili et al., 2010; Leistad et al., 2008).  For 
example, repeated inability to recover from stress may create a vicious cycle resulting in 
chronic pain. These various contributing factors can make chronic migraine difficult to 
manage and treat. Thus, identifying and managing environmental stressors and psychosocial 
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features that may contribute to symptoms of chronic migraine appear to be important 
treatment considerations. 
1.2.3 Complex Regional Pain Syndrome 
Another common chronic pain condition is Complex Regional Pain Syndrome 
(CRPS; Bruehl, 2015). Research suggests that it is most commonly encountered following 
trauma (i.e., surgery, combat) to a limb and is maintained by abnormalities in the nervous 
system (Demir, Özaras, Karamehmetoğlu, Karacan & Aytekin, 2010). Depending on the 
specific features, location, and nature of the pain, CRPS may be defined as one of two 
categories, CRPS I and CRPS II (Bruehl, 2015). CRPS I is characterised by spontaneous or 
evoked pain that is out of proportion to the injury and usually affects the entire distal 
extremity. Pain of this type has no discernible nerve damage present and is often not limited 
to the distribution of any particular nerve. This may cause a delay in proper diagnosis and 
treatment which is likely to have a negative effect on patient outcome. In contrast, CRPS II is 
characterised by severe and unbearably intense pain that occurs in the distribution of the 
injured nerves (Bruehl, 2015). Most cases follow nerve or tissue injury that result from 
fractures, infarctions (i.e., shoulder-hand syndromes), and strokes, with the upper extremity 
more often involved than the lower extremity (Demir et al., 2010). Whilst the aetiology of 
CRPS is largely misunderstood, there is consensus that psychological factors play some role 
in symptomatology. Whereas, some authors suggest that psychological factors play a role in 
the course of CRPS rather than its development (Lohnberg & Altmaier, 2013), others claim 
that the long-lasting symptoms of CRPS result in psychological changes for patients over 
time (Harden et al., 2010). More recent research (Bean, Johnson, Heiss-Dunlop, Lee & Kydd, 
2015) examining the psychological factors involved in the development and course of CRPS 
is helping to uncover more effective treatment pathways and, thus, improve CRPS-related 
outcomes. 
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1.2.4 Abdominal pain 
Chronic abdominal pain has been studied less than other localisations of pain; 
nevertheless, it is a common chronic pain problem. Abdominal pain is thought to occur in 25 
percent of adults, with women significantly more likely to report chronic abdominal pain than 
men (Tolba, Shroll, Kanu & Rizk, 2015). Similar to other pain localisations, the cause and 
pathogenesis of chronic abdominal pain is undoubtedly multifactorial. That is, interactions of 
organic, psychological and psychosocial factors are considered essential in the development 
of chronic abdominal pain (Berger, Gieteling & Benninga, 2007). There is a wide range of 
variation in biological markers potentially responsible for the onset of this particular pain 
problem (e.g., inflammatory bowel disease, irritable bowel syndrome, appendicitis). 
However, individuals with abdominal pain commonly present with an unknown underlying 
cause for their pain and, therefore, are classified as having functional abdominal pain (FAP; 
Stinson & Bruce, 2009). By exclusion of an organic aetiology, chronic pain cases are often 
assumed to be somatoform (i.e., psychological) in nature (Sperber & Drossman, 2011). 
Psychological risk factors shown to predict FAP include fatigue, psychological distress, 
health anxiety and illness behaviour (Koloski, Jones, Kalantar, Weltman, Zaguirre & Talley, 
2012). The rate of work absenteeism and healthcare visits are also found to be increased 
among FAP patients (Sperber & Drossman, 2011). Further exploration of the psychosocial 
predictors of chronic abdominal pain may be useful to enhance aetiological understanding 
and important areas for targeted intervention. 
1.2.5 Multiple pain locations 
An additional predictor of poor outcome involves chronic pain that occurs at multiple 
sites (Carnes et al., 2007).  The results of a recent cross-sectional population-based study 
found multi-site pain (pain in >1 region, 33.3% of N=2,953) to be associated with reductions 
in work ability and health-related quality of life (Rathleff, Roos, Olesen & Rasmussen, 2013). 
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Interestingly, most available population-based studies have focused on a single anatomical 
site, with little research highlighting the effects of multiple pain locations. However, as many 
authors have observed, localised chronic pain is less common than multi-site (Solidaki et al., 
2010; Carnes et al., 2007) or widespread chronic pain (i.e., fibromyalgia; Kindler, Jones, 
Perrin & Bennett, 2010). And by focusing on single site pain, a distorted image of the 
distribution and nature of chronic pain may result. Consequently, pain patients may be 
mismanaged, funds and other resources may be allocated inappropriately, and other important 
factors that predict a poor overall patient outcome may be disregarded (Kamaleri, Natvig, 
Ihlebaek & Bruusgaard, 2008). According to these findings, pain problems should not be 
considered in isolation, instead, a whole-patient approach should be targeted. For these 
reasons healthcare intervention now place an emphasis on multiple-site pain and current 
research has developed a focus toward poor outcome predictors associated with multiple pain 
locations (Turk, Wilson & Cahana, 2011; Graven-Nielsen & Arendt-Nielsen, 2010). 
1.2.6 Pain Intensity and suffering 
In addition to assessing for multiple locations of pain, current conceptualisations of 
chronic pain management also argue the importance of assessing subjective pain intensity 
among patients (Dworkin et al., 2009). Despite its variability (potentially changing from one 
moment to the next), pain intensity is the most frequently used measure of chronic pain in 
both clinical work and treatment outcome research. The predictive value of pain intensity or 
interference has been reported in previous literature (Hjermstad et al., 2011). However, more 
recent research appears to be governing a shift from the use of pain intensity as an outcome 
measure, instead, focusing on reductions in the overall (i.e., biopsychosocial) suffering of 
chronic pain (Ballantyne & Sullivan, 2015; Fishbain, Lewis & Gao, 2015). This is based on 
the premise that the suffering associated with chronic pain may be related as much, if not 
more, to the meaning attributed to pain as to the level of pain intensity (Lamé, Peters, 
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Vlaeyen, Kleef & Patijn, 2005). For example, whereas, acute pain may be associated with 
less suffering if one perceives the pain to be finite and necessary to achieve some goal (e.g., 
healing from surgery, delivering a baby), persistent pain may involve more suffering and 
greater pain levels if one perceives their condition as hopeless and/or helpless (Ballantyne & 
Sullivan, 2015). For this reason, current multidisciplinary intervention aims to primarily 
reduce pain suffering and secondarily reduce pain intensity by acknowledging the several 
factors (e.g., multiple locations of pain, co-morbid psychopathology, maladaptive cognitions 
and other environmental factors) shown to consequently influence the chronic pain 
experience (Fedoroff, Blackwell & Speed, 2014; Parr et al., 2012). Despite these advances, it 
is important not to disregard the need for pain intensity ratings and their ability to help 
clinicians to better understand individual experiences of pain. Identifying patients at risk of 
potentially higher levels of pain intensity is important for several reasons. Firstly, 
understanding a patient’s perceived level of pain at any point in time may assist clinicians in 
choosing appropriate treatments. Secondly, pain intensity reported at different stages of 
treatment (i.e., pre-post treatment) may help to elucidate whether any improvements in 
chronic pain have been made over time (Hjemstad et al., 2011). For these reasons, obtaining 
self-report measures of pain intensity in addition to measuring biopsychosocial factors and 
their impact on pain suffering appears to reflect both clinical and theoretical relevance.   
1.2.7 Summary 
Several chronic pain conditions are found to occur, the most common presentation 
shown to be musculoskeletal in nature (Gore et al., 2012). The incidence and complexity of 
these chronic pain conditions is likely due to a combination of biological, psychological and 
social demands (Shaw, Main & Johnston, 2011). Identification of the biopsychosocial 
features that may be contributing to the suffering and intensity of chronic pain are, therefore, 
important treatment considerations. 
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1.3 The Biopsychosocial Model 
Chronic pain is likely to be influenced by multiple factors. To fully understand an 
individual’s pain experience, the interrelationships between these factors need to be 
considered (Gatchel et al., 2007). Previously, the biomedical model of pain was adopted; 
however, this approach offered merely sensory explanations for all pain experiences. 
Through the development of research, a one-dimensional perspective used to address the 
complexity of chronic pain problems was found to be inadequate (Innes, 2005). More recent 
research has led to a greater understanding that treatment of people with chronic pain requires 
attention not only to the biological basis of the symptoms, but also to the range of 
psychosocial factors that modulate nociception and moderate pain and disability (Kamper et 
al., 2015). With an integrated perspective of chronic pain, the biopsychosocial model 
incorporates biological (i.e. physical aspects of pain), psychological (i.e. mental, emotional, 
and behavioural aspects of pain), and social (i.e. social interactions, environmental context, 
and cultural background) factors associated with the pain experience (Gatchel et al., 2007). 
Consequently, the biopsychosocial model has become the most widely accepted heuristic 
perspective used to understand and treat chronic pain problems (Driscoll & Kerns, 2016; 
Gatchel et al., 2014). Figure 2 shows Engel’s (1980) Biopsychosocial Model of Chronic Pain 
which illustrates how the biological, psychological and social interactions are involved in the 
chronic pain experience.  
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Figure 2. Engel’s Biopsychosocial Model of Chronic Pain 
 
According to this model, it is important that the interrelationships between these 
factors be viewed in collaboration of one another and simultaneously addressed when treating 
chronic pain problems (Driscoll & Kerns, 2016). For example, there is often a distinct 
interrelationship between psychological and social factors (i.e. psychosocial factors) which 
include elements of both emotion and cognition. In these cases, emotions are considered to be 
the more immediate reactions to nociception. Cognitions then attach meaning to the 
emotional experience, subsequently triggering additional emotional reactions and thus, 
amplifying the experience of pain (Meziat Filho, 2016; Turk, Fillingim, Ohrbach & Patel, 
2016). Therefore, psychosocial factors are thought to have the greatest influence on the 
development and duration of chronic pain symptoms and associated disability (Turk et al., 
2016). Insight into the effects of psychosocial interrelationships may help to prevent or more 
appropriately manage vicious pain cycles (i.e., recurrent nociception, pain, distress) and the 
disability that ensues.  
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1.4 Pain-related disability 
Chronic pain results in varying forms and degrees of functional disability (Verkerk et 
al., 2013). Functional disability is highly subjective and may present as impairment in 
multiple ways; physically (e.g., muscle tension, limited mobility, insomnia), psychologically 
(e.g., depression, anxiety, fear of re-injury), and socio-economically (e.g., work absenteeism, 
social isolation, reduced independence; Plesh et al., 2011). As such, pain-related disability 
can present very differently, with individuals not appearing disabled in all circumstances. To 
illustrate the varying nature of functional disability associated with chronic pain, consider the 
following examples. One individual may be unable to tolerate specific jobs with high stress 
levels due to the psychological disability associated with their chronic pain condition, 
however, may present with minimal physical limitation. Another individual may experience 
difficulty in performing specific or prolonged repetitive activities as a result of physical pain-
related disability, however, copes with pain well psychologically. Furthermore, it is not 
uncommon for pain sufferers to present with multiple facets of disability (e.g., limited 
mobility, depression, work absenteeism), the complexity of these facets likely to increase the 
longer in duration pain problems remain poorly managed (Verkerk et al., 2013). Björnsdóttir, 
Jónsson and Valdimarsdóttir (2013) found chronic pain respondents (n=1292) had reduced 
mobility in the form of being unable to lift or carry groceries (53%), bend, stoop, or kneel 
(57.3%), or climb several flights of stairs (62.9%), compared to their pain-free counterparts. 
Psychosocial variations of functional disability are also common and can involve challenges 
for pain sufferers in maintaining social relationships, for example. As these findings attest, 
the potential widespread and multifactorial impact of chronic pain is considerable. Therefore, 
it is important to consider the functional implications of chronic pain problems at an 
individual level and target intervention accordingly.  
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1.5 Intervention and adherence 
1.5.1 Chronic pain management 
Given the profound consequences that can stem from serious chronic pain problems, 
the primary goal of healthcare is to enable sufferers to maximise functional ability and 
improve quality of life (Verkerk et al., 2013). To achieve this, chronic pain management 
incorporates a multimodal (i.e., physiotherapy, psychology, occupational therapy) method of 
rehabilitation which incorporates a combination of self, primary and specialty care (Stanos, 
2012). Self-management enhancing interventions that focus on the biopsychosocial predictors 
of functional disability have been found to improve outcomes in patients with chronic pain 
(Ghadyani, Tavafian, Kazemnejad & Wagner, 2017; Koele, Volker, van Vree, van Grestel, 
Köke & Vliet Vlieland, 2014). That is, the foundation for multidisciplinary pain rehabilitation 
programs (MPRPs) stem from a biopsychosocial perspective and aim to reduce disability and 
distress through cognitive-behavioural intervention (Linton & Shaw, 2011). Although 
MPRPs do not aim to ‘cure’ chronic pain conditions, they intend to achieve reduced pain-
related disability that allow the individual to return to their normal activities. These programs, 
therefore, hypothesise that changes in cognitive and psychological factors mediate reductions 
in functional disability (Koele et al., 2014). This is achieved by including multiple 
components of various therapies to address all aspects of chronic pain. In other words, the 
provision of physical, psychological, behavioural, and educational interventions are 
combined in an attempt to offset the barriers associated with delayed recovery and ongoing 
chronic pain problems (Nicholas et al., 2011).  
Research has shown MPRPs to have led to substantial improvement in important 
socio-economic outcome measures (e.g. return-to-work) in people with chronic pain 
problems (Verkerk et al., 2015). Heiskanen, Roine and Kalso (2012) also found significant 
improvements in health-related quality of life among chronic pain patients treated at a 
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multidisciplinary pain clinic. Moreover, a recent Cochrane systematic review and meta-
analysis (Kamper et al., 2015) found multidisciplinary biopsychosocial rehabilitation to be 
more effective than individual treatments in reducing pain-related disability among CLBP 
sufferers (N=6,858). Of the 41 randomised controlled trials included in the review, 16 trials 
provided moderate quality evidence in support of multidisciplinary intervention for reducing 
pain and associated disability. Overall, the literature strengthens the case for multidisciplinary 
intervention, providing substantial evidence for the long-term effectiveness of this treatment 
approach for effective chronic pain management (Kamper et al., 2015; Steiner et al., 2013; 
Oslund et al., 2009).  
1.5.2 Treatment adherence 
Despite the known benefits of a more comprehensive approach for chronic pain 
management, the effectiveness of multidisciplinary intervention is dependent on individuals 
successfully adhering to their prescribed treatment regimens. The World Health Organisation 
(2003, pg. 3) defines adherence as ‘the extent to which a person’s behaviour (i.e., taking 
medication, following a diet or exercise plan, and/or executing lifestyle change), corresponds 
with recommendations from a health care professional (HCP)’. Following this definition, 
measurement of adherence varies depending on the nature of the treatment recommended by 
the HCP (e.g., attendance to supervised sessions and/or assessment of unsupervised home-
based activities; Nicholas et al., 2012). Adherence to treatment recommendations is essential 
to reduce disability outcomes associated with chronic pain such as restricted mobility, 
reduced working capacity and co-morbid psycho-pathology (Dobkin et al., 2010). 
Particularly important is what happens after treatment. Unfortunately, treatment 
recommendations are not always adhered to after the completion of an intervention, and 
patients may experience exacerbated pain symptoms as a result (Kamper et al., 2015).  
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Poor adherence to post-treatment recommendations is a complex problem, especially 
for chronic pain affected individuals who, in response to persistent pain, are often faced with 
various complex physical and psychological challenges (Dobkin et al., 2010). It is clear that 
achieving and maintaining adherence to prescribed multidisciplinary regimens is important; 
however, various barriers to adherence appear to exist, thus, compromising the benefit of pain 
management (Palazzo et al., 2016). The results of a systematic review conducted by Jack et 
al. (2010) identified several factors such as low self-efficacy (6 trials, N=1,296), depression 
(4 trials, N=1,367), anxiety (2 trials, N=159), and poor social support (6 trials, N=2,286) as 
barriers to poor post-treatment adherence among people with chronic pain. Many other 
studies highlight the importance of patient characteristics including unhelpful cognitive and 
psychological factors as predictors of treatment non-adherence (Thompson, Broadbent, 
Bertino & Staiger, 2016). Chronic pain intensity (Stern, Sánchez-Magro & Rull, 2011), 
characteristics of the treatment regimen, and the relationship between healthcare provider and 
patient (Escolar-Reina et al., 2010) among various other factors (Cheatle, Comer, Wunsch, 
Skoufalos & Reddy, 2014; Zuccaro et al., 2012), have also been examined in the literature for 
their predictive value on treatment adherence.   
The impact of poor post-treatment adherence is extensive; not only impairing 
patient’s quality of life but also contributing to the growing prevalence and economic burden 
of chronic pain problems on the public health system (Palazzo et al., 2016). Therefore, 
additional research aimed at further understanding what factors contribute to treatment non-
adherence among chronic pain patients is crucial. Improved knowledge in this area will 
enable for the development of more effective adherence-enhancing interventions, ideally 
resulting in less re-admissions into rehabilitative pain programmes. Not surprisingly, the 
majority of previous research on this topic to date focuses on adherence to pain medication 
alone (Zuccaro et al., 2012; Nicklas et al., 2010; Manchikanti et al., 2008); however, a shift in 
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the conceptualisation and treatment of chronic pain as biological to biopsychosocial calls for 
broader examination of factors affecting treatment outcomes. For these reasons, examination 
of adherence in response to multidisciplinary intervention is gaining momentum in current 
literature (Thompson et al., 2016). Research aimed at further understanding the modifiable 
psychosocial factors known to contribute to poor post-treatment adherence is essential to 
bolster long-term self-management and improve overall functioning for chronic pain patients. 
Not covered in this thesis, however, also an area for future research, involves further 
investigation of other modifiable clinician factors (e.g., communication, level of education) 
residing in the client that are shown to predict treatment outcome.  
1.5.3 Summary 
Several aspects of individuals’ physical, emotional, familial, and social functioning 
are often affected by chronic pain. Consequently, MPRPs have proliferated and the 
integration of cognitive and psychological, as well as biological factors are seen as important 
measures of outcome in the treatment of chronic pain problems (Verkerk et al., 2015; Linton 
& Shaw, 2011). Despite their effectiveness, problems relating to post-treatment adherence 
remain. Several predictors of poor post-treatment adherence have been highlighted (e.g. 
Thompson et al., 2016); however, research aimed at better understanding the modifiable 
psychosocial factors affecting adherence to pain management is important to maximise 
treatment gains and prevent pain-related disability.  
 
1.6 Psychosocial factors influencing chronic pain and treatment adherence 
1.6.1 Pain-related cognitions 
As shown, the biopsychosocial model hypothesises an important role for psychosocial 
responses in the adjustment to chronic pain (Gatchel et al., 2007). Included in these 
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psychosocial responses may be a number of beliefs that a patient holds regarding their 
condition, potentially impacting their adjustment and functional ability in various ways 
(Jensen et al., 2011). Ideally, these cognitive processes help to provide a framework for 
interpreting incoming pain signals in a healthy and adaptive way. However, in response to 
stress, it is common for patients to demonstrate cognitive patterns that skew their perception 
of pain, affecting their ability to cope (Järemo, Arman, Gerdle, Larsson & Gottberg, 2017). 
Independent of medical diagnosis, pain location, or severity of pain, personal evaluations of 
pain and one’s ability to cope with pain are pivotal in determining disability and treatment 
outcomes (Menezes Costa et al., 2011). Unhelpful psychosocial factors may also present a 
problem for treatment adherence; hindering patients’ ability to perform and maintain 
recommended treatment strategies (Kamper et al., 2015). As a result, individuals with 
maladaptive cognitions and coping may be at greater risk of non-adherence related 
consequences such as ongoing impaired functioning. However, given that pain-related 
cognitions are potentially modifiable (Yazdi-Ravandi et al., 2013), approaches that focus on 
improving them may hold promise for reducing adverse outcomes among chronic pain 
populations.  
1.6.1.1 Pain self-efficacy 
Based on the theory of social learning, self-efficacy describes the confidence an 
individual has in his or her own ability to achieve a desired outcome (Bandura, 1977). 
According to this theory, such beliefs significantly influence the initiation and persistence of 
behaviour. In this way, self-efficacy beliefs may help to determine an individual’s adjustment 
to chronic pain. In particular, efficacy expectations with regard to pain control, pain coping, 
and daily functioning may help to determine one's ability to self-manage pain (Menezes 
Costa et al., 2011). Low pain self-efficacy is characterised by a feeling that pain is 
uncontrollable and unmanageable, given the physical demands of daily life (Linton & Shaw, 
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2011). On the other hand, higher levels of pain self-efficacy have been found to be associated 
with lower levels of pain and disability in patients with chronic pain (Menezes Costa et al., 
2011). Furthermore, individuals with strong pain self-efficacy beliefs may be better capable 
of persisting at efforts to manage pain using a variety of pain coping strategies. This is 
illustrated in Jackson, Wang, Wang and Fan’s (2014) study examining the relationships 
between pain self-efficacy beliefs and the outcome of behavioural pain treatment programs. 
They found that patients with higher levels of pain self-efficacy reported less intense pain, 
less daily interference due to pain, greater perceived life control, less emotional distress, and 
higher activity levels than patients with lower levels of pain self-efficacy. Based on these and 
other similar findings (e.g. Skidmore, Koenig, Dyson, Kupper, Garner & Keller, 2015), 
patients who believe that they can cope with and control pain symptoms are shown to be less 
likely to develop feelings of depression, experience less severe pain and fewer activity 
limitations.   
Self-efficacy is also likely to have implications for how other pain-related beliefs are 
interpreted. That is, by improving pain self-efficacy, the reliance on medication and 
assistance from other people may be reduced, there may be improvements in the individual’s 
perception of pain and disability (Keedy, Keffala, Altmaier & Chen, 2014), and individual’s 
may be less likely to engage in catastrophising and fear-avoidance beliefs (Menezes Costa et 
al., 2011). The presence of such relationships are based on the findings from a number of 
correlational studies that have shown that pain self-efficacy levels are statistically significant 
predictors of functioning (Schulz et al., 2015; Rooij et al., 2011). For example, Menezes 
Costa et al. (2011) found pain self-efficacy to be a significant predictor of fear-avoidance 
beliefs, whereby, high pain self-efficacy levels significantly reduced the likelihood that 
patients would engage in fear-avoidance beliefs and behaviours. The overlap between pain 
self-efficacy and other cognitive factors is encouraging and supports the importance of self-
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efficacy, either directly or indirectly (e.g., via improved education and understanding of the 
biopsychosocial contributors), on chronic pain.    
The effects of pain self-efficacy on treatment adherence are also well documented 
(Coppack et al., 2012; Nicholas et al., 2012; Dobkin et al., 2010). In a systematic review 
conducted by Jack et al. (2010), low self-efficacy was found to be a significant barrier to 
treatment adherence (6 trials, N=1,296). Similarly, Krein, Heisler, Piette, Butchart and Kerr 
(2007) found self-efficacy to play an important intervening role among older patients’ ability 
to self-manage chronic pain. That is, higher self-efficacy was found to reduce the association 
between chronic pain and reported difficulty performing pain management techniques. It 
makes sense that poor self-confidence may limit an individual’s ability to overcome obstacles 
required to initiate and maintain pain management strategies. Therefore, treatment of chronic 
pain that focuses on enhancing pain self-efficacy beliefs is important to improve confidence 
in one’s ability to continue to perform the necessary prescribed strategies for pain 
management, post-treatment. However, to the author’s knowledge, the effectiveness of 
changing various pain-related cognitions, including pain self-efficacy, during treatment, as 
well as the impact of the interactions between pain-related cognitions on post-treatment 
adherence specifically have not been explored. 
1.6.1.2 Expectation of solicitousness 
In addition to maladaptive beliefs concerning medical cure, patients may also 
manifest unhelpful beliefs that other people are responsible for assisting them when they are 
in pain (Mohammadi, Dehghani, Sanderman & Hagdoorn, 2017). Patients believing this may 
seek assistance and obtain reinforcement for pain behaviours, thereby, limiting their 
opportunities to acquire and practice behaviours incompatible with pain (Molton, Stoelb, 
Jensen, Ehde, Raichle & Cardenas, 2009). Known as solicitous responding (i.e., offering 
sympathy and assistance, or taking over a task in response to a patient’s pain behaviours), 
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these beliefs have been linked to greater pain intensity and interference, increased pain 
behaviours, depression, and disability (McWilliams, Edmonton, Higgins, Dick & Verrier, 
2014). Although social relationships and support play important roles in the experience and 
expression of pain-related disability, not all types of support are beneficial. Solicitous 
responses from others, while well-intentioned, tend to reinforce pain and disability 
behaviours in patients and may unintentionally impede their progress. This is illustrated by 
Jensen, Turner, and Romano (2007) study who found an association between solicitous 
responses to patient pain behaviours and patient dysfunction. By asking significant others for 
more assistance and receiving solicitous responses from family and friends following 
treatment, patients were more likely to experience worsening disability over time. On the 
other hand, responses provided unconditionally (i.e., not contingent on pain behaviour) were 
more likely to result in adaptive patient behaviours, not pain or disability focused.  
Increased solicitousness from others is a likely contributing factor to treatment non-
adherence. That is, if others continue to aid in achieving certain activities of daily living (e.g., 
household chores, shopping), patients may not realise the need or importance to perform 
these activities for themselves, and thus, pain management strategies aimed at improving 
disability and function may not be prioritised (Mohammadi et al., 2017). This is shown 
among paediatric chronic pain patients, whereby, solicitous parenting behaviours were found 
to be associated with a greater likelihood of poor treatment participation and drop-out (Carter 
& Threlkeld, 2012). Research that explores the impact of solicitousness on treatment 
adherence within an adult chronic pain population would be beneficial. Moreover, 
intervention identifying what factors maintain solicitous responding from others whilst 
providing patients with active self-management strategies to reduce the reliance on other 
people to assist with pain is needed. Potential factors contributing to increased solicitousness 
may include other pain-related cognitions such as poor pain self-efficacy (Molton et al., 
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2010). After review of the literature, further research is needed to more clearly establish 
whether associations between pain-related cognitions (and other risk factors) and treatment 
adherence exist. This knowledge will assist to advance rehabilitative practices whilst likely 
reducing the risk of non-adherence and subsequent program re-admissions.  
1.6.1.3 Perceived disability  
The degree to which a patient believes that they are disabled by their pain, is another 
powerful factor in the extent of their functional impairment (Glombiewski, Hartwish-Tersek 
& Rief, 2010). A direct influence of such beliefs on behaviour and disability is seen in 
patients who perceive themselves as more disabled, whereby, submaximal effort and lower 
levels of function are often displayed (Luk et al., 2010). The opposite may also apply; pain 
sufferers who suffer considerable functional impairment may consequently exhibit greater 
perceptions of disability. The more disabled individuals perceive themselves to be, the less 
likely that they will demonstrate maximal effort in performing prescribed self-management 
strategies. Less proactive engagement in chronic pain management, in turn, may affect a 
broader sense of biopsychosocial functioning; adversely impacting activities of daily living 
(i.e., work, independent self-care, socialisation) and psychological wellbeing (Wong, Chow, 
Chen, Wong & Fielding, 2015). Consequently, psychological features such as depressive 
symptoms may be more likely to co-occur among individuals who perceive themselves as 
more disabled and adversely affected by pain (Roh, Lee, Noh, Oh, Gong & Baek, 2012). 
Although more research regarding this relationship is needed, the premise that perceived 
disability and other related psychosocial factors can modify the pain experience and 
likelihood of successful intervention is promising.   
There is considerable literature examining perceived and/or actual disability among 
chronic pain patients. However, (similar to other pain-related cognitions) much of the 
literature tends to focus on examining disability in relation to treatment effectiveness (Pérez-
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Fernández et al., 2015; Luk et al., 2010), with less research exploring the relationship 
between disability and treatment adherence specifically (Dobkin et al., 2010). Of the latter 
research, understanding the direct effects of treatment adherence on disability outcomes have 
been prioritised. Although, the impact of perceived disability on treatment adherence 
outcomes have received less attention, there is some evidence to suggest that a relationship 
exists between these variables. For example, Dobkin et al. (2010) found a moderate to strong 
negative association between perceived disability and treatment adherence; whereby, 
experiencing high perceived disability at baseline was associated with reduced adherence to 
treatment recommendations post-intervention. Additional research examining this 
relationship specifically would be useful to further clarify the influence of perceived 
disability on chronic pain self-management post-intervention.  
1.6.1.4 Catastrophising and fear-avoidance beliefs  
With regard to cognitions and coping responses, a great deal of empirical research has 
focused on catastrophising, which is characterised by unrealistic and excessively negative 
self-statements in response to pain (e.g., labelling pain sensations as awful, horrible, and 
unbearable; Parr et al., 2012; Linton & Shaw, 2011; Richardson et al., 2009). In studies 
involving individuals with chronic pain, catastrophising and fear-avoidance beliefs (i.e., an 
excessive fear of pain that can lead to avoidant behaviour) have been related to a variety of 
negative outcomes, including greater pain intensity and pain interference (Doménech, 
Sanchis-Alfonso & Espejo, 2014), poorer psychological functioning (Richardson et al., 
2009), and increased use of analgesics and healthcare services (Katz, Buis & Cohen, 2008). 
This leads to the consideration of the fear avoidance model which was proposed to explain 
why patients who are experiencing noxious or threatening stimuli reduce their activities 
(Lethem et al., 1983). In this model, initial adaptive responses to threat become, over time, 
maladaptive and are termed avoidance behaviours which have the potential to increase fear, 
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pain, and limited activity. Based on this association, Vlaeyen and Linton (2000) proposed a 
model of chronic pain where patient’s catastrophic thoughts and fear of movement beliefs can 
lead to greater pain disability. This model suggests that fear of pain develops as a result of a 
cognitive interpretation of pain as threatening (i.e. the result of pain catastrophising), which 
affects attention processes (i.e. causing hypervigilance) leading to fear-avoidance behaviours, 
followed by disability and potential psychopathology. Consequently, pain catastrophising and 
fear avoidance have been associated with a variety of problems that hinder recovery, making 
treatment more difficult and increasing the risk of developing chronic pain and disability 
(Linton & Shaw, 2011).   
Chronic pain patients presenting with a fear of pain may also report higher levels of 
kinesiophobia (i.e., fear of movement and injury; Kori, Miller & Todd, 1990). In which case, 
fear of pain is generalised to other situations that are closely linked to the feared stimulus. 
This is found to be particularly pertinent among patients who develop chronic pain following 
traumatic injury (Hudes, 2011). Individuals who are displaying fear-avoidance beliefs may 
experience difficulty in returning to the place of injury, such as a work environment for 
example. These individuals may then avoid performing tasks that are similar to those that 
caused the initial injury and limit their participation in activities perceived to be harmful. 
Over time, fear of pain is considered to result in musculoskeletal deconditioning, reducing 
pain tolerance, and fewer attempts to overcome functional limitations. For example, 
Doménech at al. (2014) found kinesiophobia and catastrophizing to predict higher ratings of 
pain and disability in patients with chronic anterior knee pain. An accumulation of past 
literature (Doménech et al., 2014; Parr et al., 2012; Wideman & Sullivan, 2011) supports the 
significance of kinesiophobia and catastrophizing in maintaining unhelpful cycles of pain, 
disability, and avoidance.  
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There is some evidence to suggest that catastrophising and fear-avoidance beliefs may 
also be predictive of poor treatment adherence (Nicholas et al., 2012; Mannion et al., 2009). 
In addition, much of the research has examined catastrophising and fear-avoidance in relation 
to treatment program effectiveness rather than treatment adherence specifically (Wertli, 
Rasmussen-Bar, Held, Weiser, Bachmann & Brunner, 2014; George & Stryker, 2011) this is 
also the case for other cognitive factors. More recently, Palazzo et al. (2016) found fear of 
movement and false beliefs regarding exercises found to be associated with limited 
adherence. Clearly, catastrophising and fear-avoidance beliefs are significant markers for the 
development of persistent pain problems. Considerable research has highlighted the 
importance of structure based education programmes to reduce fear and damage related pain 
beliefs (Butler & Moseley, 2013; Louw, Diener, Butler & Puentedura, 2011; Clarke, Ryan & 
Martin, 2011). However, a window of opportunity remains to further establish the impact of 
these cognitive factors on treatment adherence. 
1.6.1.5 Perceived control and belief in medical cure 
Beliefs that one has the ability and resources to control pain (i.e., internal control) is 
thought to enhance adjustment and coping; thereby, reducing impairment and improving 
functioning (de Waal, Hegeman, Gussekloo, Verhaak, van der Mast & Comics, 2016). 
Multidisciplinary rehabilitation has shown to be effective in enhancing perceived control 
beliefs among chronic pain patients. This is illustrated in Keedy et al.’s (2014) study which 
found participants to display an increased sense of personal control over their pain and 
substantial decreases in external (i.e., powerful others) pain control attributions one month 
following an intensive multidisciplinary program. Similar findings pertaining to the 
importance of control beliefs are seen among other chronic populations (Howren, Cozad & 
Christensen, 2016a; Law, Tolgyesi & Howard, 2014). Despite previous research identifying 
control attributions among chronic pain populations (Baker et al., 2008), more recent research 
  31 
 
 
examining pain control beliefs is limited. It would be advantageous to build on the 
connections outlined in the literature and investigate the nature of this phenomenon among 
current chronic pain populations.  
Along the lines of perceived control, external control can result in the belief that 
medication can cure or control pain. Beliefs in medical cure for pain have been shown to be 
associated with greater reliance on medication and use of rest (Karoly, Ruehlman & Okun, 
2013). Certainly, using pain medication to control pain can be an adaptive response in some 
instances. However, on other occasions it may serve as part of a pattern of avoidance of pain, 
a pattern that could constrict daily functioning and lead to other health problems such as 
opioid dependence (Jamison et al., 2010). Similar to perceived control, patients who believe 
that pain can be cured by medication or powerful others (e.g., medical professional/s) may be 
more likely to attend pain management programs and adhere to aspects of such programs that 
target an immediate reduction in pain and/or fulfil their beliefs regarding appropriate 
intervention (e.g., medication, surgery or other invasive procedures). However, other pain 
management components that require patients to independently and routinely complete active 
self-management strategies whilst targeting other aspects of quality of life and function may 
not be given the same priority. That is, despite the tendency to comply with prescribed 
medication treatment, these patients may be more likely to rely on maladaptive and passive 
coping strategies such as medication, consequently exhibiting greater levels of psychological 
distress and poorer functioning (Peres & Lucchetti, 2010). In terms of treatment adherence, 
patients who rely on external (rather than internal) sources to treat their pain may be less 
likely to engage in and maintain proactive self-management strategies (e.g., exercise). 
Nicklas et al.’s (2010) cross-sectional study assessing chronic pain patient’s adherence to 
treatment, found that a perception of pain as chronic, uncontrollable, and unremitting was 
associated with a greater reliance on medication and a belief that pharmacological treatment 
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was necessary. Future studies are needed to explore the role that perceived control and belief 
in medical cure have on multidisciplinary treatment adherence. Interventions aimed at 
shifting pain control beliefs from external (e.g., belief in medical cure) to internal (e.g., 
perceived control) may facilitate the use of more proactive methods of self-management 
(Nicklas et al., 2010).   
1.6.2 Co-morbid psychopathology 
The co-morbidity of chronic pain and psychopathology is well known to contribute to 
poorer outcomes for chronic pain patients (Chen, Cheng, Huang, Liu & Luo, 2012; Gormsen 
et al., 2010). Research has demonstrated that physical and psychological symptoms increase 
together, and as the number or severity of physical symptoms increases, so does the 
likelihood of a psychological disorder (Linton & Shaw, 2011). This holds true for pain 
symptoms with and without a diagnosable aetiology (i.e., fibromyalgia; Gormsen et al., 
2010). There are several reasons why it is important to identify co-morbid psychopathology 
in chronic pain patients. Firstly, unrecognised and untreated co-morbid psychopathology can 
significantly interfere with successful rehabilitation of these patients (Pompili et al., 2012). 
Secondly, poor psychological health may also increase pain intensity and disability, thus 
serving to perpetuate pain-related dysfunction (Glombiewski et al., 2010). Thirdly, many 
chronic pain patients are exposed to traumatic injury and compensation or litigation stress 
which is frequently associated with psychological symptoms, thus worsening patient outcome 
(Elbers et al., 2012).  
Many disorders have been found to co-occur with chronic pain, including depression 
(Ang, Bair, Damush, Wu, Tu & Kroenke, 2010), anxiety (Asmundson & Katz, 2009), Post-
Traumatic Stress Disorder (PTSD; Phifer et al., 2011), substance abuse (Boscarino, Rukstalis, 
Hoffman, Han, Erlich & Ross, 2011) as well as some personality disorders (Sansone & 
Sansone, 2012). Of those listed, co-morbid depression is most commonly reported, however, 
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some questions remain regarding its aetiology. Anxiety is also frequently shown to co-occur 
among chronic pain patients, according to recent research and clinical reports. Based on these 
findings, a review of the literature concerning co-morbid depression and anxiety will each be 
presented. 
1.6.2.1 Depression and chronic pain 
The association between chronic pain and depression is well known, receiving the 
most research and theoretical attention (Ang et al., 2010; Asghari, Julaeiha & Godarsi, 2008; 
Elliot, Renier & Palcher, 2003). However, this relationship is complex, and the findings have 
been widely divergent. Depression is a condition of mental disturbance, typically presenting 
as lack of energy and difficulty in maintaining concentration or interest in life, and often 
includes feelings of hopelessness and inadequacy (Chen et al., 2012). A review of several 
large population studies showed mood disorders of various types (i.e., Major Depressive 
Disorder, depressive episode, dysthymia) to be two to seven times more prevalent among 
chronic pain sufferers (Tunks, Crook & Weir, 2008). And controversy still exists as to 
whether depression is an antecedent or a consequence of chronic pain (Kroenke et al., 2012). 
It is likely that there is a bi-directional relationship involved. Assessment of depression in 
chronic pain patients has been further complicated by overlapping symptomatology. That is, 
the diagnostic criteria for Major Depressive Disorder (MDD) include several somatic 
symptoms that can also be attributed to chronic pain (e.g., sleep disturbance, loss of energy, 
motor retardation; Ang et al., 2010). Therefore, diagnosing depression in chronic pain 
populations is not always straightforward.   
Various research studies suggest that the association between depression and chronic 
pain may be strengthened by unhelpful cognitions (Glombiewski et al., 2010; Baker et al., 
2008), in particular, poor pain self-efficacy (Craig et al., 2013). The accumulation of 
literature provides substantial support for a correlation between depression and pain self-
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efficacy, with positive self-efficacy shown to directly reduce vulnerability to co-morbid 
depression among chronic pain patients (Craig et al., 2013; Miró et al., 2011). Whereby, more 
self-efficacious patients show a greater tolerance of pain and less depressive 
symptomatology. Studies elaborating on this relationship suggest that pain patients with co-
morbid depression are more likely to evaluate their performance and ability to cope with pain 
more negatively than their non-depressed counterparts (Ang et al., 2010). Due to a lack of 
self-belief, these patients are less likely to demonstrate necessary coping strategies to 
effectively manage pain; thereby, impeding future opportunities to gain confidence, 
maintaining pain-related disability, and limiting the release of ‘feel good’ chemical 
neurotransmitters (e.g., serotonin) important for psychological wellbeing (Chen et al., 2012). 
Consequently, a cycle of low self-confidence, passive coping and depression may be more 
likely to ensue. Several research findings support the importance of pain self-efficacy for 
depression above and beyond other known contributing factors. For example, Asghari et al.’s 
(2008) study found pain self-efficacy to be more strongly related to depression and associated 
disability than pain intensity and demographic variables. Research is needed to continue to 
build a better understanding of pain self-efficacy and its relative impact on co-morbid 
depression which may, in turn, lead to improved treatment and prevention. 
Depression is a major barrier to effective pain management, amplifying the 
experience and perception of pain (Linton & Shaw, 2011). Many longitudinal studies have 
illustrated this, with depressed individuals more likely to develop multiple pain symptoms 
and greater levels of pain (on self-report pain intensity measures), than non-depressed 
subjects over time (Kroenke, Wu, Bair, Krebs, Damush & Tu, 2011; Hawker et al., 2011). 
This may be due, in part, to depressed chronic pain patients engaging less in proactive self-
management strategies (e.g., physical activity) and more in passive coping (i.e., surrendering 
control over pain) than their non-depressed counterparts (Kroenke et al., 2011). That is, 
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depressed patients may adopt a helpless attitude toward their pain and use more negative self-
statements, increasing the experience of pain as well as the disability interference (Hawker et 
al., 2011). Heightened levels of depression post-treatment may, therefore, put individuals at 
greater risk of exhibiting poor adherence behaviour and subsequent relapse of pain 
symptoms. A greater understanding of what factors contribute to co-morbid depression 
among chronic pain patients is needed to improve intervention and post-treatment outcomes. 
While it may not be realistic for presentations of clinical depression to be properly treated 
during a time-limited pain management program, it is important that patients receive the 
skills necessary to enable them to independently manage chronic pain, despite episodes of 
low mood. In addition to receiving adequate community support for ongoing treatment for 
depression. As a result, pain-related disability may be reduced and psychological wellbeing 
inadvertently improved.       
1.6.2.2 Anxiety and chronic pain 
Chronic pain is frequently associated with anxiety symptoms. This is not surprising 
given that many pain conditions are acquired as a result of traumatic injury (e.g., motor 
vehicle accidents, military combat; Demir et al., 2010; Norman, Stein, Dimsdale & Hoyt, 
2007). A growing number of studies have examined the prevalence and nature of comorbid 
chronic pain and anxiety disorders (Kroenke et al., 2013; Asmundson & Katz, 2009); 
however, the majority of this research has focused on Panic Disorder (PD) and Post-
Traumatic Stress Disorder (PTSD) specifically (Phifer et al., 2011; Hofmann et al., 2012). 
According to Otis et al., (2003), 30% of PTSD community outpatients and 50-80% of 
military veterans and volunteer firefighters with PTSD report comorbid chronic pain. More 
recently, Phifer et al. (2011) found patients with co-morbid chronic pain and PTSD reported 
greater pain-related impairment in addition to increased prescribed opioid use for pain 
control, compared to patients with chronic pain alone. What adds to the complexity in 
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understanding this relationship are the shared cognitive, behavioural and physiological 
response patterns among PTSD and chronic pain (Bosco, Gallinati & Clark, 2013). For 
example, both are characterised by somatic hypervigilance, biases in attention toward 
threatening stimuli and avoidance behaviours, among other overlapping symptoms 
(Asmundson & Katz, 2009). Despite this, these findings provide further support for the 
impact that emotional interpretation and response to painful stimuli can have on coping 
ability and outcome.  
Similar to depression, there may be several factors that contribute to the development 
and maintenance of co-morbid pain and anxiety (Asmundson & Katz, 2009). According to 
several authors, fear-avoidance beliefs are the most frequently associated maladaptive 
cognition among patients with co-morbid chronic pain and anxiety (Hasenbring, Chehadi, 
Titze & Kreddig, 2014; Bailey, Carleton, Vlaeyen & Asmundson, 2010). Chronic pain 
patients may develop fear and avoidance of movements or activities that they perceive to 
exacerbate pain. Similarly, for a person with anxiety, fear of re-experiencing disturbing 
thoughts or events and avoidance of reminders associated with the trauma are core 
components of the disorder. This fear and avoidance can prevent effective processing of the 
event and may lead to the maintenance of intrusive symptoms and arousal (Bailey et al., 
2010). In this way, fear-avoidance beliefs serve to mutually maintain co-morbid chronic pain 
and anxiety. By helping patients to resolve unhelpful fear-avoidance beliefs, treatment of 
these patients may be more effective. 
Given the interference caused by persistent co-morbid anxiety and chronic pain, it is 
understandable that adherence to strategies for pain management would be considerably 
difficult. There is some research in support of this; whereby, increased anxiety symptoms 
have been found to predict poor treatment adherence (Nicklas et al., 2010). However, there 
are relatively few studies examining the impact of anxiety on treatment adherence among 
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samples of chronic pain patients specifically. Of the literature that does exist, findings are 
invariably mixed. Whereas, a systematic review conducted by Jack et al. (2010) found 
evidence (2 of 20 high quality trials) that low treatment adherence was associated with 
anxiety (among other factors), other studies show no association between anxiety and 
treatment adherence (Arrieta et al., 2013). Further examination of the links between these 
variables is needed to elucidate the importance of anxiety in predicting adherence behaviour 
among chronic pain patients. This knowledge will hopefully allow for more refined methods 
of intervention and better utilisation of treatment resources.    
1.6.3 Summary  
From this research, various psychosocial factors are shown to be important predictors 
of chronic pain and associated outcomes. Of the pain-related cognitions reviewed, pain self-
efficacy has received the most attention in regards to chronic pain management (Menezes 
Costa et al., 2011). Depression and anxiety are also found to frequently co-occur among 
chronic pain patients (Artner et al., 2012). The interrelationships between psychological and 
cognitive factors associated with chronic pain have also been emphasised (Kamper et al., 
2015). By identifying the psychosocial factors and the interrelationships between them that 
influence how people with chronic pain adapt and cope, intervention may be better refined 
for individual needs. Additional consideration of the impact that various psychosocial factors 
have on self-management behaviour post-intervention is also important. Ongoing research 
into the effects of pain-related cognitions, especially pain self-efficacy, and psychological 
factors including depression and anxiety on chronic pain and adherence behaviour is 
encouraged.   
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1.7 Summary and Rationale 
Based on the accumulation of previous research, intervention should be targeted at 
overcoming psychosocial factors such as unhelpful belief systems and co-morbid 
psychopathology, given their potential to improve treatment and disability outcomes. The 
present research contributes three empirical studies to the literature on this topic. The 
rationale, aims, and methodology for each study will be introduced, in turn. 
1.7.1 Study One 
The rationale for Study One was two-fold. Firstly, limited research investigating the 
interrelationships between chronic pain, cognitions, and treatment adherence concurrently 
was evident. Secondly, a large majority of the chronic pain literature was found to focus on 
pharmacological adherence with considerably fewer studies investigating the effects of pain-
related cognitions on multidisciplinary intervention. The aim of Study One was to conduct a 
systematic review of empirical studies which have examined the associations between 
cognitions and treatment adherence among chronic pain patients attending multidisciplinary 
pain management intervention. More specifically, Study One sought to address the following 
two questions. Firstly, which pain-related cognitions predict increased treatment adherence 
during a multidisciplinary program? Secondly, to what extent do these pain-related cognitions 
influence adherence to treatment recommendations post-treatment? Three combinations of 
keywords (‘chronic pain’, ‘beliefs’ and ‘treatment adherence’) and their relevant MeSH 
terms, subject headings, text words, and word variants were searched against five electronic 
databases (Medline, CINAHL, PsycINFO, Academic Search Complete and Scopus). Study 
One was accepted for publication in the Clinical Journal of Pain (Thompson, Broadbent, 
Bertino, & Staiger, 2016). 
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1.7.2 Study Two 
The rationale for Study Two was centred on the lack of research found to examine 
various specific cognitive factors (i.e., pain self-efficacy, fear-avoidance beliefs, perceived 
control, perceived disability) as predictors of affective disorder symptoms severity (i.e., 
depression, anxiety) within the same conceptual model. Study Two aimed to identify the key 
cognitive contributors to the co-morbidity of chronic pain and affective disorder symptoms 
using a novel network model. Based on prior research, it was hypothesised that all of the 
pain-related cognitions assessed would be inter-related, and also relate to pain intensity and 
affective disorder symptom severity. It was further hypothesised that pain intensity would be 
related to affective disorder symptoms. Cross-sectional by design, Study Two comprised 169 
chronic pain patients receiving multidisciplinary treatment intervention. Participants 
completed a battery of questionnaires (DASS-21, PSEQ, TAMPA, SOPA-R, and PDI) at 
admission via self-report measures. Study Two is currently under review for publication in 
the British Journal of Health Psychology. 
1.7.3 Study Three 
The rationale for Study Three was based on the limited data found to exist comparing 
the interrelationships of multiple cognitive and psychological factors on adherence to 
multidisciplinary recommendations post-treatment. Similarly, the appropriate time to measure 
psychosocial factors and their predictive value on post-treatment adherence had also received 
little attention. Study Three aimed to longitudinally evaluate the influence of psychological 
factors (anxiety, depression, fear avoidance, and pain self-efficacy) in predicting treatment 
adherence post-intervention. Study Three hypothesised that: (1) adherence post-intervention 
follow-up would be lower for individuals with higher depression, anxiety, and fear avoidance 
tendencies, and lower self-efficacy at pre-intervention (Hypothesis 1) and post-intervention 
(Hypothesis 2); (2) post-intervention levels of the risk factors would be better predictors than 
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their pre-intervention levels for predicting adherence in the post-intervention phase 
(Hypothesis 3); and (3) the relationship between risk factors and adherence would be 
moderated by change in risk factors exhibited during the treatment phase (Hypothesis 4). 
Study Three comprised 61 chronic pain patients who had completed a multidisciplinary pain 
management program. Participants completed a battery of questionnaires (DASS-21, PSEQ, 
TAMPA, and TMQ) at three time-points (admission, discharge, and 3-6 month follow-up) via 
self-report measures. Study Three is currently under review for publication in Clinical 
Psychologist. 
 
1.8 Conclusion 
Chronic pain is a significant health problem which has been found to impact several 
areas of an individual’s biological, psychological, and social functioning (Goldberg & 
McGee, 2011). For this reason, a biopsychosocial perspective has become the most widely 
adopted heuristic to conceptualise chronic pain (Gatchel et al., 2007). Through the 
development of research, a greater understanding of the importance of psychosocial factors 
has been established. Since then, research of cognitive and psychological factors has 
proliferated and several pain-related cognitions and diagnosable psychopathology have been 
found to co-occur among chronic pain patients (Kamper et al., 2015). These psychosocial 
factors are consistently found to predict poor disability and treatment outcomes. Therefore, 
clinicians conducting diagnostic assessments of patients with chronic pain are required to 
assess for both co-morbid psychopathology and pain-related cognitions to gain a 
comprehensive understanding of the factors contributing to and maintaining poor pain-related 
outcomes (Linton & Shaw, 2011). Recent research has indicated the need for pain 
management to be flexible and holistic, focusing on patient’s wellness and monitoring 
significant markers of poor adherence post-treatment (Kamper et al., 2015). On review of the 
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current literature, an increased awareness of the risk factors that may lead to the persistence 
of chronic pain, particularly the interrelationships among cognitive and psychological 
features that contribute to poor self-management and treatment maintenance is needed.  
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Abstract 
Objectives: To understand how pain-related cognitions predict and influence treatment 
retention and adherence during and after a multidisciplinary rehabilitation program. 
Methods: Electronic databases including Medline, CINAHL, PsycINFO, Academic Search 
Complete, and Scopus were used to search three combinations of keywords: chronic pain, 
beliefs, and treatment adherence. 
Results: The search strategy yielded 591 results, with an additional 12 studies identified 
through reference screening. 81 full-text papers were assessed for eligibility and 10 papers 
met the inclusion and exclusion criteria for this review. The pain-related beliefs that have 
been measured in relation to treatment adherence include: pain-specific self-efficacy, 
perceived disability, catastrophizing, control beliefs, fear-avoidance beliefs, perceived 
benefits and barriers, as well as other less commonly measured beliefs. The most common 
pain-related belief investigated in relation to treatment adherence was pain-related self-
efficacy. Findings for the pain-related beliefs investigated among the studies were mixed. 
Collectively, all of the aforementioned pain-related beliefs, excluding control beliefs, were 
found to influence treatment adherence behaviours.  
Discussion: The findings suggest that treatment adherence is determined by a combination of 
pain-related beliefs either supporting or inhibiting chronic pain patients’ ability to adhere to 
treatment recommendations over time. In the studies reviewed, self-efficacy appears to be the 
most commonly researched predictor of treatment adherence, its effects also influencing other 
pain-related beliefs. More refined and standardised methodologies, consistent descriptions of 
pain-related beliefs and methods of measurement will improve our understanding of 
adherence behaviours.  
 
Keywords: chronic pain; beliefs; treatment adherence
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2.1 Introduction 
 
There has been a growing recognition that the degree of chronic pain is influenced by 
the beliefs, attitudes and expectations of individuals [1]. Pain-related cognitions that have 
been found to impede recovery include low self-efficacy [2], catastrophizing [3], fear-
avoidance beliefs [4], locus of control beliefs [5], and perceived disability [6], among others. 
These pain-related cognitions or beliefs are consistently found to predict negative outcomes 
among patients suffering from chronic pain. For example, pain patients who possess low 
pain-specific self-efficacy beliefs (i.e., reduced confidence in one’s ability to perform specific 
tasks such as coping with pain) have been found to experience worsened pain outcomes 
compared to chronic pain patients with high self-efficacy beliefs [1,2,4]. It is important to 
recognise and understand the implications of unhelpful pain-related cognitions in order to 
tailor more effective treatment interventions and thus, improve chronic pain outcomes. 
Despite the high prevalence and negative outcomes often associated with chronic pain, there 
is limited research examining the influence of pain-related cognitions on treatment adherence. 
The World Health Organisation (WHO) defines adherence as ‘the extent to which a person’s 
behaviour (i.e., taking medication, following a diet or exercise plan, and/or executing lifestyle 
change), corresponds with recommendations from a health care professional (HCP)’ [7]. 
Following this definition, measurement of adherence varies depending on the nature of the 
treatment recommended by the HCP (e.g., attendance to supervised sessions and/or assessment of 
unsupervised home-based activities). This has led to some criticism regarding the construct of 
adherence as inherently elusive. Despite this, adherence to treatment recommendations is 
essential to reduce disability outcomes associated with chronic pain such as restricted 
mobility [8], reduced working capacity [9] and co-morbid psycho-pathology [10]. However, 
treatment recommendations are not always adhered to after the completion of an intervention, 
and patients may experience exacerbated pain symptoms as a result [11]. Non-adherence not 
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only impairs patient’s quality of life, it contributes to the growing prevalence and economic 
burden on the public health system [12].  
There is a literature examining the relationships between treatment adherence and chronic 
pain [13,14], as well as cognitions associated with the experience of chronic pain [2-6] 
however, there is very little research investigating the interrelationships between chronic 
pain, cognitions, and treatment adherence concurrently. In addition, a large majority of the 
chronic pain literature that includes information on treatment adherence focuses on 
examining adherence to medical interventions (e.g., adherence to clinical guidelines for 
opioid therapy and subsequent substance misuse) [15-16]. However, a growing body of 
literature suggest that multidisciplinary intervention (i.e., a combination of physiotherapy or 
exercise physiology, psychology, occupational therapy, and hydrotherapy components) is 
often required in order to effectively manage chronic pain symptoms [17,18,19] and is largely 
becoming ‘best practice’ for the treatment of chronic pain [19-21]. Therefore, examination of 
the relationships that exist among pain-related cognitions and adherence to multidisciplinary 
treatment is important to identify the barriers to effective intervention and inform best 
practice for chronic pain management. The aim of this paper was to conduct a systematic 
review to identify empirical studies which have examined the associations between 
cognitions and treatment adherence among chronic pain patients receiving multidisciplinary 
intervention. The specific questions addressed in this review were as follows: 
1. Which pain-related cognitions predict increased treatment adherence during a 
multidisciplinary program?  
2. To what extent do these pain-related cognitions influence adherence to treatment 
recommendations post treatment? 
This review was based on the guidelines set out by the PRISMA statement for 
systematic reviews [22]. 
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2.2 Method 
 
2.2.1 Search strategy  
The search protocol for this review was developed using widely recommended methods for 
systematic reviews for observational studies [23]. Electronic databases including Medline, 
CINAHL, PsycINFO, Academic Search Complete, and Scopus were used. The search term 
combination for electronic databases contained the words chronic pain, beliefs, and treatment 
adherence (see Figure 3). Based on published advice, relevant MeSH terms, subject headings, 
text words, and word variants were used [23]. We also manually searched the bibliographies 
of all relevant articles to identify papers not captured by electronic databases.  
 
Search 1: 
“chronic pain” or “persistent pain” or “recurrent pain” 
 AND 
“treatment adherence” or “adherence to treatment recommendation*” or adherence or 
“adherence behavio?r” or “adherence enhancement” or “pain treatment adherence” or 
"guideline adherence" or compliance or “patient compliance” or “non?compliance” or 
“patient participation” or “patient dropout*” or “patient refusal of treatment” or “treatment 
engagement” or “treatment concordance” or “treatment disengagement” or “treatment 
refusal” or “treatment barrier*” or “treatment dropout*” or “treatment compliance” 
 
Limiters: adults, peer-reviewed, 2000-2014 
188 articles found 
 
Search 2: 
“chronic pain” or “persistent pain” or “recurrent pain”  
AND 
belief* or “health belief*” or perceive* or perception* or attitude* or “attitude to health” 
AND 
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“treatment adherence” or “adherence to treatment recommendation*” or adherence or 
“adherence behavio?r” or “adherence enhancement” or “pain treatment adherence” or 
"guideline adherence" or compliance or “patient compliance” or “non?compliance” or 
“patient participation” or “patient dropout*” or “patient refusal of treatment” or “treatment 
engagement” or “treatment concordance” or “treatment disengagement” or “treatment 
refusal” or “treatment barrier*” or “treatment dropout*” or “treatment compliance” 
 
Limiters: adults, peer-reviewed, 2000-2014 
48 articles found 
 
Search 3: 
“chronic pain” or “persistent pain” or “recurrent pain”  
AND 
belief* or “health belief*” or perceive* or perception* or attitude* or “attitude to health” or 
or self?efficacy or fear?avoidance or “perceived disability” or catastrophi?ing or “perceived 
control” or “recovery expectation*” 
AND 
“treatment adherence” or “adherence to treatment recommendation*” or adherence or 
“adherence behavio?r” or “adherence enhancement” or “pain treatment adherence” or 
"guideline adherence" or compliance or “patient compliance” or “non?compliance” or 
“patient participation” or “patient dropout*” or “patient refusal of treatment” or “treatment 
engagement” or “treatment concordance” or “treatment disengagement” or “treatment 
refusal” or “treatment barrier*” or “treatment dropout*” or “treatment compliance” 
 
Limiters: adults, peer-reviewed, 2000-2014 
49 articles found 
 
Figure 3. Example of a full search strategy using Medline Complete 
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2.2.2 Eligibility criteria  
Eligibility criteria included: Participants had to be adults (18+ years) with chronic pain of 
more than three months. In addition, only peer-reviewed studies published in the English 
language and between the years 2000 and 2014 were included in the review.  
 As treatment adherence was the variable of interest in the review, all studies without 
adherence data were excluded, as were studies that did not directly compare pain-related 
beliefs and treatment adherence outcomes. Also, given the psycho-social focus of the review, 
the exclusion criteria also included studies that focused on adherence to a medical approach 
or pharmacological treatment.  
 
2.2.3 Selection process  
Studies were eligible if they provided information on the association of pain-related beliefs 
with treatment adherence. Studies were not included that examined the effect of pain-related 
beliefs on chronic pain treatment outcomes (e.g., pain severity, functional outcomes) as this 
has previously been examined extensively in the literature. One author (ET) independently 
screened the titles and abstracts of identified citations for potential eligibility. Discrepancies 
were resolved by consensus (ET, JB, MB) or by a fourth author (PS) if necessary. All authors 
then examined the full texts of potential articles to determine eligibility for inclusion in the 
review. 
 
2.2.4 Data abstraction  
Data from the studies were collated and synthesised manually, and placed into tables to allow 
for the comparison of the study aims, pain-related beliefs investigated, treatment adherence 
outcomes, sample and methodology, outcomes, measures, and findings (see Table 1). Table 2 
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provides a list of the 70 excluded studies and reasons for exclusion in reverse chronological 
order. The table categorises 9 reasons for exclusion.  
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Table 1. Systematic review table (alphabetical order according to first author) 
 
First author, country 
Research aims/questions 
 
 
Pain-related beliefs 
 
Sample, mean age years 
(SD), design/method 
 
Outcome measures 
 
Measures used 
 
Findings  
Coppack et al., 2012 
 
UK 
 
Aim: 
To examine the effects of 
goal setting intervention on 
self- efficacy, treatment 
efficacy, adherence, and 
treatment outcome in 
patients undergoing a lower 
back pain rehabilitation 
programme  
Self-efficacy Sample size: 48 
 
Design method: prospective 
and longitudinal 
 
Participants: chronic low 
back pain patients referred to 
the early spines treatment 
group at the UK Defence 
Medical Rehabilitation 
Centre (DMRC) for 
inpatient rehabilitation 
 
Mean age: 32.9 (SD = 7.9) 
 
 
All groups 
completed the 
standard exercise 
program 
 
Experimental group 
(goal setting and 
exercise therapy) – 
also completed a 
goal setting 
performance profile 
assessment: Initial 
assessment (T1), 
day 6 (T2), and day 
11 (T3) 
 
Control group 1 
(C1; therapist-led 
exercise therapy)  
Sports Injury Rehabilitation Beliefs 
Survey (SIRBS)  
Sport Injury Rehabilitation Adherence 
Scale (SIRAS) – a mean value was 
calculated for the SIRAS across the 
nine appointments, to yield an overall 
adherence score 
 
Behavioural Regulation in Exercise 
Questionnaire (BREQ-2) - used as a 
covariate to account for the possible 
confound of motives for exercise 
participation on adherence 
Significant differences were found among self-efficacy 
and adherence scores over time, regardless of group 
allocation  
 
The experimental group exhibited significantly higher 
scores of goal setting and self-efficacy when compared 
to both control groups, indicating a relationship 
between self-efficacy and adherence   
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Control group 2 
(C2; non-therapist-
led exercise 
therapy) 
Curran et al., 2009 
 
UK 
 
Aim: 
To assess determinants of 
adherence to treatment 
recommendations, and to 
examine the extent to which 
cognitive and behavioural 
adherence predicts better 
outcome of cognitive 
behavioural treatment for 
persistent pain 
Self-efficacy 
 
Catastrophising 
Sample size: 2,345 
 
Design method: longitudinal 
 
Participants: pain patients 
from the UK who attended a 
two or four week (9-day or 
16-day) inpatient pain 
management programme 
 
Mean age: 45 (SD = 12) 
Battery of 
questionnaires 
completed on 4 
occasions over 6 or 
8 months 
(depending on 
programme): 
 
Before the start of 
treatment (T1) 
 
On the last day of 
treatment (either 2 
weeks or 4 weeks; 
T2) 
 
One month follow-
up (T3) 
 
Pain Self-Efficacy Questionnaire 
(PSEQ)  
 
Pain Catastrophizing Scale 
 
Coping Strategies Questionnaire (CSQ) 
 
Adherence measures using 6 separate 
self-report scales (e.g., 1 = stopped 
completely, 6 = performed daily): 
Exercise Frequency, Stretch 
Frequency, Pacing Frequency, Pacing 
Occasion, Cognitive Techniques, 
Frequency, Cognitive Techniques 
Occasion  
 
 
Adherence variables were correlated with self-efficacy 
at T2, but not at T1.   Adherence variables were 
correlated with self-efficacy and non-catastrophic 
thinking at T3   
 
6% of the variance in overall adherence is accounted for 
by level of psychological wellbeing post-treatment. 
Psychological wellbeing includes self-efficacy and 
catastrophizing, depression and coping 
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Adherence 
measured only at 
T3 
Dobkin et al., 2005 
 
Canada 
 
Aim: 
To examine the variables 
that contributes to 
maintenance of exercise for 
the 3-month critical period 
following termination of the 
program 
Self-efficacy 
 
Disability 
 
Perceived benefits 
 
Perceived barriers 
 
Sample size: 33 
 
Design method: prospective 
 
Participants: female patients 
with diagnosed 
Fibromyalgia (FM) were 
recruited into a randomised 
control trial 
 
Mean age: 49.2 (SD = 8.7) 
Battery of 
questionnaires 
completed on 3 
occasions over 6 
months: 
 
Baseline (T1) 
 
Post-treatment (T2) 
 
3 months follow-up 
(T3) 
 
Exercise logs were 
completed by 
participants at the 
end of each exercise 
session, each week, 
during the 
supervised phase of 
treatment, and 
Fibromyalgia Impact Questionnaire 
(FIQ) to assess disability over the past 
week  
 
Arthritis Self-Efficacy Scale – 2 of the 
3 subscales were used: self-efficacy for 
pain management and self-efficacy for 
other FM symptoms 
 
Exercise Beliefs Questionnaire - to 
assess self-efficacy for exercise, 
barriers to exercise, and benefits of 
exercise on FM 
 
Exercise logs included: the type of 
exercise performed, frequency, 
duration, and heart rate 
Benefits of exercise during treatment showed increased 
adherence over time, even if benefits of exercise at 
baseline did not significantly predict adherence 
 
Significantly greater increases in perceived barriers 
during treatment predicted significant decreases in post-
treatment aerobic participation, the negative effect of 
higher pre- treatment barriers was non-significant  
 
Higher pre-treatment FIQ scores did not predict worse 
maintenance.  The in- treatment change in FIQ also had 
no impact 
 
Self-efficacy was not found to predict treatment 
adherence 
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during the 
unsupervised phase 
 
Dobkin et al., 2010  
 
Canada  
 
Aim: 
To identify predictors of 
disability and pain 6 months 
after the end of a 
multimodal FM treatment 
program and to determine 
whether adherence 
influenced outcomes  
Self-efficacy 
 
Disability 
Sample size: 46 
 
Design method: prospective 
 
Participants: widespread 
pain patients in an 
established 3 month 
multimodal treatment 
program for FM at the 
Jewish Rehabilitation 
Hospital (JRH) in Montreal, 
Canada 
 
Mean age: 53.6 (SD = 14.5) 
Psychosocial 
factors were 
measured at 
baseline (T1), at the 
end of treatment (3 
months; T2), and 6 
months follow-up 
(T3) 
 
Adherence factors 
were measured 
during treatment at 
the end of each 
month, at the end of 
treatment (3 
months; T2), and 6 
months follow-up 
(T3) 
Arthritis Self-Efficacy Scale - 2 of the 
3 subscales: (1) self- efficacy for pain 
management, and (2) self-efficacy for 
other (FM) symptoms 
 
The General Adherence Scale 
(Sherbourne et al., 1992) – 5 questions 
about level of difficulty and frequency 
in following treatment 
recommendations 
 
Specific Adherence Scale - developed 
by the authors, based on the Barriers to 
Treatment Adherence Questionnaire.  
Developed to measure adherence to 
therapists' suggestions and various 
recommendations of the program 
Change in self-efficacy for pain from baseline to the 
end of treatment was found to be significantly 
associated with general adherence scores during 
treatment 
 
Patients whose average general adherence during 
treatment increased by 1 SD, in turn, decreased their 
disability scores by 10.07 SD points more than patients 
whose general adherence during treatment was 1 SD 
below the mean 
Engstrom & Oberg, 2005 
 
Sweden 
Locus of control 
 
Perceived threats 
Sample size: 353  
 
Design method: prospective 
All clinic patients 
answer a 
questionnaire pre- 
Pre therapy questionnaire: 8 statements 
about health locus of control (not 
published) 
Health belief variables differed between those with low 
or high exercise adherence.  Participants’ with low 
adherence reported higher Oswestry scores.  They also 
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Aim: 
To describe pain patients 
who did not complete their 
participation or who 
participated infrequently in 
treatment based on their 
own activity and 
responsibility, and to 
understand the phenomenon 
of adherence from a 
behavioural theoretical 
perspective 
 
Perceived consequences 
 
Perceived barriers 
 
Perceived benefits 
 
Expectation of 
treatment 
 
 
 
Participants: pain patients 
recruited from a primary 
health care PT clinic in a 
middle-sized town in 
southern Sweden. 
 
Mean age: 40  
treatment (T1), post 
treatment (6-8 
weeks; T2), and 6 
and 12 months after 
the start of 
treatment (T3) 
 
 
Questions concerning health beliefs 
were repeated at all time-points 
 
Measures of perceived threats: pain 
intensity (VAS), use of pain killers, and 
pain frequency  
Measures of perceived consequences: 
Oswestry Low Back Pain Disability 
Questionnaire, duration of pain, 
duration of sick leave and distribution 
of pain 
 
Measures of  perceived benefits and 
perceived barriers: participants’ 
experiences from earlier treatments, 
expectations of treatment outcome 
 
Adherence measures – completers and 
non-completers of the treatment 
program.  Completers also analysed for 
high, medium, or low exercise 
frequency.  
rated lower expectations of treatment.  They were 
mainly younger and mainly women 
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Glombiewski et al., 2010 
 
Germany  
 
Aim: 
To describe time of and 
reasons for dropout from 
Cognitive Behavior 
Therapy (CBT) for chronic 
back pain and to examine 
the relevance of patients' 
attitudes toward treatment 
associated with dropout 
from CBT for chronic back 
pain 
Attitude toward 
treatment 
 
Pain disability 
Sample size: 128 
 
Design method: prospective 
 
Participants: 
musculoskeletal pain 
patients recruited over a 3 
year period directly in two 
outpatient anaesthesiology 
centres and general 
practitioner’s offices, or self-
referred through media 
publicity 
 
Mean age: completers: 50 
(SD = 11.32), dropouts: 43.3 
(SD = 12.25)  
Measures were 
taken at pre-
treatment (T1) and 
additionally 4 
months before 
treatment for the 
wait list control 
group, after session 
5 (T2), after session 
17 (T3), at post-
treatment (T4), and 
at 6 months follow-
up (T5) 
Attribution of Chronic Pain Patients 
(KAUKON) Questionnaire 
 
5 Likert-type ratings measuring 
attitudes toward psychological 
treatment 
 
Adherence measure - Dropout 
questionnaire which assessed the 
reasons for dropping out of treatment 
 
Those who did not complete the 
dropout questionnaire were called by 
phone and interviewed about dropout 
reasons 
Treatment adherers and treatment non-adherers did not 
differ on their attitude toward treatment, nor did they 
differ regarding psychological and medical control and 
causal attributions 
Heapy et al., 2005 
 
USA 
 
Aim: 
To examine the relative 
ability of self- efficacy 
Self-efficacy Sample size: 78 
 
Design method: prospective 
 
Participants: chronic pain 
patients recruited from a 
Self-efficacy was 
measured at 
baseline (T1) 
 
Adherence to the 
goals were assessed 
The patient’s completed a rating of 
adherence on a 0 (not at all 
accomplished) to 10 (completely 
accomplished) scale 
 
Self-efficacy at baseline was not found to be 
significantly associated with adherence 
 
Treatment adherence was not a mediator between self-
efficacy and goal accomplishment  
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ratings to predict adherence 
and goal accomplishment. 
To examine the hypothesis 
that adherence mediates the 
relationship between self-
efficacy and post- treatment 
outcomes 
(Veteran’s Affairs)VA 
primary care clinic  
 
Mean age: 54.1 (SD = 10.9) 
at each treatment 
session (T2) 
 
 
A patient goal expectancy rating was 
used to assess goal-specific self-
efficacy 
 
 
Mannion et al., 2009 
 
Switzerland 
 
Aim: 
To evaluate the influence of 
various cognitive factors 
and beliefs on adherence to 
a programme of therapeutic 
“spinal segmental 
stabilisation” exercises 
Self-efficacy 
 
Locus of control 
 
Fear-avoidance beliefs 
 
Catastrophising 
 
 
Sample size: 32 
 
Design method: prospective 
 
Participants: chronic low 
back pain patients recruited 
from the departments of 
rheumatology, orthopaedics, 
and neurology of local 
participating hospitals (one 
university hospital, two 
foundation hospitals, and a 
local GP practice). 
 
Mean age: 44.0 (SD = 12.3)  
Before (T1) and 
after (T3) treatment 
patients completed 
a battery of 
questionnaires 
 
Adherence diaries 
were completed by 
patients each week 
(T2) 
 
The remaining 
adherence measures 
were assessed by 
the clinician after 
each session (T2) 
Exercise Self-Efficacy Questionnaire 
 
Multidimensional Health Locus of 
Control (MHLC) Questionnaire 
 
Fear-avoidance beliefs Questionnaire 
 
Pain catastrophising Questionnaire 
 
Self-report daily exercise diary to 
document the frequency of exercises 
performed at home. 
 
Sports Injury Rehabilitation Adherence 
Scale (SIRAS) 
 
Exercise self-efficacy at baseline showed low, but 
significant, correlation with adherence  
 
None of the scores for the different domains of the 
MHLC (internal, powerful others, fate) showed any 
significant correlation with the MAI scores 
 
None of the psychological questionnaire scores at 
baseline (fear-avoidance beliefs, catastrophising) were 
significantly correlated with adherence (MAI scores) 
 
Forward stepwise multiple linear regression analysis of 
gender and self-efficacy scores on the transformed MAI 
adherence scores revealed that both variables were 
significant predictors, together accounting for 
approximately 32% of variance in MAI and self-
efficacy  
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Multidimensional Adherence Index 
(MAI) 
 
 
Nicholas et al., 2012 
 
Australia 
 
Aim : 
To test adherence to self- 
management strategies, 
using unhelpful beliefs 
about pain at baseline as 
moderators of treatment 
outcome 
Self-efficacy 
 
Catastrophising 
 
Fear-avoidance beliefs 
 
 
Sample size: 567 
 
Design method: prospective 
 
Participants: pain patients 
admitted to a 3-week out-
patient pain management 
program (ADAPT) at the 
Pain Management and 
Research Centre, Royal 
North Shore Hospital, 
Sydney, Australia, from 
2004 to early 2008 
 
Mean age: 44 (SD = 11.8)
  
Questionnaires 
were completed pre 
(T1) and post 
treatment (T2) 
 
Clinicians 
monitored patient 
adherence on a 
daily basis, and 
categorised overall 
adherence at the 
end of the program 
 
Pain Self-Efficacy Questionnaire 
(PSEQ)  
 
Catastrophising Scale of the Pain 
Response Self- Statements Scale 
(PRSS) 
 
Tampa Scale for Kinesiophobia (TSK)
  
Patient's completed daily worksheets 
which recorded their practice of each 
strategy. The treatment team later 
examined each worksheet and 
summarised each patient's adherence 
(using a 0-2 scale, where 0=’not using 
the strategy at all’, 1=’using it 
inconsistently’, and 2=’using it 
consistently’) for each recommendation 
Higher degrees of adherence to the strategies were 
predictive of greater pre-post treatment changes in the 
three cognitive process variables – catastrophizing , 
fear-avoidance , and pain self- efficacy beliefs  
 
Robinson et al., 2004 
 
USA 
 
Perceived control of 
managing pain 
 
Sample size: 180 
 
Design method: prospective 
 
The timing and 
duration of 
treatments was 
Pre-treatment: 
 
There was no significant difference between 
participants' and HCPs' mean ratings of perceived 
health benefits from complying with treatment 
recommendations. Perceived benefits and interference 
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Aim: 
To explore the variables 
associated with adherence 
to pain rehabilitation 
recommendations from two 
perspectives: the patient and 
the provider 
Perceived control of 
treatment compliance 
 
Perceived benefits 
 
Perceived interference 
Participants: pain patients 
recruited from 2 pain clinics 
at a large South-Eastern 
University Medical Centre. 
 
Mean age: 50.12 (SD = 
12.59) 
tailored to the 
individual 
 
Patients completed 
pre-treatment 
measures at the 
initial assessment 
(T1) 
 
Patients completed 
post-treatment 
measures at the 
follow-up 
assessment (T2) 
Pain-Anxiety Symptoms Scale (PASS) 
to evaluate fear and anxiety related to 
pain (e.g., avoidance behaviours) 
 
Post-treatment: 
 
Participant Compliance Reporting 
Scale (PCRS), developed by the 
authors, assessing level of adherence to 
treatment recommendations and the 
perceived impact that adherence or 
non-adherence had on overall levels of 
improvement 
 
Health Professional Compliance 
Evaluation (HPCE), developed by the 
authors.  Similar in content and rating 
to the PCRS, assessing practitioner-
report of participant adherence 
 
Participant Pain Reporting Scale 
(PPRS) to measure psychosocial 
predictors of pain 
showed a moderate and positive relationship for 
participants’ ratings of adherence  
 
No relationship was evident between perceived 
compliance, psychological recommendations, benefit or 
perceived interference 
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Table 2. List of excluded studies and reasons for exclusion in reverse chronological order 
No. Authors Reason 
1 Crandall et al. Phys Ther 2013;93:17-21. Review paper 
2 Licciardone et al. Ann Fam Med 2013;11:122-129. No beliefs and TA 
3 Mertens et al. Trials 2013;14:1-14. Feasibility paper 
4 Schauer & Hoenig. Tech Orthop 2013;28:98-102. Descriptive paper 
5 Anderson et al. Qual Prim Care 2012;20:421-433. No beliefs and TA 
6 Bennell et al. BMC Musculoskelet Disord 2012;13:1-17. Feasibility paper 
7 Budge et al. J Prim Health Care 2012;4:306-312. Qualitative study 
8 Hicks et al. Clin J Pain 2012;28:195-203.  No beliefs and TA 
9 Hunter et al. Clin J Pain 2012;28:259-267.  No beliefs and TA 
10 Lakke et al. Arch Phys Med Rehabil 2012;93:446-457. Review paper 
11 Lassen et al. Schmerz 2012;26:402-409. Not in English 
12 Lonsdale et al. BMC Musculoskelet Disord 2012;13:1-15. Feasibility paper 
13 Salo et al. Disabil Rehabil 2012;34:1971-1977. No beliefs and TA 
14 Sullivan & Simon. TBM 2012;2:149-158. No beliefs and TA 
15 Tse et al. J Clin Nurs 2012;22:1843-1856. No beliefs and TA 
16 Bearne et al. Musculoskeletal Care 2011;9:160-168. No beliefs and TA 
17 Langley. Curr Med Res Opin 2011;27:463-480. No beliefs and TA  
18 Langley et al. J Med Econ 2011;14:367-380. No beliefs and TA  
19 Huge et al. Schmerz 2010;24:459-467. Not in English 
20 Huis in ‘t Veld et al. J Telemed Telecare 2010;16:322-328. No beliefs and TA 
21 McDonough et al. BMC Musculoskelet Disord 2010;11:1-8. Feasibility paper 
22 Nicklas. Psychol Health 2010;25:601-615. Pharmacological focus 
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23 Sokunbi et al. Man Ther 2010;15:179-184. No beliefs and TA 
24 Bair et al. Pain Med 2009;10:1280-1290.  Qualitative study 
25 Escolar-Reina et al. Arch Phys Med Rehabil 2009;90:1734-
1739. 
No beliefs and TA 
26 Medina-Mirapeix et al. J Rehabil Med 2009;41:347-352. Qualitative study 
27 Salah Frih et al, Ann Phys Rehabil Med 2009;52:485-496. No beliefs and TA 
28 Slade & Keating. BMC Musculoskelet Disord 2009;10:1-8. Feasibility paper 
29 Allen et al. Nurs Res 2008;57:107-112. No beliefs and TA 
30 Brenner et al. Perspect 2008;32:5-11. No beliefs and TA 
31 Davis et al. Pain Manage Nurs 2008;9:171-179. No beliefs and TA 
32 Häkkinen et al. Clin Rehabil 2008;22:592-600. No beliefs and TA 
33 Jensen et al. Intl J Clin Experi Hyp 2008;56:156-169. No beliefs and TA 
34 McDonough et al. BMC Musculoskelet Disord 2008; 9:1-
10. 
Feasibility paper 
35 Molton et al. J Pain 2008;9:606-612. No beliefs and TA 
36 Oliveira et al. J Clin Psychol Med Settings 2008;15:338-
343. 
Qualitative study 
37 Schwarzer et al. Health Psychol 2008;27:54-63. Not purely CP 
38 Basler et al. Eur J Pain 2007;11:31-37. No beliefs and TA 
39 Krein et al. Gerontologist 2007;47:61-68. Not purely CP 
40 Liddle et al. Disabil Rehabil 2007;29:1899-1909. Qualitative study 
41 McGowan et al. Br J Health Psychol 2007;12:261-274. Qualitative study 
42 Cook & DeGood. Clin J Pain 2006;22:332-345. No beliefs and TA 
43 Dobkin et al. Clin J Pain 2006;22:286-294. No beliefs and TA 
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44 Mailloux et al. Am J Phys Med Rehabil 2006;85:120-126. No beliefs and TA 
45 Mori et al. Mil Med 2006;171:917-923. Not purely CP 
46 Morsø et al. BMC Musculoskelet Disord 2006;7:1-5. No beliefs and TA  
47 Austrian et al. J Am Geriatr Soc 2005;53:856-861.  Qualitative study 
48 Hirsh et al. Clin J Pain 2005;21:302-310. No beliefs and TA 
49 Lyngcoln et al. J Hand Ther 2005;18:2-8. No beliefs and TA 
50 Michalsen et al. J Alt Comp Med 2005;11:601-607. No beliefs and TA 
51 Proctor et al. Arch Phys Med Rehabil 2005;86:1509-1515. No beliefs and TA 
52 Middleton. Phys Ther Rev 2005;9:153-160. Descriptive paper 
53 Bassett. NZ J Physio, 31(2), 60-66. Descriptive paper 
54 Broderick et al, 2003, Ann Behav Med 2003;26:139-148. No beliefs and TA 
55 Carroll & Whyte. Br J Ther Rehabil 2003;10:53-58. No pre-post measure 
56 Iversen et al. Arch Phys Med Rehabil 2003;84:1324-1331. No beliefs and TA 
57 Jensen et al. J Pain 2003;4:477-492. Descriptive paper 
58 Kolt & McEvoy. Man Ther, 2003;8:110-116. No beliefs and TA 
59 Reid et al. Pain Med 2003;4:223-230. No beliefs and TA 
60 Stone et al. Pain 2003;104:343-351. No beliefs and TA 
61 Stone et al. Control Clin Trials 2003;24:182-199. No beliefs and TA 
62 Alexandre et al. Pan Am J Public Health 2002;12:86-94. Not purely CP 
63 Cipher et al. J Health Psychol 2002;7:665-673. No beliefs and TA 
64 Evers et al. Pain 2002;100:141-153. Pharmacological focus 
65 Jamison et al. Pain Med 2002;3:92-101.  No beliefs and TA 
66 Naylor et al. J Pain 2002;3:429-438. No beliefs and TA 
67 Rainville et al. Spine J 2002;2:402-407. No beliefs and TA 
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68 Jamison et al. Pain 2001;91:277-285. No beliefs and TA 
69 Gibson & Helme. Pain 2000;85:375-383.  No pre-post measure 
70 Hoodin et al. Headache 2000;40:377-383.  No beliefs and TA 
 
2.3 Results 
2.3.1 Description of included studies  
The search strategy yielded 591 results, with an additional 12 studies identified through 
reference screening; 81 full-text papers were assessed for eligibility and 10 papers met the 
inclusion and exclusion criteria for this review. Figure 4 outlines the flow diagram of studies 
included in this review. Two of the included studies were conducted in Canada, two in the 
United States of America, and two in the United Kingdom, and one study each in Australia, 
Switzerland, Sweden and Germany.  
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Figure 4. Flow diagram of studies included in the review 
 
 
2.3.2 Methodology  
Of the 10 studies included in the review, treatment adherence and pain belief data were 
Records identified through 
database searching 
(n = 1,208) 
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Additional records identified 
through other sources 
(n = 12) 
Records after duplicates removed 
(n = 603) 
Records screened 
(n =603) 
Records excluded 
(n = 590)  
Full-text articles 
assessed for eligibility 
(n = 80) 
Full-text articles excluded, 
with reasons 
(n = 70) 
 
No measure of pain beliefs 
and treatment adherence, 
n = 41 
Pharmacological focus,       
n = 2 
No pre-post measure, n = 2 
Not investigating chronic 
pain specifically, n = 4 
Non-English, n = 2 
Review paper, n = 2 
Qualitative paper, n = 7 
Feasibility paper, n = 6 
Descriptive paper, n = 4 
 
Studies included in 
qualitative synthesis and 
review (n = 10) 
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obtained from participant’s own self-report in seven studies. The remaining three studies 
collected data using a combination of self-reported data from participants and data reported 
by the patient’s practitioner [24-26]. Data collection varied among the studies included in the 
review. Data was collected on-site during the participant’s treatment in five studies [24,26-
28,32], via telephone interview in one study [25], and via mail in one study [29]. The 
remaining three studies did not specify their data collection method [30,31,33]. 
A meta-analysis was not possible given that the studies included here were too 
heterogeneous with very little consistency in relation to the collection and measurement of 
outcome data. 
 
2.3.3 Outcome measures  
Of the 10 studies reviewed, six studies examined chronic pain according to the International 
Association for the Study of Pain (IASP; i.e., pain symptoms with duration of greater than 
three months) definition [25-27,29-31]. One study examined chronic pain according to the 
American College of Rheumatology criteria for Fibromyalgia [28], and three studies had no 
definition of chronic pain [24,32,33]. However, as all of the 10 studies confirmed chronic 
pain by clinical interview, the latter three studies were considered eligible to be included in 
the review. 
 Of the 10 studies reviewed, five studies assessed adherence to the recommendations 
provided among multidisciplinary treatment programs, including a combination of 
psychology, physiotherapy, occupational therapy, and hydrotherapy treatment components 
[25,27,29,31,32]. One study assessed adherence to psychological recommendations [30]. The 
remaining four studies focused on adherence to exercise regimens [24,26,28,33]. Three 
studies assessed adherence to specific and standardized treatment recommendations for all 
participants [25,27,32]. Four studies tailored the prescribed treatment recommendations (i.e., 
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timing and duration) to the individual and their level of impairment [25-28]. The remaining 
five studies did not specify what recommendations were provided to participants for each of 
the treatment modalities [24,29-31,33]. Six of the 10 studies measured adherence at multiple 
time points including pre-treatment, mid-treatment and post-treatment [24,26-30]. The 
remaining four studies assessed changes in adherence only twice, at pre and post treatment 
[25,31-33]. Eight of the 10 studies reviewed used multiple regression analysis to examine 
pain-related beliefs and treatment adherence. And the remaining two studies used either 
ANOVA [33] or ANCOVA [24]. 
 
2.3.4 Pain-related beliefs investigated  
The most common pain-related belief investigated in relation to treatment adherence was 
pain-related self-efficacy, which was examined in 7 out of 10 studies [24,26-29,31,32]. Three 
studies examined the effect of perceived disability on treatment adherence [26-30]. 
Catastrophising was examined by three studies [26-32], control beliefs were also examined 
by three studies [25,26,33] and two studies examined the effect of fear-avoidance beliefs 
[26,27]. Other pain-related beliefs that were examined to a lesser degree included perceived 
threats and perceived consequences [33], perceived interference [25], perceived benefits 
[25,28,33], perceived barriers [28,33], expectation of treatment [33] and attitude toward 
treatment [25].  
2.3.4.1 Self-efficacy Self-efficacy beliefs in people with chronic pain have been assessed both 
by reference to confidence in ability to perform specific tasks and to confidence in 
performing more generalised constructs like coping with pain [34]. Seven of the reviewed 
studies examined the effect of pain-related self-efficacy on treatment adherence. Two studies 
measured pain-related self-efficacy using the Pain Self-Efficacy Questionnaire [27,32]. Two 
studies used the Arthritis Self-Efficacy Scale [28,29]. Only one study used The Exercise Self-
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Efficacy Questionnaire [26], the Sports Injury Rehabilitation Survey [24], or a patient goal 
expectancy rating [31] to measure pain-related self-efficacy.  
Five of the seven studies that measured self-efficacy found a significant relationship 
between self-efficacy and treatment adherence; whereby, low self-efficacy at baseline was 
associated with reduced adherence to treatment recommendations post treatment 
[24,26,27,29,32]. The strength of these relationships between pain-related self-efficacy and 
treatment adherence was strong and positive in four out of the five studies [24,27,29,32]. One 
study found low, but significant, positive correlations between pain-related self-efficacy 
scores and treatment adherence scores [26]. The remaining two studies showed no 
relationship between self-efficacy and treatment adherence [28,31].  
2.3.4.2 Perceived disability Perceived disability in people with chronic pain is 
generally assessed by reference to a person’s perceived ability to perform specific tasks (e.g., 
home duties) [35]. Three studies examined the effect of perceived disability on treatment 
adherence, with varying descriptions. For example, some studies measured disability [28,29]; 
whereas, another study measured pain disability specifically [30]. Two studies measured 
perceived disability using the Fibromyalgia Impact Questionnaire [28-29].  One study used 
the Pain Disability Index [30] to measure perceived disability. Two studies found moderate to 
strong negative associations between perceived disability and treatment adherence [28,29]. 
The one study that used the Perceived Disability Questionnaire showed no relationship [30]. 
Two of the three studies highlighted that experiencing high perceived disability at baseline 
was associated with reduced adherence to treatment recommendations post treatment [28,29]. 
Moreover, pain patients with low perceived disability at baseline were more likely to actively 
engage in treatment and adhere to treatment recommendations post treatment. 
2.3.4.3 Catastrophising Pain catastrophising is characterised by the tendency to 
exaggerate and ruminate negative cognitions and emotions during actual or perceived painful 
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stimulation [36]. Three studies examined the relationship between catastrophising and 
treatment adherence [27,26,32]. Two studies used the Pain Catastrophising Scale [26,32]. The 
remaining study used the Catastrophising Scale of the Pain Response Self-Statements Scale 
[27]. Two studies reported a strong negative relationship between catastrophising scores and 
treatment adherence [27,32]. In these studies, individuals with high catastrophising scores at 
baseline were at greater risk of early cessation of treatment and were less likely to adhere to 
treatment recommendations over time than those with low catastrophising scores at baseline. 
The remaining study found no relationship between catastrophising and treatment adherence 
[26]. 
2.3.4.4 Control beliefs Control beliefs in relation to pain refer to an individual's belief 
about the presence of factors that may facilitate or impede their ability to manage pain 
symptoms [37]. Control beliefs were examined in three studies [25,26,33]. More specifically, 
two studies examined Locus of Control [26,33], and one study examined the patient’s 
perceived control of managing their pain as well as their perceived control of treatment [25]. 
All three studies showed no relationship between control belief scores and treatment 
adherence. 
2.3.4.5 Fear-avoidance beliefs Fear-avoidance is characterised by a trajectory of 
avoidant behaviour due fear of pain, injury, or re-injury. This increases deterioration of 
functioning and worsens pain over time; subsequently, trapping fear-avoidant individuals in a 
cycle of disability and suffering [38]. Fear avoidance beliefs were examined in two studies 
[26,27]. Nicholas et al [27] used the Tampa Scale for Kinesiophobia (TSK) and found a 
negative correlation between fear-avoidance beliefs and treatment adherence. Whereby, 
higher degrees of adherence to treatment recommendations were predictive of greater pre-
post treatment changes in fear-avoidance beliefs. However, Mannion et al [26] used the Fear-
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Avoidance Beliefs Questionnaire and found no significant association between fear-
avoidance beliefs and treatment adherence. 
2.3.4.6 Other pain-related beliefs Perceived barriers relate to individual’s opinions of 
the tangible and psychological costs associated with treatment adherence [39]. Perceived 
barriers were examined in two studies [28,33]. The results from each study show a significant 
negative association between perceived barriers and adherence to treatment 
recommendations. Perceived benefits relate to individual’s beliefs in the efficacy of treatment 
adherence to reduce risk or seriousness of chronic pain symptoms [39]. Perceived benefits 
were examined in three studies [25,28,33], with two of those studies showing a significant 
positive association [25,28], and one study showing no significant relationship [33].  
A range of other pain-related beliefs were also investigated in the reviewed studies. 
One study each examined perceived threats [33], perceived consequences [33], perceived 
interference [25], expectation of treatment [33], and attitude toward treatment [30]. However, 
given that each of the aforementioned pain-related beliefs were only examined in a single 
study, the authors of this review considered there to be not enough evidence for reliable 
conclusions to be drawn. Therefore, these studies are not discussed further. 
2.4 Discussion 
This review provides a systematic evaluation of the existing literature on pain-related 
beliefs and their associations with treatment adherence among chronic pain patients. Ten 
studies met the inclusion criteria for this review. Given the differences between the 
descriptions of pain-related beliefs, the wide variety of treatment recommendations, and the 
numerous methodologies included, a narrative methodology was selected. While this review 
summarised the findings of each type of pain-related belief separately, it is important to note 
that most of the reviewed studies examined a combination of these beliefs. The multiple 
positive relationships identified here suggest that treatment adherence is determined by a 
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combination of pain-related beliefs either supporting or inhibiting chronic pain patients’ 
ability to adhere to treatment recommendations over time. 
 
2.4.1 Which pain-related beliefs have been investigated as correlates of treatment adherence 
and what do the findings reveal?  
Pain-related beliefs such as self-efficacy, perceived disability, catastrophising, fear-avoidance 
beliefs as well as other pain beliefs such as perceived benefits and barriers of treatment have 
been implicated in treatment adherence. To date, the pain-related belief with the most 
empirical support is self-efficacy. The findings of the studies included in this review 
consistently showed that high baseline levels of self-efficacy related to one’s ability to 
manage pain were predictive of increased adherence to treatment recommendations. 
According to the results of one study [26], increases in self-efficacy over the course of 
treatment also predicted increased adherence. This result indicates that high self-efficacy at 
the beginning of treatment is important for establishing treatment adherence mid and post-
treatment; additional research may be needed to confirm these findings.  
Perceived disability was also reported as a predictor of treatment adherence among 
chronic pain patients. The extent that patients perceive themselves to be disabled by their 
chronic pain can strongly predict the likelihood that they will adhere to treatment regimens 
[6]. Additional literature shows that self-efficacy has considerable implications for perceived 
disability and treatment adherence [4,38]. Low self-efficacy beliefs appear to serve as a 
cognitive barrier to patient’s attempts to function normally by increasing perceptions of a 
long-term disability. That is, patients who exhibit high self-efficacy for managing chronic 
pain symptoms are also more likely to have significantly higher pain thresholds, have fewer 
severe symptoms, a better quality of life and possibly fewer problems with mobility and 
suffering; thereby, reducing perceptions of disability [41]. This, in turn, may increase the 
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likelihood that patients will demonstrate self-managing behaviours and adhere to treatment 
over time.  
The results of this review also suggest that pain patients who present with high 
catastrophising beliefs about their pain prior to treatment may be at greater risk of non-
adherence to treatment recommendations compared to pain patients with low catastrophising 
beliefs. According to Edwards et al [42], the construct of catastrophising is closely associated 
with depression; including, magnification of pain-related symptoms, rumination about pain, 
feelings of helplessness, as well as pessimism about treatment and pain-related outcomes. 
Cognitions such as these are likely to impede patient’s ability to engage and persevere with 
intervention. Subsequently, treatment aimed to reduce catastrophising and/or co-morbid 
depression prior to or during the treatment of chronic pain may increase adherence behaviour. 
This is likely to be relevant for all of the reviewed pain-related beliefs. That is, baseline 
indicators of treatment barriers that are not identified and addressed prior to or during chronic 
pain intervention may adversely impact treatment outcomes, and potentially worsen pain-
related beliefs and/or contribute to the development of co-morbid psychological problems 
[43].  
Contrary to expectation, no one construct of control was found to significantly predict 
adherence to treatment recommendations over time. This finding may be the result of 
heterogeneity between studies measuring control beliefs; with three different constructs of 
control (i.e., Locus of Control, perceived control of managing pain, perceived control of 
treatment) being measured among four studies. According to Skinner [44], the lack of clarity 
about constructs has led to theoretical, empirical, and practical costs to the study of control 
beliefs. Theoretically, the large number of terms used to describe control has produced 
confusion about the boundaries on the topic of control, the interrelationships that exist among 
constructs, and which constructs can be appropriately included in the research of control [44]. 
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Researchers may need to be more explicit in their assessment of control beliefs if they want 
to operationalize their target constructs successfully.  
According to additional literature [4,38,45], fear-avoidance beliefs are common 
cognitive distortions among chronic pain patients. However, of the two studies which 
explored this relationship in this review, only one found fear-avoidance beliefs to be 
predictive of treatment adherence outcomes. According to this study [27], pain sufferers who 
avoid activity because of fear of pain, injury, or re-injury may be less likely to engage and 
adhere to treatment. Ongoing avoidance of treatment may then lead to additional health 
problems and worsened disability; propelling patients in to what is known as the ‘fear 
avoidance pain cycle’ [45]. However, given the limited number of studies investigating the 
relationship between fear-avoidance beliefs and treatment adherence it is difficult to draw 
conclusions from these findings. Finally, there is some evidence to suggest that perceived 
benefits and barriers to treatment are correlated with adherence to recommendations. That is, 
chronic pain patients who perceive benefits of treatment prior to the commencement of 
intervention are more likely to adhere to recommendations post-treatment and over time 
compared to patients who perceive no benefits or patients who perceive barriers of treatment 
at the outset. These findings support the notion of the Health Belief Model (HBM), that 
perceived benefits and barriers are important predictors of behaviour change [39]. However, 
these findings should be interpreted with caution given that perceived benefits and barriers 
were investigated in relatively few studies.  
 
2.4.2 What methodological issues arise in studies of pain-related beliefs and treatment 
adherence to date?  
Similar to other systematic reviews, our review is bound to publication bias and we cannot 
exclude that we may have missed some relevant studies, despite the fact that we used a highly 
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sensitive search strategy and consulted an experienced librarian, as recommended by 
Crumley et al. [46]. 
Given that pain-related beliefs and, in some cases, treatment adherence are examined 
using self-report measures, it is possible that a relationship between beliefs and treatment 
adherence reflect a social desirability response bias [47]. For example, perhaps some patients 
chose to ‘fake bad’ or present a more favourable image of themselves in order to gain 
approval. In addition, many studies examined the effects of psychological variables such as 
depression on treatment adherence. Pain patients with unhelpful beliefs as well as depression 
may make more negative assertions about his or her level of disability, potentially increasing 
the likelihood of self-report bias [48]. While the majority of empirical findings support the 
notion that pain-related beliefs impact the likelihood that treatment recommendations will be 
adhered to, the relationship of pain-related beliefs to adherence behaviour alone may not be 
sufficient to improve outcomes; with other factors, such as psychological variables, 
potentially contributing to or mediating adherence changes. In this case, shared variance with 
other factors such as depression may have obscured an independent relationship in the 
analyses.  
In addition, while pain-related beliefs and treatment adherence were measured at pre 
and post treatment for all studies, no study measured the variables at the same time points 
(e.g. 2 months, 6 months etc.). It is largely to be expected that adherence during treatment 
will differ to some extent compared to adherence post-treatment as behaviour is self-directed 
without the additional guidance and motivation provided by a treating clinician. However, 
individual differences that exist among pain sufferers are also likely to dictate the 
applicability and duration of use of particular strategies, adding further complexity and 
limitation to obtaining homogeneity among time points. Curren et al [32] highlights this point 
with the following example. Whereby, a patient who returns to a genuinely active lifestyle 
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may not require ongoing adherence to pacing of activities compared to a patient who 
experiences frequent and recurrent pain flares. These individual differences and varying 
responses to intervention serve to illustrate the ongoing challenges of measuring adherence 
and interpreting comparative studies.  
Another issue relates to the various measures of adherence used in individual studies, 
which resulted in different types of adherence being measured. That is, among the 10 studies 
included in the review, 12 different measures of adherence were used. Some studies included 
general measures of adherence (e.g., program attendance), other studies included specific 
measures of adherence (e.g., adherence frequency), and a few studies included both general 
and specific measures of adherence. This variation between studies made it difficult to collate 
the measures used, potentially implicating the interpretation of findings. These differences 
undeniably stem from the broad definition of adherence itself which implies various potential 
methods of measurement. The all-encompassing nature of this definition is considered to be 
beneficial, in many cases; however, research that aims to establish more homogenous 
methodologies for measuring adherence, specifically, may be useful to better determine the 
efficacy of treatment interventions and the implications for self-management. 
Finally, the papers in this review investigate adherence to treatment recommendations 
by means of various psychological approaches (e.g., Acceptance and Commitment Therapy, 
ACT; Cognitive Behavioural Therapy, CBT). This is a theoretical issue which not only raises 
questions about what constitutes appropriate treatment for chronic pain; it also appears to 
have implications for adherence behaviour. For example, whereas, Curren et al [32] found 
adherence to ACT-based treatment recommendations to be only weakly related to pain-
related beliefs. Nicholas et al [27] found adherence to CBT-based treatment 
recommendations to be more strongly related to pain-related beliefs. More thorough 
investigation of the differences between psychological (as well as the varying treatment 
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approaches among other disciplines required for chronic pain management) approaches on 
chronic pain outcomes is needed to progress the literature in this field. 
 
2.4.3 What recommendations can be made based on research to-date?  
More research is needed to further investigate the role that pain-related beliefs play in 
treatment adherence. A longitudinal prospective study examining pain-related beliefs and 
treatment adherence throughout treatment and post-treatment would provide the most 
comprehensive review of the pain-related beliefs which impact on treatment adherence. This 
proposed methodology is rare as only 3 out of the 10 studies included in this review 
followed-up on pain patient’s adherence to treatment recommendations after 6 months 
[29,30,33]. This is surprising as the literature has long established that patients who adhere to 
treatment recommendations consistently for 6 to 12 months are significantly more likely to 
maintain adherence behaviour over time and, thus, improve treatment outcomes [14]. 
Although the WHO continues to support the general notion that the longer treatment 
recommendations are adhered to, the better the outcomes will be [7]. There appears to be an 
enhanced understanding of individual characteristics (e.g., unhelpful pain beliefs, pain 
intensity, co-morbid mental illness) which are likely to confound the period of time required 
for adherence to improve treatment outcomes. For example, a patient with low pain intensity 
may successfully manage pain symptoms by adhering to treatment recommendations for less 
than 6 months compared to a patient with high levels of pain. Subsequently, research which 
includes follow-up pre-post 6 months of treatment alongside investigations of individual 
characteristics and their impact on the necessary time frame for adherence is needed. 
Although the results from this review indicated that higher baseline self-efficacy, 
lower perceived disability, and lower catastrophizing were variously related to improved 
adherence (in the subset of studies measuring them), few studies measured how changes in 
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these pain-related beliefs from pre to post treatment impact adherence. This research would 
help to identify if specific pain-related beliefs (compared to others) and/or changes (e.g., 
improvements) in pain-related beliefs over time impact adherence behaviour. Currently, there 
is evidence to support the efficacy of tailoring treatments to target specific pain-related 
beliefs; this, in turn, may maximise treatment adherence outcomes. However, there needs to 
be more consistency in the descriptions of pain-related beliefs measured in the literature to 
allow for more meaningful collation of results [44].  
This issue of inconsistency extends to the broader methodology used to measure 
treatment adherence. Although, the Initiative on Methods, Measurement, and Pain 
Assessment in Clinical Trials (IMMPACT) have highlighted the importance of obtaining 
both objective (i.e., observation) and subjective (i.e., self-report) measures of pain outcomes 
[49]; there remains no consensus on the optimal method for measuring adherence to 
treatment recommendations (as indicated in Hall et al., 2014 systematic review), with the 
majority of literature examining adherence using self-report diaries and/or non-standardised 
questionnaires. Subsequently, it is recommended that research focus on establishing valid and 
reliable methodological guidelines, such as: (1) consistent research designs and study 
instruments, (2) use of standardised and specific (as opposed to general) adherence measures, 
(3) larger sample sizes (increase the likelihood of detecting significant associations between 
variables), and (4) improved control of potentially confounding variables (e.g., 
miscommunication between patient and provider, deficits in the knowledge or skills of the 
patient, as well as age, gender, and cultural factors)[50]. Improving the methodology for 
measuring adherence will allow for greater comparability of studies and an enhanced 
understanding of the relevant predictors of treatment non-adherence.  
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2.5 Conclusion 
Collectively, the empirical findings from this review highlight the importance of 
addressing pain-related beliefs prior to or during intervention, as improvement of unhelpful 
beliefs may increase patients’ ability to engage in treatment and reduce disability outcomes. 
In the studies reviewed, self-efficacy regarding one’s ability to manage pain appears to be the 
most consistently measured pain-related belief in relation to treatment adherence, and its 
effects may also influence other pain-related beliefs. Therefore, programs that specifically 
incorporate self-efficacy enhancing components such as self-management education are 
likely to yield important and beneficial effects that can be valuable in the management of 
chronic pain. Given the immense scale of the problem, and the potential for efficacious 
treatment adherence to significantly improve the lives of both pain sufferers, their families 
and communities; it is very important that research in this area continue and thus provide a 
more solid base on which to further develop chronic pain interventions. 
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Chapter 3  
 
Method 
 
 The chapters to follow will present two investigative studies (under review). Study 
Two examines the links between chronic pain symptoms and affective disorders. This is a 
retrospective study using network analysis, a novel approach which provided insights into the 
relationship between chronic pain and psychological variables. Study Three addresses the 
important question about treatment adherence and maintenance in chronic pain patients 
following pain management intervention. This is a prospective longitudinal study assessing 
chronic pain patients at pre-intervention (intake), post-intervention (discharge) and 3 to 6 
months post-intervention (follow-up). Below, the methodology involved in undertaking each 
study will be discussed in-depth before presenting Studies Two and Three individually as 
subsequent chapters.  
 
 
3.1 Study Two method expanded 
3.1.1 Participants  
The initial sample pool consisted of 743 chronic pain patients who had attended a pain 
management program at The Victorian Rehabilitation Centre (TVRC) Pain Management 
Clinic (PMC). The final sample comprised of 169 consenting chronic pain patients who had 
received treatment from TVRC PMC between 2007 and 2016. The age of the participants at 
the time they began treatment ranged from 22 to 80 years (M=49.72, SD=11.48). The final 
sample comprised of 71 males (42%) with a mean age of 48.39 years (26 to 71 years) and 98 
females (58%) with a mean age of 50.85 years (24 to 80 years).   
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The sample was predominantly Australian born (N=123, 72.8%), with 4.7% (N=8) 
born in Europe, 5.9% (N=10) born in England, 4.7% (N=8) born in Asia, 3.6% (N=6) born in 
the United States, and 3% (N=5) born in Africa. The remaining 5.3% (N=9) did not specify 
their country of birth. Fifty six percent of participants (N=94) were married, 19.5% (N=35) 
were single, 11.3% (N=19) were divorced or separated, 4.7% (N=8) were in a defacto 
relationship and 1.8% (N=3) were widowed. The remaining 6.7% (N=10) did not specify 
their marital status.  
Chronic pain conditions varied considerably among participants. For this reason, and 
for ease of interpretation, they have been categorised according to participants’ primary pain 
complaint, as follows: 87.6% (N=148) reported general musculoskeletal pain (e.g., back, 
limbs), 8.3% (N=14) widespread pain (e.g., fibromyalgia), 2.4% (N=4) specific whiplash 
pain, and 1.8% (N=3) headache. Among the participants in this sample, 56.2% (N=95) had 
pain at three or more locations, 26.6% (N=45) had pain at two locations, and 17.2% (N=29) 
had pain at a single location. Fifty five percent (N=94) of participants acquired chronic pain 
in the past 0-5 years, 21.3% (N=36) in the past 5-10 years, 14.8% (N=25) in the past 10+ 
years, and 8.3% (N=14) did not specify a pain onset date.   
 
3.1.2 Materials 
Participants completed the following questionnaires: (1) Depression, Anxiety, and 
Stress Scale, short form (DASS-21); (2) Pain Self-Efficacy Scale (PSEQ); (3) The TAMPA 
Scale of Kinesiophobia (TSK); (4) The Survey of Pain Attitudes, revised version (SOPA-R) 
and; (5) Perceived Disability Index (PDI). Cronbach’s alpha scores of greater than α = .70 are 
considered sufficient for the use of a scale (DeVellis, 2003). Chronbach’s alpha is sensitive to 
item number, as such scales with less than ten items which do not meet α = .70 or above 
requirement should report the mean inter-item correlation which between .2 to .4 is 
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considered sufficient reliability (Briggs & Cheek, 1986). All scales had a Cronbach’s alpha 
score greater than or equal to α = .70. Descriptions of each questionnaire are detailed in the 
measures section to follow. 
 
3.1.3 Measures 
3.1.3.1 Demographic information  
Demographic information was collected from the intake assessment form. This 
included current age and sex of the participant, marital status, and country of birth. Pain 
characteristics detailing the presenting complaint and pain location, pain intensity and onset 
date of pain (or injury) were also collected. 
3.1.3.2 Affective symptoms  
Affective symptoms were measured by the Depression Anxiety and Stress Scale 21 
(DASS-21) is a shortened form of Lovibond and Lovibond’s (1995) original 42-item self-
report measure of depression, anxiety and stress. The DASS-21 is a 21-item self-report 
questionnaire used to measure the severity of symptoms common to depression (e.g., ‘I felt 
that life was meaningless’), anxiety (e.g., ‘I felt scared without any good reason’) and stress 
(e.g., ‘I found it hard to wind down’). Given the specific interest in depression and anxiety 
symptomatology, the current research utilised only the Depression and Anxiety subscales. 
The DASS-21 is not a diagnostic tool but is widely used as a screening tool for psychiatric 
symptoms. Participants were asked to respond to each item in terms of the presence of the 
symptom over the last seven days. Each item is scored from zero (did not apply to me at all 
over the last week) to three (applied to me very much or most of the time over the last week). 
Scores for each subscale are summed and multiplied by two (for the 21 item short form) to 
produce an overall score for each of depression, anxiety and stress. Scores for each subscale 
can range from zero to 126 with higher scores reflecting elevated symptomatology. Henry 
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and Crawford (2005) tested the validity of the DASS-21 on a large non-clinical sample (N = 
1794). Chronbach’s alpha was α =.89 for the ‘depression’ scale, α =.82 for ‘anxiety’, α =.90 
for ‘stress’ and α =.93 for the total ‘psychological adjustment’ scale. The current study used 
two of the DASS subscales, Depression and Anxiety for analyses. In the present study, 
Cronbach’s alpha was .96 alpha for both depression and anxiety 
3.1.3.3 Pain self-efficacy  
Pain Self-efficacy symptoms were measured by the Pain Self-Efficacy Questionnaire 
(PSEQ; Nicholas, 1989) was developed as a behaviour specific measure of self-efficacy, 
measuring participants’ confidence in their ability to perform a range of activities while in 
pain. The PSEQ is a 10-item self-report questionnaire, covering a range of functions, 
including household chores, socialising, work, as well as coping with pain without 
medication. The scores are anchored with a 7-point Likert scale (0 = not at all confident to 6 
= always confident) and participants are asked to indicate to what extent they agree with each 
statement. Each item on the scale is worded positively and preceded by the phrase ‘I can’ 
(e.g., ‘I can enjoy things, despite pain’). The scores for each item are summed to produce a 
total pain self-efficacy score and produce a range from 0 - 60, with higher scores indicating 
clinically-significant functional levels and greater confidence in managing pain. 
Psychometric testing of the PSEQ showed a high internal consistency (α = 0.92; van der 
Maas et al., 2012). The PSEQ also has strong construct validity, with testing showing 
evidence of the PSEQ’s sensitivity to change over time. The current study used the total 
PSEQ score for analyses. In the present study, Cronbach’s alpha was .92. 
3.1.3.4 Fear-avoidance beliefs 
 Fear avoidance beliefs were measured by the TAMPA Scale of Kinesiophobia (TSK; 
Miller, Kori & Todd, 1991) was developed as a measure of fear of movement or (re)injury. 
Kinesiophobia as an irrational and debilitating fear of physical movement and activity 
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resulting from a feeling of vulnerability to painful (re)injury. The formulation of this scale 
has been based on the model of fear avoidance, fear or work-related activities, fear of 
movement, and fear of re-injury and has been linked to elements of catastrophic thinking 
(Vlaeyan et al., 1995). The TSK is a 17-item self-report questionnaire and each item is scored 
from one (strongly disagree) to four (strongly agree). ‘I’m afraid that I might injure myself if 
I exercise’ is an example of an item on the TSK. The total score ranges between 17 and 68 
with a high value on TSK indicating a high degree of kinesiophobia (i.e., an excessive, 
irrational and debilitating fear of physical movement and activity due to injury or re-injury). 
Roelofs et al (2004) tested the validity of the TSK on a sample of chronic low back pain 
(CLBP) and fibromyalgia patients. The current study used the total TAMPA score for 
analyses. In the present study, Cronbach’s alpha was .76. 
3.1.3.5 Perceived control 
Perceived Control was measured by the Survey of Pain Attitudes revised version 
(SOPA-R; Jensen & Karoly, 1989) is a measure of beliefs which possibly influence long term 
adjustment for people with chronic pain. The SOPA-R requires patients to indicate their level 
of agreement to 35 items using a 5-point Likert scale (0 = this is very untrue for me to 4 = 
this is very true for me) to indicate the extent to which they agree with statements such as 
‘when I am hurting, I deserve to be treated with care and concern’. The beliefs measured are 
divided into two general categories: (1) Adaptive Beliefs (i.e., beliefs that are thought to 
contribute to less pain and disability over time) which includes two subscales (Control and 
Emotion), and (2) Maladaptive Beliefs (i.e., beliefs that are thought to contribute to greater 
pain and disability over time) which includes five subscales (Disability, Harm, Medication, 
Solicitude, Medical Cure). Of the seven SOPA-R subscales, the current study used the 
Control subscale (5 items), with possible scores ranging from zero to 20. Lower scores on the 
SOPA-R Control subscale indicate low perceived control. Psychometric testing of the SOPA-
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R showed internal consistency ratings for the seven SOPA-R subscales to range from α = .65 
to .82 (Jensen, Turner & Romano, 2000). In the present study, Cronbach’s alpha was .83. 
3.1.3.6 Pain disability  
Pain Disability was measured by the Pain Disability Index (PDI) was developed to measure 
the impact that pain has on the ability of a person to participate in essential life activities 
(Pollard, 1984). The PDI is an inventory that asks respondents the rate to which pain 
interferes with their functioning pertaining to six broad areas (items): family/home 
responsibilities (item 1), recreation (item 2), social activity (item 3), occupation (item 4), 
sexual behaviour (item 5), and life-support activity (item 6). Scores are assigned based on an 
11-point Likert scale ranging from 0 (no disability) to 10 (worst disability). Each item is 
explained under its respective heading; for example, ‘Recreation – This category includes 
hobbies, sports, and other similar leisure time activities’. The total score ranges from 0-60 
with higher PDI scores indicating greater disability associated with pain. The PDI has been 
found to be internally consistent (Cronbach’s Alpha = .87) and to exhibit a factor structure 
that represents disability in voluntary and obligatory activities shown to be consistent with 
the model of disability proposed by Fordyce (1984). The current study used the total PDI 
score for analyses. In the present study, Cronbach’s alpha was .85. 
3.1.4 Procedure 
The Deakin University Human Research Ethics Committee (DU HREC: 2012-147) 
and The Melbourne Clinic Research Ethics Committee (TMC REC: 206) approved this 
research (refer to Appendix A and B). As a requirement to access the TVRC medical records, 
the researchers of this study were required to sign a confidentiality agreement. Participant 
information was gained retrospectively from medical records. To ethically access this 
information, all patients, aged 18 years or older, who had received pain treatment at TVRC 
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were sent a letter from the TVRC director (Appendix C), a Plain Language Statement 
(Appendix D), and a consent form (Appendix E) inviting them to participate in the study. 
Participants were informed that the study was voluntary, that their participation would not 
impede their relationship with TVRC, and that they may withdraw participation from the 
study at any time without negative consequences. Only patients who consented, were 
included in the study.  
Each archival medical record comprised one assessment form containing 
demographic information and details of pain characteristics which was obtained during 
participants’ initial consultation by TVRC clinicians. At the time, the intake assessment took 
approximately 30 to 45 minutes to complete. Medical records also contained a battery of 
questionnaires (DASS-21, PSEQ, TAMPA, SOPA-R, and PDI) completed by participants 
pre-treatment. The battery of questionnaires took participants approximately 15 minutes to 
complete. Participants were not provided with any incentive or reward to participate in this 
study.  
 
3.2 Study Three method expanded 
3.2.1 Participants 
The initial sample consisted of 169 chronic pain patients who had completed 
treatment at The Victorian Rehabilitation Centre (TVRC) Pain Management Clinic between 
2007 and 2016. Participants were excluded from the study for any one or more of the 
following reasons: 1) incomplete time points, 2) data had expired beyond the timeframe of 
data collection for the study, and 3) no consent or return follow-up measures provided. This 
resulted in a total sample of 61 eligible chronic pain patients who had received treatment 
from TVRC PMC between 2014 to 2016 who completed the study to follow-up. This is equal 
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to an attrition rate of 64%. Figure 5 outlines participant numbers, measures administered by 
time-point as well as inclusion and exclusion criteria for Studies 2 and 3. 
The age of the participants in the final sample at the time they began treatment ranged 
from 31 to 72 years (M=54.28, SD=10.32). Of the 61 participants, 36 males (59%) with a 
mean age of 47 years and 25 females (41%) with a mean age of 54.2 years. The sample was 
predominantly Australian born (N=44, 72.3%), with 12% (N=7) born in Europe, 6.4% (N=4) 
born in Asia, and 3.5% (N=2) born in the United States. The remaining 5.8% (N=4) did not 
specify their country of birth.  Forty three percent (N=26) were married, 28.3% (N=17) were 
divorced or separated, 14% (N=9) were single, and 7.4% (N=5) were in a defacto 
relationship. The remaining 7.3% (N=4) did not specify their marital status. The majority of 
participants experienced musculoskeletal pain (N=39, 64.8%), 14.3% (N=9) widespread pain 
(e.g., fibromyalgia), 10.6% (N=6) specific whiplash pain, 6.1% (N=4) headache, and 4.2% 
(N=3) abdominal pain. Among the participants in this sample, 54.2% (N=33) had pain at 
three or more locations, 26.7% (N=16) had pain at two locations, and 19.1% (N=12) had pain 
at a single location.   
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        Study 2                                              Study 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Participant numbers, measures administered by time-point and inclusion and 
exclusion criteria for Studies 2 and 3 
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3.2.2 Treatment 
The treatment programs were individually tailored to the patient goals and needs 
identified during the multidisciplinary assessment. The range of length for the programs was 
between 6 and 12 weeks’ duration, 2-3 days per week for 1-4 hours per day, depending on 
patient goals, needs, and individual capacity and ability to attend.  
The programs were all delivered by a multidisciplinary team including a 
physiotherapist (delivering land and water based therapy weekly), psychologist (all 
participants had individual sessions with the psychologist weekly), and occupational therapist 
(delivering weekly sessions focused on functional and vocational goals). All clinicians were 
fully qualified and experienced practitioners working within a private pain clinic. 
All participants received individual treatment sessions from all three disciplines, and 
those who were appropriate to attend group education and relaxation sessions (no major 
psychological, physical, language or intellectual barriers, not hearing impaired, etc.) were 
also encouraged to attend group sessions. The group sessions included 4-6 participants in 
each group, and the education topics and relaxation training sessions were delivered over a 
period of 6 weeks (2-3 days per week). Those who did not attend the group sessions had this 
educational content and relaxation training delivered within their individual sessions. All 
participants were given a copy of the same patient manual, outlining the key concepts and 
recommendations from each of the three disciplines involved in delivering the pain 
management program (physiotherapist, psychologist, and occupational therapist). 
3.2.3 Materials 
Three batteries of questionnaires were used in this study. Each battery contained the 
same questionnaires, with the exception of the Treatment Maintenance Questionnaire (TMQ) 
which was administered only at time three (3 to 6 months follow-up). The latter questionnaire 
asked participants to report their adherence behaviour to various activities recommended to 
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them during their treatment at TVRC. Table 3 outlines the measures included at each time 
point. Refer to Appendix J and K for the complete battery of questionnaires. As the majority 
of questionnaires for this study are the same as the questionnaires used in study two, detail of 
these measures and the psychometric properties will not be repeated here. Please refer back to 
the materials section of study two in this chapter for these details. The additional measure, the 
TMQ is described below.   
 
Table 3. Study three time points and Cronbach’s alpha measures included 
Time Point Measures α 
Pre-Treatment (baseline) Depression Anxiety and Stress Scale 
Pain Self-Efficacy Questionnaire 
The TAMPA Scale of Kinesiophobia 
Survey of Pain Attitudes 
.90 
.93 
.88 
.60 
Post-Treatment (discharge) Depression Anxiety and Stress Scale .95 
 Pain Self-Efficacy Questionnaire 
The TAMPA Scale of Kinesiophobia 
.95 
.77 
Post-Treatment (3-6 months) Depression Anxiety and Stress Scale .93 
 Pain Self-Efficacy Questionnaire 
The TAMPA Scale of Kinesiophobia 
Treatment Maintenance Questionnaire 
.95 
.83 
.87 
 
3.2.4 Measures 
3.2.3.1 Depression and Anxiety  
The Depression, Anxiety, and Stress Scale (DASS-21; Lovibond & Lovibond, 1995) 
was included at each time point in this study. For more information on this scale refer back to 
the Measures section for Study Two. 
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3.2.3.2 Pain Self-Efficacy Questionnaire 
The Pain Self-Efficacy Questionnaire (PSEQ; Nicholas, 1989) was measured at each 
time point in this study. For more information on this scale refer back to the Measures section 
for Study Two. 
3.2.3.3 The TAMPA Scale of Kinesiophobia 
The TAMPA Scale of Kinesiophobia (TSK; Miller et al., 1991) was measured at each 
time point in this study. For more information on this scale refer back to the Measures section 
for Study Two. 
3.2.3.4 Survey of Pain Attitudes 
 The 5-item disability subscale of the Survey of Pain Attitudes, revised version 
(SOPA-R; Jensen, Karoly, & Huger, 1987) was used to measure patient’s self-perceived 
disability at baseline due to their chronic pain. For more information on the SOPA-R refer to 
section 3.1.3.5 of Study Two. 
3.2.3.4 Treatment Maintenance Questionnaire 
The Treatment Maintenance Questionnaire (TMQ) was developed by the researchers 
for this study. The TMQ is a 20-item questionnaire which was designed to measure 
adherence behaviour post-treatment. It was included in the final battery of questionnaires for 
participants to return as part of their follow-up measures. The questionnaire assessed 
adherence to a range of recommended activities specific to the pain treatment provided as 
part of TVRC PMP. Participants were asked to rate their level of adherence on a 4 point 
Likert Scale (where 1 = I use this strategy not at all to 4 = I use this strategy all of the time) 
in relation to five broad categories of treatment recommendations (regular exercise; 
biomechanics; relaxation techniques; activity pacing; stress and mood management). 
Participants were informed that they could score a zero if they had not been recommended to 
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use a particular strategy listed (0 = I was not recommended to use this strategy). Each 
category contained 3 items, with the exception of stress and mood management which 
contained 4 items. In total, participants could score between 0 and 64 on the TMQ.  
3.2.4 Procedure 
The Deakin University Human Research Ethics Committee (DU HREC: 2012-147) 
and The Melbourne Clinic Research Ethics Committee (TMC REC: 206) granted Ethics 
approval for this study (see Appendix A and B). As a requirement to access the TVRC 
medical records, the researchers of this study were required to sign a confidentiality 
agreement. Participant information was gained retrospectively from medical records. In order 
to ethically access this information, all patients, aged 18 years or older, who had received 
pain treatment at TVRC were sent a letter from the TVRC director (Appendix G), a Plain 
Language Statement (Appendix H), and a consent form (see Appendix I) inviting them to 
participate in the study. Participants were informed that the study was voluntary, that their 
participation would not impede their relationship with TVRC, and that they may withdraw 
participation from the study at any time without negative consequences. Only the patients 
who consented to participate in Study Three (after reviewing the cover letter and Plain 
Language Statement) had their follow-up data entered into the research database. Patients 
who participated in Study Two who had already attended their follow-up appointment, and 
whose discharge period had not exceeded that of six months, were mailed out the cover letter, 
Plain Language Statement, consent form, and questionnaire booklet, with reply paid 
envelope. Those who agreed to participate returned their signed consent forms and 
questionnaire booklets in the reply-paid envelope provided.   
Each archival medical record comprised two assessment forms containing 
demographic information and details of pain characteristics which were obtained by TVRC 
clinicians during participants’ initial consultation and at program completion. At the time, 
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both assessments took approximately 30 to 45 minutes to complete. Medical records also 
contained three batteries of questionnaires (DASS-21, PSEQ, TAMPA, SOPA-R, and PDI) 
completed by participants at each time-point; pre-treatment, discharge, and 3-6 months post-
treatment. Each battery of questionnaires took participants approximately 15-20 minutes to 
complete. Participants were not provided with any incentive or reward to participate in this 
study.  
As part of the follow-up procedure at TVRC, patients are required to attend a three 
and/or six month follow-up appointment to review their progress post-treatment. This follow-
up period was considered by the researchers to be more accommodating for the tail-end of 
potential participants who were, at the time, still completing their treatment. This meant that 
patients could participate in the study once the minimum three month period had elapsed, 
ensuring that all potential participant data could be included in the study.     
A data tracking file was kept with detailed records of each time point, the date that 
each participant was due to receive each questionnaire (i.e. the date each participant would be 
discharged and expected for a follow-up appointment). The data from the returned 
questionnaire booklets were entered into SPSS (version 21; IBM, 2013). A record was kept of 
the date each questionnaire was sent out and the date it was received back. Participants who 
did not return a questionnaire were followed up with one reminder phone call provided by the 
principle researcher of the study and re-sent the study materials via mail if their voluntary 
consent was ongoing.   
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Abstract 
 
Objective. A range of psychological constructs, including perceived pain, self-efficacy, and 
pain avoidance, have been proposed to account for the comorbidity of chronic pain and 
affective disorder symptoms. Despite the likely inter-relation among these constructs, few 
studies have explored these predictors simultaneously. As such, the relative contributions of 
these psychological influences remain an open question. The present study uses a novel, 
network model approach to help to identify the key psychological contributors to the pain-
affective disorder link. 
Design. A cross-sectional design was implemented. The sample comprised 169 chronic pain 
patients (Mage 49.82; range 22-80 years; 58% female) admitted to a metropolitan chronic pain 
clinic in Victoria, Australia. 
Method. Participants completed self-report measures of anxiety, depressive, and pain 
symptoms, pain self-efficacy, fear avoidance beliefs, perceived control, and pain-related 
disability. 
Results. Network analysis identified self-efficacy, fear avoidance, and perceived disability as 
key constructs in the relationship between pain and affective disorders, albeit in different 
ways. While self-efficacy appeared to have direct links to other constructs in the network 
model, fear avoidance and perceived disability seemed to function more as mediators, linking 
other constructs in the model. Perceived control and anxiety were found to be less influential 
in the model. 
Conclusions. Collectively, these results suggest that targeted treatment of self-efficacy, fear 
avoidance, and perceived disability may disrupt the link between pain experience and 
affective disorder symptoms. Given their independent links to pain and affective disorder 
symptoms, targeting of all three psychological constructs may be the most beneficial 
approach. 
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4.1 Introduction 
Depression and anxiety are common mental health problems with elevated prevalence 
rates among chronic pain sufferers relative to rates found in the general population 
(Demyttenaere et al., 2007; Means-Christensen, Roy-Byrne, Sherbourne, Craske, & Stein, 
2008). Accumulated evidence suggests that this relationship between chronic pain and 
affective disorder symptoms may be causal and bidirectional (e.g., Edwards et al., 2007; 
Gerrits, van Marwijk, van Oppen, van der Horst, & Pennix, 2015; Kroenke et al., 2011). 
Evidence also suggests that these prospective effects may be underpinned by a variety of 
psychological mechanisms that influence the way an individual processes pain-related 
information and perceives her/his capacity to manage their condition (Campbell, Clauw, & 
Keefe, 2003: Gatchel, Peng, Peters, Fuchs, & Turk, 2007). The present study utilises a novel, 
network-based approach to identify: (i) how well psychological processes identified in extant 
literature account for the relationship between pain severity and affective disorder symptoms, 
and (ii) which of these psychological processes are most influential for explaining the noted 
co-occurrence of these conditions. 
4.1.1 Psychological mechanisms linking affective disorder and pain symptoms 
The experience of chronic pain is associated with a range of pain-related beliefs that 
may both arise from and contribute to these pain symptoms. Perceptions of intense, enduring 
pain symptoms are likely to shape the sufferer’s beliefs about their level of perceived 
disability, control over their symptoms and prognosis, and pain-related self-efficacy (Baird & 
Sheffield, 2016; Cross, March, Lapsley, Byrne, & Brooks, 2006; Denison, Asenlöf, & 
Lindberg, 2004; Menezes Costa, Maher, McAuley, Hancock, & Smeets, 2011; Lau-Walker, 
2006). These beliefs are inter-related (Baird & Sheffield, 2016; Keefe, Rumble, Scipio, 
Giordano, & Perri, 2004), and may influence each other. For instance, an individual’s 
perceived self-efficacy in dealing with her/his symptoms may influence perceived disability 
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(Jackson, Wang, Wang, & Fan, 2014). Similarly, level of perceived disability may be the 
basis for determining the level of control one exerts over efforts to reduce pain symptoms – 
including the decision to rely on primarily passive or active self-management strategies 
(Blyth, March, Nicholas, & Cousins, 2005). 
Unfortunately, these pain-related beliefs may have a self-reinforcing nature, 
impacting the extent to which individuals engage in activities to reduce or self-manage pain 
symptoms and, in turn, the extent to which their symptoms improve, persist, or worsen over 
time (French et al., 2000). Over time, these negative pain-related beliefs may also engender 
feelings of helplessness regarding their pain symptoms, and in turn, confer risk for depressive 
and anxiety symptoms as the individual recognises the severity of their symptoms, level of 
impairment, and inability to improve their health (Allaz & Cedraschi, 2015). 
 Whilst a person’s subjective pain ratings may at times be predictable and expected 
given the extent of preceding tissue damage, it is also clear that some individuals are more 
likely than others to report intense pain experiences; regardless of whether the pain is of 
neuropathic or nociceptive origin (Butler & Moseley, 2013). For instance, individuals with 
fear avoidance beliefs tend to be hyper-vigilant to signs of pain, to be fearful or concerned 
that certain movements that may aggravate pain, and have difficulty shifting away from pain-
related thoughts (Ramírez-Maestre, Esteve & López-Martínez, 2014). They are also more 
likely to over-predict the intensity of pain they will experience in the future (Pfingsten et al., 
2001). Individuals with depression and anxiety show similar biases in information 
processing, with particular focus on negative evaluations of the self, the world and the future 
(i.e. Beck’s cognitive triad; Beck, 1976), catastrophising beliefs, and underestimating one’s 
ability to cope with difficult situations (Beck & Emery, 1985). Together, these cognitive 
distortions may serve to increase an individuals’ perceived intensity of pain symptoms, their 
perceived level of disability, decrease their sense of control over their pain, and reduce their 
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self-efficacy (i.e. confidence) in being able to self-manage their pain symptoms (Pincus & 
Morley, 2001). 
Taken together, this pattern of findings highlights a complex network of inter-related 
and potentially mutually influencing psychological factors that may perpetuate the link 
between affective disorders and pain symptom experience. However, the inter-connectedness 
of these constructs makes it difficult to identify a clear direction of effects to plausibly test 
using a longitudinal design. This inter-connectedness of symptoms also makes it difficult to 
identify the psychological factors that are most influential for the relationship between 
affective disorders and pain symptoms. 
4.1.2 A network perspective on psychological influences on affective and pain symptoms 
One intermediary step that may help to direct future efforts at longitudinal evaluation 
of proposed mediation pathways is network analysis. In standard implementation 
(Constantini et al., 2015), this analytic approach derives a visual (and numeric) network of 
associations among variables from a partial correlation matrix. In addition to highlighting the 
strength of association a variable has with another specific variable (as per a bivariate 
correlation), network analysis provides summary metrics that indicate across all associations 
how strongly related an individual variable is to other modelled variables and, by extension, 
indicates its influence. These summary metrics break down the influence of a variable in 
terms of total strength of associations with other variables (called ‘strength’ in network 
analysis parlance), as well as direct links (‘closeness’) and whether the variable functions to 
link other constructs in the model that are not directly related (‘betweenness’). 
By using partial correlations between modelled variables instead of bivariate 
correlations, the model shows any residual relationships that exist among variables after 
controlling for all other modelled variables. In this way, shared variance among a variety of 
putative predictors are removed, and it is easier to ascertain which variables may be most 
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influential for one or more outcome variables of interest. In cases such as the present study, 
where modelled variables are all anticipated to correlate to some extent, evaluation of the 
number and strength of these partial correlations helps to identify variables that may be most 
influential in the network model and for which variables they may be most influential.  
4.1.3 The present study 
Hence, the present study augmented correlational analyses with network analysis to 
gain further insights into the role of specific pain beliefs in affective disorder and pain 
severity among persistent pain patients. Based on prior research, it was anticipated that 
bivariate correlational analyses would confirm each of these pain-specific psychological 
variables (perceived disability due to pain, perceived control over pain, self-efficacy for pain 
self-management, and pain related fear-avoidance beliefs) are inter-related, and also relate to 
pain intensity and affective disorder symptom severity (anxiety and depression). It was 
further anticipated that pain intensity would be related to these affective disorder symptoms. 
To our knowledge, no prior studies have tested all of these psychological factors as predictors 
of affective disorder symptoms or pain intensity within the same model. As such, we have no 
hypotheses about which of the psychological factors will be most influential. Nevertheless, 
we will utilise centrality measures from the network analysis to make recommendations about 
which variables may be most important targets for further testing, in better understanding the 
relationships between pain symptoms, affective disorder symptoms, and pain-related 
cognitions. This is also likely to be beneficial in determining treatment targets for early 
intervention and prevention work with pain sufferers.  
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4.2 Method 
4.2.1 Participants 
In the current study, 743 patients assessed at [anonymous pain clinic] were originally 
invited to participate in the research. The final sample consisted of 169 consenting chronic 
pain patients between 22 to 80 years of age (M = 49.82, SD = 11.31) who had received 
treatment from [anonymous pain clinic] between 2007 and 2016. Entry into the treatment 
program is based on an intake assessment conducted by a multidisciplinary team comprising 
a pain specialist physician, occupational therapist, psychologist, and physiotherapist. 
Diagnosis was based on the presenting symptoms via subjective report in addition to 
physical, psychological, and functional examinations.  
4.2.2 Measures 
4.2.2.1 Demographics. Demographic information was collected from the intake 
assessment form.  This included current age and sex of the participant, marital status, and 
country of birth.  Pain characteristics detailing the presenting complaint and pain location, 
average pain intensity on the Numerical Rating Scale (NRS; rated 0-10), and onset date of 
pain (or injury) were also collected. 
  4.2.2.2 Affective symptoms. Depression and anxiety subscales from the 21-item 
Depression Anxiety Stress Scale (DASS-21; Lovibond & Lovibond, 1995) were used to 
evaluate level of depressive and anxiety symptoms. Higher scores reflect elevated 
symptomatology. In the present study, Cronbach’s alpha was .96 for both the depression and 
anxiety subscales. 
4.2.2.3 Pain self-efficacy. The 10-item Pain Self-Efficacy Questionnaire (PSEQ; 
Nicholas, 1989) was used to measure confidence in participants’ ability to perform a range of 
activities while in pain.  Participants reported how confident they felt performing a range of 
functions, including household chores, socialising, work, and coping with pain without 
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medication.  Higher scores indicate higher levels of pain self-efficacy e.g. greater confidence 
in managing pain. Cronbach’s alpha was .92 in the present study. Both the PSEQ and DASS-
21 are part of the core recommended measures currently included in the electronic Persistent 
Pain Outcomes Centre (ePPOC) national benchmarking evaluation, for both government 
funded and privatised pain management clinics in Australia (see 
http://ahsri.uow.edu.au/eppoc/index.html). 
4.2.2.4 Fear-avoidance beliefs. The 17-item TAMPA Scale of Kinesiophobia (TSK; 
Miller, Kori, & Todd, 1991) was used to measure fear of movement or (re)injury and consists 
of two subscales: ‘activity avoidance’ (i.e., avoiding movements connected with physical 
activity) and ‘somatic focus’ (i.e., pain is interpreted as a sign of harmful bodily processes). 
Higher scores indicate stronger perceptions of each subscale e.g. greater fear of movement or 
(re)injury (Swinkels-Meewisse et al., 2003). The internal consistency was alpha = .76 in the 
present study. 
4.2.2.5 Perceived control. The 35-item Survey of Pain Attitudes, revised version 
(SOPA-R; Jensen & Karoly, 1991) was used to measure the influence of beliefs and feelings 
on long term adjustment for people with chronic pain. Of the seven subscales included in the 
SOPA-R (i.e., disability, harm, medication, solicitude, medical cure, control, and emotion), 
the current study included the ‘control’ subscale only; with low scores indicating low 
perceived control. In the current study, Cronbach’s alpha was .83. 
4.2.2.6 Pain disability. The Pain Disability Index (PDI) was used to measure the self-
perceived impact that pain has on the ability of a person to participate in essential life 
activities.  Participants rate the level of interference that pain has in six broad areas of 
functioning: family/home responsibilities, recreation, social activity, occupation, sexual 
behaviour, and life-support activity. Higher PDI scores indicate greater disability associated 
with pain. Cronbach’s alpha was .85 in the present study. 
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4.2.3 Procedure 
[anonymous University] and [anonymous pain clinic] ethics committees’ approval 
was granted for this study.  Participants included were 18 years or older who had received 
treatment from [anonymous pain clinic] between 2007 and 2016. Participants completed a 
battery of questionnaires (DASS-21, PSEQ, TAMPA, SOPA-R, and PDI) at admission via 
self-report measures. Files were accessed for consenting participants only. Participants who 
had not completed at least 60 percent of the full battery of questionnaires were later excluded.  
4.2.4 Analytic strategy 
 Network analyses were conducted using the qgraph (Epskamp, Cramer, Waldorp, 
Schmittmann, & Borsboom, 2012) and parcor (Krämer, Schäfer, & Boulesteix, 2009) 
packages within the statistical platform R. The adaptive least absolute shrinkage and selection 
operator (LASSO) approach was implemented as an efficient means for eliminating spurious, 
non-zero associations (Krämer et al., 2009). 
The generated network consists of variables (referred to as nodes in network 
analysis), connected by lines (edges). Several aspects of the visual network map are 
informative. First, the width and colour of edges indicate the strength (with wider edges 
indicating stronger partial correlations) and direction (positive associations typically as green 
lines and negative association as red lines) of associations between nodes. The absence of a 
direct line connecting two nodes suggests that, after adjusting for all other nodes in the 
model, the remaining (or partial) association between these two nodes is not reliably different 
from zero. Nevertheless, two nodes may still be associated via a third node that links them 
together indirectly. Second, the location of nodes within the network map help to identify 
influential nodes and also clusters of nodes. Nodes cluster within the network when they are 
strongly correlated. The more peripherally a node is located, the less correlated it is to other 
nodes.  
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As with other statistical techniques, visual scrutiny does not always lead to conclusive 
interpretation of results. Consequently, quantitative centrality measures are also reported in 
order to help identify nodes that are most influential in the network map. A variety of such 
measures is available; however, the present study relies on the three most commonly reported 
in the literature: strength, closeness, and betweenness. Strength refers to the overall relation 
of a node to others in the model, and is calculated by aggregating all (absolute values of) 
partial correlations involving a particular node. Higher scores reflects greater strength of 
connectivity within the model. Closeness refers to how quickly a node connects to other 
nodes within the model, and is calculated as the inverse of partial associations between nodes. 
The notion of closeness is that the stronger a partial correlation between two nodes, the 
quicker the influence of one node on the other may occur. Betweenness refers to the extent to 
which a node is an intermediary in the shortest path from one node to another. In instances 
where two nodes are not directly related (i.e., there is no edge linking them), any influence of 
one node on the other is necessarily engaged via other bridging nodes, in a similar fashion to 
indirect effects in mediation. However, it is also worth noting that two nodes may be directly 
related and yet the shortest path between them may still be a mediated one. This is likely 
when the direct link is relatively weak, and the bridging node has stronger associations to 
both of these nodes. 
4.3 Results 
4.3.1 Sample characteristics  
The final sample comprised of 98 females (58%) with a mean age of 50.85 years (24 
to 80 years) and 71 males (42%) with a mean age of 48.39 years (26 to 71 years). Of the 
participants included in this study, 66.9% were Australian born. Fifty-six percent were 
married, 19.5% were single, 11.3% were separated or divorced, 4.7% were in a de-facto 
relationship, and 1.8% were widowed.  
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Chronic pain conditions varied considerably among participants. For this reason, and 
for ease of interpretation, they have been categorised according to participants’ primary pain 
complaint, as follows: 87.6% reported general musculoskeletal pain (e.g., back, limbs), 8.3% 
widespread pain (e.g., fibromyalgia), 2.4% specific whiplash pain, and 1.8% headache. 
Among the participants in this sample, 56.2% (n=95) had pain at three or more locations, 
26.6% (n=45) had pain at two locations, and 17.2% (n=29) had pain at a single location.  
Fifty five percent (n=94) of participants acquired chronic pain in the past 0-5 years, 21.3% 
(n=36) in the past 5-10 years, 14.8% (n=25) in the past 10+ years, and 8.3% (n=14) did not 
specify a pain onset date.   
4.3.2 Severity of depression and anxiety symptoms  
Descriptive statistics and correlations are presented in Table 4. Means and standard 
deviations for the depression (M = 10.31; SD = 6.46) and anxiety (M = 5.82; SD = 5.82) 
scales of the DASS-21 both represent moderately severe levels, which is similar to what has 
been reported in previous studies using clinical samples (e.g., Wood et al., 2010). On 
average, scores on pain intensity, perceived disability, and fear avoidance were high, whereas 
scores on perceived control and pain-related self-efficacy were low, suggesting high levels of 
pain for the sample, coupled with belief that pain symptoms were overwhelming, debilitating, 
and beyond the patient’s control.  
As shown in Table 4, depressive and anxiety symptoms were strongly correlated. 
Both variables were also significantly associated with all of the pain-related beliefs 
(perceived disability, pain self-efficacy, fear avoidance, and perceived control) and pain 
intensity, with magnitude of association ranging from small to large. There was also 
substantial inter-relation among the pain-related beliefs.  
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Table 4. Means, standard deviations and inter-correlations among pain-related factors 
implicated in depression and anxiety 
 1 2 3 4 5 6 7 
1. Depression  1 .75** .28** .42** -.48** .62** -.48** 
2. Anxiety  1 .25** .35** -.40** .49** -.36** 
3. Pain intensity   1 .37** -.36** .26** -.26** 
4. Perceived disability    1 -.64** .47** -.35** 
5. Pain self-efficacy     1 -.45** .47** 
6. Fear-avoidance beliefs      1 -.45** 
7. Perceived control       1 
M 10.3 7.2 8.8 43.8 20.3 45.7 1.6 
SD 6.5 5.8 1.1 9.5 11.0 9.3 .8 
Range of scores 0-21 0-21 5-10 15-60 0-55 20-68 0-3.8 
α = Cronbach’s Alpha (Scale reliability), ** Correlation is significant at the 0.01 level 
4.3.3 Network analyses 
 Figure 6 shows the network map (left-hand side) and associated centrality statistics 
(right-hand side). The network map shows that, controlling for other variables in the model, 
pain intensity and the affective disorder symptoms (anxiety and depression) were not directly 
linked. Fear avoidance, perceived control, and self-efficacy retained direct links to depressive 
symptoms, whereas perceived disability and self-efficacy were directly linked to pain 
intensity. With the exception of depressive symptoms, none of the modelled variables directly 
linked to anxiety. 
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Figure 6. Network map (left-hand side) and associated plot of centrality measures (right-
hand side) for modelled variables 
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The centrality measures indicated that there was not a single variable in the model that was 
highest across all three measures (betweenness, closeness, and strength), although several of 
the variables were clearly more influential than the others. Depression had the highest 
strength value – attributable in part to a strong association with anxiety (see Appendix F for 
network model with anxiety excluded). It also had relatively high (although not highest) 
levels of betweenness, serving as the shortest (and only) path to anxiety for other variables in 
the model. Depression also had a moderate closeness value, reflected by its close proximity to 
several variables in the model. Perceived disability and fear avoidance were involved in the 
shortest paths to other variables in the model, both as a bridging variable (highest 
betweenness values) and as direct links to these variables (closeness values). Finally, 
although pain self-efficacy had a relatively low betweenness value, it had a reasonably high 
closeness value, due to its direct association with four other variables in the model. 
4.4 Discussion 
 A variety of psychological constructs have been identified as potential mediators of 
the relationship between affective disorder symptoms and experience of pain among chronic 
pain patients, including fear avoidance, pain-related self-efficacy, locus of control, and 
perceived level of disability (Fisher & Johnston, 1998; Menezes Costa et al., 2011; Miró, 
Martínez, Sánchez, Prados, & Medina, 2011; Pincus & Williams, 1999; Rudy, Kerns, & 
Turk, 1988). However, evidence also suggests considerable overlap between these constructs 
(Baird & Sheffield, 2016; Denison et al., 2004; Keefe et al., 2004; Woby, Urmston, & 
Watson, 2007), and potential bi-directional flow of effects among them (Holmes, Christelis, 
& Arnold, 2013: Leeuw et al., 2007), complicating efforts to ascertain which of these 
psychological mechanisms may be most influential in explaining the link between affective 
symptoms and pain experience. The present study utilised an innovative analytic technique 
(network analysis) to gain further insights into the inter-relationships among these 
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psychological variables and pain symptoms. These insights and their implications for theory 
and treatment are detailed below. 
 First, although affective disorder symptoms (anxiety and depression) and pain 
intensity were significantly related in a bivariate context – consistent with prior studies (e.g., 
Alschuler, Theisen-Goodvich, Haig, & Geisser, 2008; Ryan & McGuire, 2016; Tayer, 
Nicassio, Radojevic, & Krall, 1996) – there was a lack of direct association between affective 
disorder and pain symptoms in the generated network map. This supports the notion that 
these relationships may be accounted for by the proposed psychological mediators in the 
model. It may also indicate that intensity of pain experience and affective disorders are better 
accounted for by these psychological factors (especially the ones that showed direct links in 
the network model) than each other. Indeed, prior studies that have tested the mediating 
influence of psychological factors for the relationship between pain intensity and affective 
disorder symptoms have found that evidence of full mediation (that is, the direct effect is 
non-significant after controlling for indirect, mediating effects) (e.g., Meredith, Strong, & 
Feeney, 2006; Miró et al., 2011; Rudy et al., 1988). Clinically, the lack of direct association 
between these factors is somewhat unsurprising. Multidisciplinary pain management 
programs (MPMP) generally target shifting patients’ unhelpful pain-related beliefs, 
improving physical strength and functional capacity, and improving psychological symptoms 
- as opposed to actively trying to change pain intensity ratings. Prior research suggests that 
these factors are modifiable during a MPMP, whereas pain intensity ratings may or may not 
shift following a pain management program.  
Second, aside from a connection between depressive and anxiety symptoms in 
relation to one’s pain experience in the network model, anxiety was not directly related to any 
other constructs in the psychological network of pain experience. This may be partially 
explained by the strong correlation found between anxiety and depressive symptoms. 
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However, it should also be noted that the relationships with psychological factors and pain 
experience were consistently weaker for anxiety than for depressive symptoms. One possible 
explanation for this is the DASS-21 anxiety measure may be more heavily 
influenced/confounded with co-morbid medical conditions and medication side effects than 
the depression measure (i.e. 4 of the 7 items including dry mouth, breathing difficulty, racing 
heart and trembling hands).  
Third, the centrality measures suggest that self-efficacy, perceived disability, and fear 
avoidance may be particularly influential for both pain intensity and affective disorder 
symptoms, but in potentially different ways. Fear avoidance and perceived disability had both 
the highest betweenness values (indicating that they were on the shortest path linking several 
other variables in the model) and closeness values (indicating potentially stronger partial 
correlations with other variables in the model). However, whereas fear avoidance was 
directly linked to depressive symptoms and perceived control, perceived disability directly 
linked to pain intensity and self-efficacy. Their range of associations with other modelled 
variables, as well as their betweenness values suggesting that they serve as bridging 
variables, indicate that these may be suitable candidates for longitudinal investigation as 
potential risk factors for development and maintenance of affective disorder and intensity of 
pain symptoms. The finding that fear avoidance and perceived disability seem to link directly 
to different variables from each other suggests that both constructs may warrant further 
attention, and may be expected to behave differently in relation to affective disorder and pain 
intensity of pain symptoms.  
While pain self-efficacy had a low betweenness value, it had moderately high 
closeness and strength values, and a diffuse range of direct links to other constructs in the 
network map. Such a pattern suggests that, while it is not the only link to any of these 
modelled variables, it has some sizable direct associations with them that remain after 
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controlling for other noted predictors. Although the cross-sectional nature of these data 
preclude firm conclusions about causality or direction of effects, when viewed in conjunction 
with prior longitudinal findings of self-efficacy influencing these other variables (Jackson et 
al., 2014; Menez Costa et al., 2011), present findings highlight the influence of self-efficacy 
in this network. This suggests that treatments that seek to bolster pain-related self-efficacy 
may have benefits for multiple other symptoms in the network. In other words, increasing 
self-efficacy for pain self-management is likely to have multiple beneficial impacts on the 
persistent pain sufferer, and is therefore a common goal set with persistent pain sufferers 
participating in MPMPs. 
 Finally, although perceived control had direct links to other variables in the model, it 
had a low betweenness value, indicating that it is not the most expedient way to link one 
variable to another. For instance, fear avoidance appears to function as a stronger bridge to 
depression, and perceived disability is a stronger link to pain-related self-efficacy. Thus, 
while the present findings do not completely discount the possibility that perceived control 
acts as an influence (direct or as a mediator) on other modelled constructs, it is clear that 
other proposed predictors and mediators in the model are more important. Consequently, 
these findings suggest that if one were to prioritise future research into pain experience or 
affective disorder symptoms, it may be more useful to start with these other proposed risk 
factors. 
Clinically, it makes sense that fear-avoidance and depression are directly linked. Avoidance 
of feared situations is likely to result in reductions in socialisation, functional capacity, 
enjoyable activities and purposeful/meaningful activities; and hence, result in the 
development of poorer self-perception. In fact, changing these behaviours is one of the main 
aims of MPMPs, and behavioural and cognitive therapies for depression and persistent pain. 
It also makes sense clinically, that perceived disability and self-efficacy are closely linked. 
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Having a low degree of confidence in ones’ ability to manage their own pain is 
understandably associated with feeling more disabled by that pain, and conversely, feeling 
more able to manage their pain across various situations is associated with feeling more able 
despite the pain. However, to be able to manage ones’ pain does not necessarily mean to be 
able to control it. Another major tenant of MPMPs and cognitive-behavioural therapies for 
persistent pain, is to assist the sufferer to learn about their pain, to learn to control what they 
can, and to accept and adapt to what they cannot control (e.g. through flare up management, 
pacing training, adapting the environment, cognitive therapy and mindfulness training).   
4.4.1 Limitations 
A number of limitations to the current research should be considered. Firstly, this 
study was cross-sectional and the positive associations found do not permit any causal 
inferences to be made. It is thus possible that the variables identified as influential in the 
network analysis co-occur because they have a shared, generic common cause with a wide 
range of modelled variables. However, if such an explanation holds true, then the partial 
correlation nature of this analysis suggests that the underlying third variable is not among 
those modelled in the present study. An alternative explanation for the present results is that 
these influential variables may instead be a common outcome for these variables. Further 
testing, with a longitudinal network map, may help to disentangle direction of effects, whilst 
maintaining the advantages of network analysis (e.g., its focus on the aggregate influence of a 
variable in the whole model rather than for a single outcome). 
Secondly, self-report is considered the gold standard of pain measurement given its 
consistency with the ‘subjective’ definition of pain (Pautex et al., 2007). However, limitations 
are inherent in the subjective nature of self-reported measures, such as ability to discern and 
effectively communicate one’s pain state. It is thus reassuring that the present sample 
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comprises chronic pain patients whose symptoms were evaluated by a multi-disciplinary 
team involved in their treatment planning and implementation. 
Thirdly, given that the majority of pain localisations included in this study were 
musculoskeletal in nature, it might be concluded that these findings lack generalizability to 
other pain locations. This issue of generalizability may be of particular concern if certain 
beliefs are found to be more common among individuals with specific pain localisations. For 
example, fear-avoidance beliefs have been shown to be the most important psychosocial 
predictor of disability among patients with chronic low back pain (CLBP; Lethem et al., 
1983; Brox et al., 2005). Thus, interpretation of the relationships supported in this study may 
be limited to similar samples of chronic pain patients.  
4.4.2 Conclusion 
 Despite these limitations, the present study offers several key insights into the nature 
of the relationship between pain intensity and affective disorders. It showed that a direct 
relationship between these variables disappears once controlling for proposed psychological 
mediators. Further, despite observed inter-relations among the psychological factors, self-
efficacy, fear avoidance, and perceived disability were each identified as having influence in 
the network model. Whereas self-efficacy tended to have more direct associations with other 
variables, both fear avoidance and perceived disability often served as links between other 
variables, and may thus be best conceptualised as mediators that explain the inter-relations of 
other symptoms in this network. Longitudinal investigation in which these variables are 
manipulated are needed to confirm or disconfirm predictions about the nature and direction of 
their influence on the other constructs in the presently tested network. A greater 
understanding of the implications of unhelpful pain-related cognitions is needed to improve 
the efficacy of treatment programs and associated outcomes for chronic pain sufferers.  
 
  139 
 
 
 
References 
Allaz, A.F., & Cedraschi, C. (2015). Emotional aspects of chronic pain (pp.21-34). In 
Pickering & Gibson (Eds), Pain, Emotions and Cognition: A complex nexus. 
Switzerland: Springer International. 
Alschuler, K N., Theisen-Goodvich, M E., Haig, A J., & Geisser, M E. (2008). A comparison 
of the relationship between depression, perceived disability, and physical performance 
in persons with chronic pain. European Journal of Pain, 12, 757-764. DOI: 
10.1016/j.ejpain.2007.11.003 
Asmundson, G J G., Norton, G R., & Allerdings, M D. (1997). Fear and avoidance in 
dysfunctional chronic back pain patients. Pain, 69(3), 231-236. DOI: 
10.1016/S03043959(96)03288-5 
Arraras, J I., Wright, S J., Jusue, G., Tejedor, M., & Calvo, J I. (2002). Coping style, locus of 
control, psychological distress and pain-related behaviours in cancer and other diseases. 
Psychology, Health & Medicine, 7(2), 181-197. DOI: 10.1080/13548500120116139 
Bair, M J., Robinson, R L., Katon, W., & Kroenke, K. (2003). Depression and 
paincomorbidity: a literature review. Archives of Internal Medicine, 163, 2433–45. 
DOI: 10.1001/archinte.163.20.2433 
Bair, M J., Wu J., Damush, T M., Sutherland, J M., & Kroenke, K. (2008). Association of 
depression and anxiety alone and in combination with chronic musculoskeletal pain in 
primary care patients. Psychosomatic Medicine, 70(8), 890-897. DOI: 
10.1097/PSY.0b013e318185c510 
Baird, A., & Sheffield, D. (2016). The relationship between pain beliefs and physical and 
mental health outcome measures in chronic low back pain: Direct and indirect effects. 
Healthcare, 4, 58-68. DOI: 10.3390/healthcare4030058 
  140 
 
 
 
Baker, T A., Buchanan, N T., & Corson, N. (2008). Factors influencing chronic pain intensity 
in older black women: examining depression, locus of control, andphysical health. 
Journal of Women’s Health, 17, 869-878. DOI: 10.1089/jwh.2007.0452 
Bandura, A., Pastorelli, C., Barbaranelli, C., & Caprara, G V. (1999). Self-efficacy pathways 
to childhood depression. Journal of Personality and Social Psychology,76(2), 258-269. 
Beck, A.T. (1976). Cognitive therapy and the emotional disorders. New York, NY: Meridian. 
Beck, A.T., Emery, G., & Greenberg, R. (1985). Anxiety disorders and phobias: A cognitive 
perspective. New York, NY: Basic Books. 
Beesdo, K., Jacobi, F., Hoyer, J., Low, N C P., Höfler, M., & Wittchen, H. (2010). 
Painassociated with specific anxiety and depressive disorders in a nationally 
representativepopulation sample. Social Psychiatry Epidemiology, 45, 89-104. DOI: 
10.1007/s00127-009-0045-1 
Blyth, F.M., March, L.M., Nicholas, M.K., & Cousins, M.J. (2005). Self-management of 
chronic pain: A population-based study. Pain, 113(3), 285-292. DOI: 
10.1016/j.pain.2004.12.004 
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006). Survey of 
chronic pain in Europe: Prevalence, impact on daily life, and treatment. European 
Journal of Pain,10, 287-333. DOI: 10.1016/j.ejpain.2005.06.009 
Brox, J I., Storheim, K., Holm, I., Friis A., & Reikerâs, O. (2005). Disability, pain, 
psychological factors and physical performance in healthy controls, patients with sub-
acute and chronic low back pain: A case control study. Journal of Rehabilitation 
Medicine, 37, 95-99. DOI: 10.1080/16501970410017738 
Buhrman, M., Nilsson-Ihrfelt, E., Jannert, M., Ström, L., & Andersson, G. (2011). Guided 
internet-based cognitive behavioural treatment for chronic back pain reduces pain 
  141 
 
 
 
catastrophizing: A randomized controlled trial. Journal of Rehabilitation Medicine, 43, 
500-505. DOI: 10.2340/16501977-0805 
Butler, D., & Moseley, L. (2013). Explain pain. (2nd ed.). South Australia, Australia: 
Noigroup Publications. 
Campbell, L.C., Clauw, D.J., & Keefe, F.J. (2003). Persistent pain and depression: A 
biopsychosocial perspective. Biological Psychiatry, 54, 399-409. DOI: 10.1016/S0006-
3223(03)00545-6 
Carpino, E., Segal, S., Logan, D., Lebel, A., & Simons, L. E. (2014). The interplay of pain-
related self-efficacy and fear on functional outcomes among youth with headache. The 
Journal of Pain, 15(5), 527-534. DOI: 10.1016/j.jpain.2014.01.493 
Ciechanowski, P., Sullivan, M., Jensen, M., Romano, J., & Summers, H. (2003). The 
relationship of attachment style to depression, catastrophizing and health care 
utilization in patients with chronic pain, Pain, 104(3), 627-637. 
Costantini, G., Epskamp, S., Borsboom, D., Perugini, M., Móttus, R., Waldorp, L.J., et al. 
(2015). State of the aRt personality research: A tutorial on network analysis of 
personality data in R. Journal of Research in Personality, 54, 13-29. DOI: 
10.1016/j.jrp.2014.07.003 
Crombez, G., Eccleston, C., Van Damme, S., Vlaeyen, J W S., & Karoly, P. (2012). The fear 
avoidance model of chronic pain: The next generation. Clinical Journal of Pain, 28(6), 
475-483. DOI: 10.1097/AJP.0b013e2182385392 
Cross, M J., March, L M., Lapsley, H M., Byrne, E., & Brooks, P M. (2006). Patient self-
efficacy and health locus of control: relationships with health status and arthritis-related 
expenditure. Rheumatology, 45(1), 92-96. DOI: 10.1093/rheumatology/kei114 
Currie, S R., & Wang J. (2004). Chronic back pain and major depression in the general 
Canadian population. Pain, 107, 54-60. 
  142 
 
 
 
Demyttenaere, K., Bruffaerts, R., Lee, S., Posada-Villa, J., Kovess, V., Angermeyer, M.C., et 
al. (2007). Mental disorders among persons with chronic back or neck pain: Results 
from the world mental health surveys. Pain, 129, 332-342. DOI: 
10.1016/j.pain/2007.01.022 
Denison, E., Ǻsenlӧf, P., & Lindberg, P. (2004). Self-efficacy, fear-avoidance, and 
painintensity as predictors of disability in subacute and chronic musculoskeletal 
painpatients in primary health care. Pain, 111, 245-252. DOI: 
10.1016/j.pain.2004.07.001 
Denison, E., Ǻsenlӧf, P., Sandborgh, M., & Lindberg, P. (2007). Musculoskeletal pain in 
primary health care: Subgroups based on pain intensity, disability, self-efficacy, and 
fear-avoidance variables. Journal of Pain, 8(1), 67-74. DOI: 
10.1016/j.jpain.2006.06.007 
Edwards, R.R., Smith, M.T., Klick, B., Magyar-Russell, G., Haythornthwaite, J.A., 
Holavanahalli, R., et al. (2007). Symptoms of depression and anxiety as unique 
predictors of pain-related outcomes following burn injury. Annals of Behavioral 
Medicine, 34(3), 313-322. DOI: 10.1080/08836610701677725 
Feuerstein, M., & Thebarge, R W. (1991). Perceptions of disability and occupational stress as 
discriminators of work disability in patients with chronic pain. Journal of Occupational 
Rehabilitation, 1(3), 185-195. DOI: 10.1007/BF01073455 
Field, A. (2009). Discovering Statistics Using SPSS (3rd ed), Sage, Thousand Oakes, 
California. 
Fisher, K., & Johnston, M. (1998). Emotional distress and control cognition as predictors of 
the impact of chronic pain on disability. British Journal of Health Psychology, 3(3), 
225-236. DOI: 10.1111/j.2044-8287.1998.tb00569.x 
  143 
 
 
 
Fordyce, W E., Roberts, A H., & Sternbach, R A. (1985). The behavioural management of 
chronic pain: A response to critics. Pain, 22(2), 113-125. 
Fransen, M., Woodward, M., Norton, R., Coggan, C., Dawe, M., & Sheridan, N. (2002). Risk 
factors associated with the transition from acute to chronic occupational back pain. 
Spine, 27(1), 92-98. DOI: 10.1097/00007632-200201010-00022 
French, D J., Holroyd, K A., Pinell, C., Malinoski, P T., O’Donnell, F., & Hill, K R. (2000). 
Perceived self-efficacy and headache-related disability. Journal of Head and Face Pain, 
40(8), 647-656. DOI: 10.1046/j.1526-4610.2000.040008647.x 
Gallagher, R M., & Verma, S. (1999). Managing pain and comorbid depression: A public 
health challenge. Seminars in Clinical Neuropsychiatry, 4, 203–20. 
Gatchel, R J., Peng, Y B., Peters, M L., Fuchs, P N., & Turk, D C. (2007). 
Thebiopsychosocial approach to chronic pain: Scientific advances and future directions. 
Psychological Bulletin, 133(4), 581-624. DOI: 10.1037/0033-2909.133.4.581 
Gerrits MM, van Oppen P, Van Marwijk HW, Penninx BW, van der Horst HE. (2014). Pain 
and the onset of depressive and anxiety disorders. Pain, 155, 53–9. DOI: 
10.1016/j.pain.2013.09.005 
Gerrits, M.M.J.G., van Marwijk, H.W.J., van Oppen, P., van der Horst, H., & Penninx, 
B.W.J.H. (2015). Longitudinal association between pain, and depression and anxiety 
over four years. Journal of Psychosomatic Research, 78, 64-70. DOI: 
10.1016/j.jpsychores.2014.10.011 
Guzmán, J., Esmail, R., Karjalainen, K., Malmivaara, A., Irvin, E., & Bombardier, C. (2001). 
Multidisciplinary rehabilitation for chronic low back pain: systematic review. British 
Medical Journal, 322(7301), 1511-1516. 
Hansen, G R., & Streltzer, J. (2005). The psychology of pain. Emergency Medicine Clinics of 
North America, 23, 339-348. 
  144 
 
 
 
Hasenbring, M I., & Verbunt, J A. (2010). Fear-avoidance and endurance-related responses to 
pain: New models of behaviour and their consequences for clinical practice. Clinical 
Journal of Pain, 29(9), 747-753. DOI: 10.1097/AJP.0b013e3181e104f2 
Heath, R L., Saliba, M., Mahmassani, O., Major, S C., & Khoury, B A. (2008). Locus of 
control moderate the relationship between headache pain and depression. Journal of 
Headache Pain, 9, 301-308. DOI: 10.1007/s10194-008-0055-5 
Hechler, T., Dobe, M., Damschen, U., Blakenburg, M., Schroeder, S., Kosfelder, J., et al. 
(2010). The pain provocation technique for adolescents withchronic pain: Preliminary 
evidence for its effectiveness. Pain Medicine, 11(6), 897-910. DOI: 10.111/j.1526-
4637.2010.00839.x 
Henry, J D., & Crawford, J R. (2005). The short-form version of the depression anxiety stress 
scales (DASS-21): Construct validity and normative data in a large non-clinical sample. 
British Journal of Clinical Psychology, 44, 227-239. DOI: 10.1348/014466505X29657 
Holmes, A., Christelis, N., & Arnold, C. (2013). Depression and clinical pain. Medical 
Journal of Australia, 199(6 Suppl), S17-S20. DOI: 10.5694/mja12.10589 
Innes, S I. (2005). Psychosocial factors and their role in chronic pain: a brief review of 
development and current status. Chiropractic and Osteopathy, 13(6), 1-4. DOI: 
10.1186/1746-1340-13-6 
Jackson, T., Wang, Y., Wang, Y., & Fan, H. (2014). Self-efficacy and chronic pain outcomes: 
A meta-analytic review. The Journal of Pain, 15(8), 800-814. DOI: 
10.1016/j.jpain.2014.05.002 
Jensen, M.P., & Karoly, P. (1991). Control beliefs, coping efforts, and adjustment to chronic 
pain. Journal of Consulting and Clinical Psychology, 59(3), 431-438. 
  145 
 
 
 
Keefe, F.J., Rumble, M.E., Scipio, C.D., Giordano, L.A., & Perri, L.M. (2004). Psychological 
aspects of persistent pain: Current state of the science. The Journal of Pain, 5(4), 195-
211. DOI: 10.1016/j.jpain.2004.02.576 
Krämer, N., Schäfer, J., & Boulesteix, A.-L. (2009). Regularized estimation of large-scale 
gene association networks using graphical Gaussian models. BMC Bioinformatics, 10, 
384. DOI: 10.1186/1471-2105-10-384 
Kroenke, K., Wu, J., Bair, M. J., Krebs, E. E., Damush, T. M., & Tu, W. (2011). Reciprocal 
relationship between pain and depression: a 12-month longitudinal analysis in primary 
care. The Journal of Pain, 12(9), 964-973. DOI: 10.1016/j.jpain.2011.03.003 
Lau-Walker, M. (2006). A conceptual care model for individualized care approach in cardiac 
rehabilitation – combining both illness representation and self-efficacy. British Journal 
of Health Psychology, 11(1), 103-117. DOI: 10.1348/135910705X41914 
Leeuw, M., Goossens, M E J B., Linton, S J., Crombez, G., Boersma, K., & Vlaeyen, J.W.S. 
(2007). The fear-avoidance model of musculoskeletal pain: Current state of scientific 
evidence. Journal of Behavioral Medicine, 30(1), 77-94. DOI: 10.1007/s10865-
0069085-0 
Lethem, J., Slade P D., Troup, J D., & Bentley, G. (1983). Outline of a fear-avoidance 
modelof exaggerated pain perception – I. Behaviour Research and Therapy, 21, 401-
408. 
Lovibond, P F., & Lovibond, S H. (1995). The structure of negative emotional states: 
Comparison of the depression anxiety stress scales (DASS) with the Beck depression 
and anxiety inventories. Behaviour Research and Therapy, 33(3), 335-343. 
Means-Christensen, A.J., Roy-Byrne, P.P., Sherbourne, C.D., Craske, M.G., & Stein, M.B. 
(2008). Relationships among pain, anxiety, and depression in primary care. Depression 
and Anxiety, 25(7), 593-600. DOI: 10.1002/da.20342 
  146 
 
 
 
Menezes Costa, L C., Maher, C G., McAuley, J H., Hancock, M J., & Smeets, R J E M. 
(2011). Self-efficacy is more important than fear of movement in mediating 
therelationship between pain and disability in chronic low back pain. European Journal 
of Pain, 15, 213-219. DOI: 10.1016/j.ejpain.2010.06.014 
Meredith, P., Strong, J., & Feeney, J A. (2006). Adult attachment, anxiety, and pain self-
efficacy as predictors of pain intensity and disability. Pain, 123, 146-154. DOI: 
10.1016/j.pain.2006.02.025 
Miller, R.P., Kori, S., & Todd, D. (1991). The Tampa Scale: A measure of kinesiophobia. 
Clinical Journal of Pain, 7(1), 51-52. 
Miró, E., Martínez, Sánchez, A.I., Prados, G., & Medina, A. (2011). When is pain related to 
emotional distress and daily functioning in fibromyalgia syndrome? The mediating 
roles of self-efficacy and sleep quality. British Journal of Health Psychology, 16(4), 
799-814. DOI: 10.111/j.2044-8287.2011.02016.x 
Nicholas, M.K. (1989). Self-efficacy and chronic pain. Paper presented at the annual 
conference of the British Psychological Society. St. Andrews. 
Pautex, S., Herrmann, F., Michon, A., Giannakopoulos, P., & Gold, G. (2007). Psychometric 
properties of the Doloplus-2 observational pain assessment scale and comparison to 
self-assessment in hospitalized elderly. Clinical Journal of Pain, 23(9), 774-779. DOI: 
10.1097/AJP.0b013e318154b6e3 
Pincus, T., & Morley, S. (2001). Cognitive-processing bias in chronic pain: A review and 
integration. Psychological Bulletin, 127(5), 599-617. 
Ramírez-Maestre, C., Esteve, R., & López-Martínez, A. (2014). Fear-avoidance, pain 
acceptance and adjustment to chronic pain: A cross-sectional study on a sample of 686 
patients with chronic spinal pain. Annals of Behavioral Medicine, 48(3), 402-410. DOI: 
10.1007/s12160-014-9619-6 
  147 
 
 
 
Pfingsten, M., Leibing, E., Harter, W., Kröner-Herwig, B., Hempel, D., Kronshage, U., et al.. 
(2001). Fear-avoidance behaviour and anticipation of pain in patients with chronic low 
back pain: A randomized controlled study. Pain Medicine, 2(4), 259-266. DOI: 
10.1046/j.1526-4637.2001.01044.x 
Pincus, T., & Williams, A. (1999). Models and measurement of depression in chronic pain. 
Journal of Psychosomatic Research, 47(3), 211-219. DOI: 
10.1016/S00223999(99)00045-8 
Rudy, T E., Kerns, R D., & Turk, D C. (1988). Chronic pain and depression: Toward 
acognitive-behavioral mediation model. Pain, 35(2), 129-140. 
Ryan, S., & McGuire, B. (2016). Psychological predictors of pain severity, pain interference, 
depression, and anxiety in rheumatoid arthritis patients with chronic pain. British 
Journal of Health Psychology, 21, 336-350. DOI: 10.1111/bjhp.12171 
Swinkels-Meewisse, I E J., Roelofs, J., Verbeek, A L M., Oostendorp, R A B., & Vlaeyen, J 
W S. (2003). Fear of movement/(re)injury, disability and participation in acute low 
back pain. Pain, 105, 371-379. 
Tayer, W.G., Nicassio, P.M., Radojevic, V., & Krall, T. (1996). Pain and helplessness as 
correlates of depression in systemic lupus erythematosus. British Journal of Health 
Psychology, 1(3), 253-262. DOI: 10.1111/j.2044-8287.1996.tb00507.x 
Woby, S R., Urmston, M., & Watson, P J. (2007). Self-efficacy mediates the relation between 
pain-related fear and outcome in chronic low back pain patients. European Journal of 
Pain, 11(7), 711-718. DOI: 10.1016/j.ejpain.2006.10.009 
 
 
  148 
 
 
 
Chapter 5  
 
Study Three: Post-intervention treatment adherence for chronic pain patients may 
depend on psychological factors2 
 
Emma Thompson1, Jaclyn Broadent1, Matthew Fuller-Tyszkiewicz1, Melanie Bertino1,2 and 
Petra Staiger1 
1 School of Psychology, Deakin University, Burwood 
2 The Victorian Rehabilitation Centre 
 
Word Count: 5,141; no. of references: 35; no. of tables: 2; no. of figures: 1 
 
Declaration of interest: The authors report no conflicts of interest or financial disclosures. 
The authors alone are responsible for the content and writing of the paper. 
 
Correspondence:  
Dr Jaclyn Broadbent 
Deakin University, School of Psychology 
221 Burwood Hwy, Burwood, Victoria, Australia 3125 
Email: jaclyn.broadbent@deakin.edu.au 
Phone: +61 3 92443043 
Fax: +61 3 92446858 
 
 
                                                 
2 This paper is currently under review for publication to the journal, Clinical Psychologist. 
Clinical Psychologist have specific guidelines for structure, formatting and referencing. This 
paper was prepared in accordance with those guidelines 
  149 
 
 
 
Abstract 
Objectives: The present study evaluated the influence of psychological factors (anxiety, 
depression, fear avoidance, and self-efficacy) in predicting patient adherence to their 
personalised post-intervention treatment maintenance plan for the interval between discharge 
from an out-patient treatment and follow-up at 3-6 months.  
Design and Method:  Participants included sixty-one chronic pain patients aged 31 to 72 
years (M = 54.28, SD = 10.32) who had completed a pain management program between 
2014 and 2016 at a rehabilitation centre. Participants completed the psychological measures 
at pre-intervention into the pain management program and at the completion of the program; 
and a measure of treatment maintenance adherence at 3-6 months post-intervention to 
measure compliance with the post-discharge treatment plan. The psychological variables at 
both timepoints were included in regression models to determine whether pre- or post-
intervention scores predict adherence, and whether these effects are dependent on how much 
these symptoms change during the intervention phase.  
Results: Hierarchical regression analyses showed that 28% variance in post-intervention 
adherence to post-intervention treatment maintenance plans was accounted for by the 
predictors. Fear avoidance and depressive symptoms (both at post-intervention) made 
significant unique contributions to prediction. Moderation analyses showed that individuals 
with initially low levels of anxiety, whose symptom severity worsened during the 
intervention phase, were more likely to adhere to the post-discharge treatment plan. 
Conclusions: This pattern of findings shows relevance for psychological factors in treatment 
adherence. Nevertheless, questions remain about the nature of their influence on adherence, 
and clinical and research implications are discussed in this light.  
 
Key words: Self-Efficacy; Fear-avoidance; Depression; Anxiety; Pain treatment adherence 
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5.1 Introduction 
The burden of chronic pain is exacerbated by poorly managed presentations, frequent 
hospital admissions, and the need for patients to attend multiple treatment programmes 
(Imani & Safari, 2011). Between 25 and 50 percent of patients who receive treatment are 
non-adherent to treatment recommendations (Roebuck, Liberman, Gemmill-Toyama, & 
Brennan, 2011). This non-adherence may be viewed along a continuum, ranging from 
complete non-adherence to perfect adherence to a treatment plan. As such, non-adherence can 
be quantified both in terms of the level of adherence along that continuum, and the forms of 
non-adherence, such as missing appointments or treatment sessions, not taking medications 
as directed, or not following recommended lifestyle changes both during and after treatment 
has terminated (Dworkin et al., 2009). Non-adherence is a significant issue, increasing the 
likelihood of re-admissions to already strained programme waitlists and further contributes to 
the healthcare burden (Broekmans, Dobbels, Milisen, Morlion, & Vanderschueren, 2009). 
The present study limits its focus to evaluation of the role of psychological factors for 
adherence in a chronic pain treatment context as these may be amenable to change. 
A variety of theoretical frameworks have been used to account for the influence of 
psychological factors on treatment adherence, including the Common-Sense Model of Self-
Regulation (Leventhal, Phillips, & Burns, 2016), the Health Beliefs Model (Rosenstock, 
Strecher, & Becker, 1988), the Protection Motivation Theory (Maddux & Rogers, 1983), and 
the Theory of Planned Behavior (Azjen, 1991). A common element for these models is the 
proposed role of self-efficacy in determining the extent to which an individual initiates and 
maintains a treatment regime. It is reasoned that individuals who feel confident in their ability 
to undertake the treatment plan may be more motivated to invest time in the treatment, and 
may be more likely to persist in the face of setbacks or initial challenges. Recent reviews by 
Thompson, Broadbent, Bertino, and Staiger (2016) and Holmes, Hughes, and Morrison 
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(2014) support the role of self-efficacy as a consistent predictor of treatment adherence. 
These reviews demonstrate the potential robustness of self-efficacy’s effect on adherence as it 
was found to be a significant unique predictor across models with differing combinations of 
predictors, and across different stages of treatment. 
Severity of the patient’s symptoms may also be reasoned to impact treatment 
adherence (Leventhal et al., 2016; Maddux & Rogers, 1983). On the one hand, perceptions 
regarding the severity of one’s condition and the likelihood of sustained or worsening 
symptoms into the future may motivate an individual to seek treatment (Milne, Sheeran, & 
Orbell, 2000). On the other hand, the nature of one’s condition (including co-morbidities) 
may reduce the treatment options or the likelihood of recovery. For instance, affective 
disorders such as depression and anxiety, which are commonly present in chronic pain 
populations (Demyttenaere et al., 2007), may both exacerbate pain symptoms and influence 
one’s willingness to adhere to treatment plans due to reduced quality of life, impaired 
cognitive focus, feelings of hopelessness, and loss of energy and motivation (Cipher, 
Fernandez, & Clifford, 2002; Ferreira & Pereira, 2014; Gormsen, Rosenberg, Bach & Jensen, 
2010; Orenius et al., 2012). Similarly, a review by Wertli, Rasmussen-Barr, Weiser, 
Bachmann, and Brunner (2014) found high fear-avoidance beliefs to be associated with poor 
treatment outcomes (including low treatment adherence) in patients with chronic low back 
pain. The authors reasoned that fear avoidance beliefs may entail focusing on the worst 
possible outcomes (pain catastrophizing) of one’s condition and that this, in turn, encourages 
avoidance of the health condition rather than treating it directly. 
Despite growing evidence of potential psychological predictors of treatment 
adherence, gaps remain. First, whereas adherence during the treatment phase is a common 
focus in past research, adherence to post-treatment plans is less consistently evaluated 
(Thompson et al., 2016). While it is important to identify predictors of success during this 
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phase, in many instances chronic pain patients are recommended ongoing physical and 
cognitive exercises post-intervention to maintain or further enhance treatment effects. 
Contact with a healthcare professional post-intervention is likely to be far less frequent and, 
as such, there is greater reliance upon the patient to self-manage their post-intervention 
treatment plan. Accordingly, these psychological predictors may become more relevant 
during this latter phase. Second, the bulk of prior research into the predictors of adherence 
has employed cross-sectional designs (Holmes et al., 2014). Leventhal et al. (2016) 
emphasize that treatment adherence is likely to be a dynamic process, and the predictors may 
change over the course of one’s treatment plan. For instance, self-efficacy may be a focus of 
treatment and, hence, an individual’s low level of self-efficacy pre-treatment may be less 
predictive of their overall adherence than later in the treatment, once self-efficacy levels have 
improved. Thus, timing of measurement and ability to monitor change in these predictors 
may impact results obtained.  
The theories and empirical evidence detailed above identified the potential influence 
of symptom severity (including co-morbid conditions, such as depression, anxiety, and fear 
avoidance tendencies) and self-efficacy as key drivers of treatment adherence during the 
intervention phase. The present study builds upon this prior research by exploring, using a 
prospective design, whether these psychological factors are predictive of adherence post-
intervention (i.e., between discharge and a 3-6 month follow-up session) for a sample of 
chronic pain sufferers. We explored adherence in terms of extent to which a prescribed 
treatment plan was followed, acknowledging that a binary adherence/non-adherence decision 
would likely miss this variability. Further, given the dynamic nature of these predictors 
(Leventhal et al., 2016), the predictive value of these psychological variables were tested by 
regressing post-intervention level of adherence to prescribed treatment plan onto scores on 
these psychological variables collected at baseline (pre-intervention) as well as post-
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intervention. Measurement times were limited to pre- and post-intervention as, in many 
settings, at least some of the proposed predictors are measured at these times as part of 
routine care. As such, findings of predictive value at these time-points would allow for rapid 
translation into practice. 
On the basis of prior research findings and arguments proposed above, it was 
hypothesised that:  
1. Adherence post-intervention follow-up would be lower for individuals with higher 
depression, anxiety, and fear avoidance tendencies, and lower self-efficacy at pre-
intervention (Hypothesis 1) and post-intervention (Hypothesis 2). 
2. Given their greater proximity to the outcome variable (post-intervention adherence), 
post-intervention levels of these risk factors would be better predictors than their pre-
intervention levels for predicting adherence in the post-intervention phase 
(Hypothesis 3). 
3. Hypothesis 3 is premised on the notion that scores on these predictors might change 
over the course of treatment and, accordingly, scores measured closer to measurement 
of the outcome variable would have higher predictive value. To test this further, we 
hypothesized that: 
4. The predictive value of baseline levels scores on the psychological factors on post-
intervention adherence would be moderated by magnitude of change in these 
psychological variables from baseline to post-intervention (Hypothesis 4). 
Specifically, it was predicted that these baseline scores would be stronger predictors 
of post-intervention adherence for individuals who experienced limited change in 
these psychological variables across the period of treatment. 
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5.2 Method 
5.2.1 Participants  
Participants included sixty-one chronic pain out-patients between 31 to 72 years of 
age (M = 54.28, SD = 10.32) who had completed a pain management program between 2014 
and 2016 at a rehabilitation centre in Victoria, Australia. Entry into the treatment program 
was based on an intake assessment conducted by a multidisciplinary team comprising a pain 
specialist physician, occupational therapist, registered psychologist, and physiotherapist. 
Diagnosis was based on the presenting symptoms via subjective report in addition to 
physical, psychological, and functional examinations. The majority of participants who 
participated in the current study experienced musculoskeletal pain in three or more locations 
(n=39, 64.8%) for approximately five or less years. Participants were predominantly male (n 
= 36, 59%), born in Australia (n= 44, 72.3%), and married (n=26, 43%). 
G*Power version 3.1 (Faul, Erdfelder, Buchner, & Lang, 2009) was used to calculate 
power for the current sample. Based on the sample size of 61 and setting alpha at .05 (two-
tailed) and power at .80, the current sample was sufficiently powered to detect the 
contribution of an individual predictor in a regression model with effect size of sr2 = .12 or 
greater. For paired samples t-test comparisons of scores on a variable over time, the sample 
of 61 was sufficiently powered to detect a Cohen’s d of .36 or greater. According to 
Ferguson’s (2009) guidelines, the present sample size is sufficient to detect small yet 
practically significant effects for social science data.  
5.2.2 Treatment 
The treatment programs were individually tailored to the patient goals and needs 
identified during the multidisciplinary assessment. The range of length for the programs was 
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between 6 and 12 weeks’ duration, 2-3 days per week for 1-4 hours per day, depending on 
patient goals, needs, and individual capacity and ability to attend.  
The programs were all delivered by a multidisciplinary team including a 
physiotherapist (delivering land and water based therapy weekly), psychologist (all 
participants had individual sessions with the psychologist weekly), and occupational therapist 
(delivering weekly sessions focused on functional and vocational goals). All clinicians were 
fully qualified and experienced practitioners working within a private pain clinic. 
All participants received individual treatment sessions from all three disciplines, and 
those who were appropriate to attend group education and relaxation sessions (no major 
psychological, physical, language or intellectual barriers, not hearing impaired, etc.) were 
also encouraged to attend group sessions. The group sessions included 4-6 participants in 
each group, and the education topics and relaxation training sessions were delivered over a 
period of 6 weeks (2-3 days per week). Those who did not attend the group sessions had this 
educational content and relaxation training delivered within their individual sessions. All 
participants were given a copy of the same patient manual, outlining the key concepts and 
recommendations from each of the three disciplines involved in delivering the pain 
management program (physiotherapist, psychologist, and occupational therapist). 
5.2.3 Measures  
5.2.3.1 Affective disorder symptoms  
The 21-item Depression, Anxiety, and Stress Scale (DASS-21; Lovibond & 
Lovibond, 1995) was used to measure depression and anxiety. Response options were 
provided on a 4-point Likert-type scale (where 0 = Did not apply to me at all, and 3 = 
Applied to me most of the time). Participants were asked to respond to each item in the 
context of how they felt when experiencing ongoing pain over the last seven days. Total 
scores range from 0 to 42, with higher scores reflecting elevated depressive or anxiety 
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symptomatology. Cutoff scores of 14+ and 10+ can be used to identify participants with at 
least moderate severity depression and anxiety, respectively. The DASS-21 met scale 
reliability criteria for use with this sample with a Cronbach’s alpha of .90 at pre-intervention 
and .93 at post-intervention. 
5.2.3.2 Pain self-efficacy  
The 10-item Pain Self-Efficacy Questionnaire (PSEQ; Nicholas, 1989) was used to 
measure patients’ confidence in their ability to self-manage pain, including household chores, 
socialising, work, and coping with pain without medication. Participants responded to items 
on a 7-point, end-defined scale (0 = Not at all confident to 6 = Completely confident). Total 
scores range from 0 to 60, with higher scores indicating greater confidence in managing pain. 
Following guidelines included as part of the adult clinical change calculator from the 
electronic Persistent Pain Outcomes Collaboration (ePPOC; Australian Health Services 
Research Institute, 2017), scores on the PSEQ of less than 20 indicates severe impairment, 
20-30 = moderate impairment, 31-40 = mild impairment, and > 40 = minimal impairment. 
Prior studies have established strong test-retest reliability of the PSEQ (Asghari & Nicholas, 
2001), and construct validity as demonstrated through correlations with other measures of 
self-efficacy and pain-related disability (Kaivanto, Estlander, Moneta, & Vanharanta, 1995). 
In the present study, Cronbach’s alpha was .93 at pre-intervention and .95 at post-
intervention. 
5.2.3.3 Fear-avoidance beliefs  
The 17-item TAMPA Scale of Kinesiophobia (TSK; Kori, Miller, & Todd, 1990) was 
used to measure fear of movement or (re)injury. Participants responded to statements 
regarding fear of movement on a 4-point scale (1 = strongly disagree to 4 = strongly agree). 
Total scores range from 17 to 68, with higher scores indicating greater fear of movement or 
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(re)injury. Cronbach’s alpha of .88 at pre-intervention and .83 at post-intervention in the 
present study. 
5.2.3.4 Perceived disability  
The 5-item disability subscale of the Survey of Pain Attitudes (SOPA; Jensen, Karoly, 
& Huger, 1987) was used to measure patient’s self-perceived disability at baseline due to 
their chronic pain. Participants responded to items on a 5-point scale (0 = this very untrue for 
me to 4 = this is very true for me). Total scores range from 0 to 20, with higher scores 
reflecting greater perceived disability. Cronbach’s alpha was .60 at pre-intervention.  
5.2.3.5 Treatment maintenance  
The Treatment Maintenance Questionnaire (TMQ) was developed by the researchers 
for this study to measure adherence behaviour to post-intervention recommendations (see 
Appendix K for the full list of items). Development of this measure was based on the 
treatment modalities received and post-intervention adherence to a range of activities 
recommended during the pain program.  Treatment modalities included a) physiotherapy, b) 
psychology, c) occupational therapy, and d) hydrotherapy. Adherence to a range of 
recommended activities specific to the pain treatment provided included five categories: a) 
Regular exercise, b) Biomechanics, c) Relaxation techniques, d) Activity pacing, and e) Stress 
and mood management. Activities in each category were measured on a 4-point Likert-type 
scale (1 = I use this strategy not at all to 4 = I use this strategy all of the time). Participants 
could also select N/A if the activity was not recommended to them. N/A responses were 
scored as an average of the other scores. All activity scores were summed, with scores 
ranging from 16 to 64. High scores indicate greater adherence to treatment recommendations. 
The TMQ has adequate face validity (as it was created in consultation with employees at this 
pain clinic, and the measure covers activities that the patients are likely to be recommended), 
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and the items were shown to be internally consistent. In the present study, Cronbach’s alpha 
of .87 at 3-6 months post-intervention follow-up.  
5.2.4 Procedure  
Relevant ethics approval was gained from the hospital and University. One hundred 
and forty patients who had completed a pain management program at a pain clinic in 
Victoria, Australia between 2014 and 2016 were invited to participate. Each of the 140 
eligible individuals presenting for assessment at the pain clinic during this period were 
invited to participate by the assessing psychologist, and were given relevant verbal and 
printed information about the study. Informed consent was gained by those willing to 
participate, and the optional nature of the study was emphasized, including that it would not 
impact on their treatment in any way and that they were free to withdraw their consent at any 
time without consequence.  
Of the 140 eligible patients presenting for an assessment, sixty-one consenting 
participants completed the above battery of questionnaires at: (1) pre-intervention into the 
pain management program, (2) the completion of the program, and (3) 3-6 months post-
intervention. The remaining 79 invitees declined to participate. 
5.2.5 Data analyses  
Given the primary focus in the present study on predicting adherence, preliminary 
analyses were undertaken to contextualise main analyses. First, correlational analyses were 
performed to examine the strength of interrelationships between the pain-related variables 
and post-intervention treatment adherence. These correlational analyses addressed 
Hypotheses 1 and 2. Second, a series of paired sample t-tests were conducted to evaluate 
extent of change in the proposed predictor variables (depression, anxiety, pain self-efficacy, 
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and fear avoidance), as several subsequent analyses included change in these variables as 
predictors of patient adherence to their post-intervention treatment plans. 
For main analyses, a hierarchical regression analysis was conducted to test the 
combined and relative contributions of pre- (Step II) and post-intervention (Step III) 
measurements of depression, anxiety, pain self-efficacy, and fear-avoidance in predicting 
post-intervention treatment adherence, as per Hypothesis 3. Covariates of age, gender, and 
perceived disability were entered into the model in Step I, given potential for these 
demographic factors and perceived disability level to influence adherence. Finally, 
moderation analyses using the PROCESS plugin (Hayes, 2013) were undertaken to test 
Hypothesis 4; namely, the possibility that change in symptoms from pre- to post-intervention 
may moderate the predictive value of pre-intervention values of pain-related variables on 
post-intervention treatment adherence. Eight moderation analyses were conducted; one for 
each of the pain-related variables (depression, anxiety, pain self-efficacy, and fear avoidance) 
modelling pre-intervention or post-intervention versions of these variables separately as IVs. 
Covariates of age, gender, and perceived disability were included for each of these 
moderation models. 
Statistical significance testing for these models was augmented with estimates of 
effect size. Applying Ferguson’s (2009) guidelines, Cohen’s d values from t-tests were 
interpreted as follows: Cohen’s d < .41 = trivial effect, d = .41 – 1.14 = a small, practically 
significant effect, d = 1.15 – 2.69 = a moderate effect, and d > 2.69 = a strong effect. For 
correlational analyses, r values < .2 = trivial effect, r = .2 - .49 = a small, practically 
significant effect, r = .5 - .79 = moderate effect, and r > .79 = large effect. These r value 
guidelines were applied for semi-partial correlations as well. 
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5.3 Results 
There was less than 2% missing data overall. Missing values were imputed using 
expectation maximization (Field, 2013). No further data transformations were necessary as 
data conformed to key assumptions of the general linear model (outliers, normality, absence 
of multicollinearity, etc.). 
As shown in Table 5 pain self-efficacy was the only significant correlate of post-
intervention treatment adherence at both pre- and post-intervention; however, these 
correlation effects were relatively small. Overall, pain self-efficacy at post-intervention was 
the only variable shown to correlate with all other variables, ranging from small to large 
effects (r = -.62 to .25).  
 
Table 5. Means, standard deviations and inter-correlations among pain-related factors and 
treatment adherence 
 1 2 3 4 5 6 7 8 9 10 
1. DIS 1 1 
        
 
2. SE 1 -.62** 1         
3. SE 2 -.06 .25* 1 
      
 
4. FA 1 -.10 .14 -.37** 1 
     
 
5. FA 2 .40** -.25* -.34** .38** 1 
    
 
6. Dep 1 .06 .31** -.62** .44** .51** 1 
   
 
7. Dep 2 .03 -.21 -.62** .50** .57** .75** 1 
  
 
8. Anx 1 .17 -.49** -.34** .13 .41** .73** .47** 1 
 
 
9. Anx 2 -.02 -.18 -.53** .53** .54** .74** .87** .67** 1  
10. TA .01 .23* .25* .12 .14 -.16 -.17 -.20 -.07 1 
M 12.17 20.79 28.95 45.84 40.51 16.66 13.74 11.74 12.00 42.93 
SD 3.84 11.96 13.17 9.87 8.44 10.76 9.98 10.63 8.19 10.14 
** Correlation is significant at the .01 level, * Correlation is significant at the .05 level.   
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DIS 1 = Perceived disability pre-intervention; SE 1 = Self-efficacy pre-intervention; SE 2 = Self-efficacy post-
intervention; FA 1 = Fear avoidance pre-intervention; FA 2 = Fear avoidance post-intervention; Dep 1 = 
Depression pre-intervention; Dep 2 = Depression post-intervention; Anx 1 =Anxiety pre-intervention; Anx 2 
=Anxiety post-intervention; TA = 3-6 months post-intervention follow up of treatment adherence 
 
 
Means and standard deviations for the depression and anxiety scales both represent 
moderately severe levels (see Table 5). At pre-intervention, 55.7% (n=34) of participants 
presented with scores above the cut-off for at least moderate depression and 54% (n=33) 
participants with scores above the cut-off for moderate anxiety. At post-intervention, 54.1% 
(n=33) of participants presented with scores above the cut-off for depression and 62.2% 
(n=38) participants with scores above the cut-off for anxiety. Moderate to severe interference 
in participants’ self-efficacy for managing their pain was also observed for the sample overall 
at both pre- and post-intervention time-points.     
5.3.1 Adherence to treatment plan for post-intervention  
Various modalities of treatment were provided to participants during pain 
management, depending on individual needs; 97.4% of patients received physiotherapy, 
84.6% psychology, 62.2% occupational therapy, and 43% hydrotherapy. These modalities 
provided various treatment recommendations for patients to adhere to post-intervention. Of 
the recommendations provided, exercise was adhered to some of the time for 30% of patients 
and most or all of the time by 74% of participants; biomechanics was adhered to some of the 
time by 17% of patients and 83% reported adhering most or all of the time; 10% did not use 
their recommended relaxation tasks, while 18% reported using them some of the time, and 
the remaining 72% reported use most or all of the time; activity pacing was adhered to some 
of the time by 26% of patients and most or all of the time by 74% of the sample; 2% of 
patients who were recommended stress and mood management did not use the activities, 
while 28% adhered some of the time, and 70% adhered most or all of the time. 
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5.3.2 Paired-samples t-tests  
Paired-samples t-tests showed significant improvement from pre- to post-intervention 
for depression, t(60) = -3.10, p = .003, Cohen’s d = .41; fear-avoidance, t(60) = -4.06, p < 
.001, Cohen’s d = .52; and pain self-efficacy, t(60) = 4.12, p < .001, Cohen’s d = .53. No 
significant difference was found for anxiety from pre- to post-intervention, t(60) = -.26, p = 
.799, Cohen’s d = .04. 
5.3.3 Hierarchical regression  
As shown in Table 6, the hierarchical regression showed that the covariates (age, 
gender, and perceived disability at baseline) accounted for approximately 1% of the variance 
in adherence; R2 = .01, F(3,57) = 0.11, p = .95. At Step I, none of the predictors were 
significant. Inclusion of the variables measured pre-intervention to the model at Step II 
accounted for an additional 11% variance; ΔR2 = .11, F(4, 53) = 1.66,  p = .173. None of the 
predictors were significant at Step II. Inclusion of the post-intervention predictors at Step III 
accounted for a further 16% of variance; ΔR2 = .16, F(4, 49) = 2.73,  p = .040. Collectively, 
the predictors accounted for 28% of the variance in adherence; R2 = .28, F(11,49) = 1.71, p = 
.099. Depression and fear avoidance (both at post-intervention) were the only significant 
unique predictors (β = -.84, p = .024, sr = -.28 and β = .37, p = .048, sr = .25, respectively). 
 
Table 6. Summary of pain-related variables predicting 3-6 month post-intervention treatment 
non-adherence 
 
 
B t sr p 
Step I     
 Age .00 -0.50 -.07 .619 
 Gender -.03 -0.27 -.04 .787 
 Disability pre-intervention .00 0.03 .00 .975 
  163 
 
 
 
*p<.05 (two-tailed) 
5.3.4 Moderation  
Moderation analyses were conducted to evaluate the possibility that the effects of the 
risk factors (depression, anxiety, pain self-efficacy, and fear avoidance) on post-intervention 
treatment adherence may depend on level of improvement in these symptoms. The interaction 
between pre-intervention anxiety and change in anxiety from pre- to post-intervention was 
significant (b =.002, p = .04, R2 = .09). As shown in Figure 7, the effect of pre-intervention 
anxiety on post-intervention treatment adherence depended on level of change in anxiety 
from pre- to post-intervention. Individuals who initially had lower levels of anxiety (i.e., pre-
intervention) were more likely to adhere to post-intervention treatment if their anxiety 
Step II 
 Age .00 -0.22 -.03 .824 
 Gender -.03 -0.28 -.04 .782 
 Disability pre-intervention .02 1.21 .16 .230 
 Fear-avoidance pre-intervention .01 1.16 .15 .251 
 Pain self-efficacy pre-intervention .01 1.45 .19 .153 
 Depression pre-intervention -.01 -0.80 -.10 .428 
 Anxiety pre-intervention .00 0.08 .01 .938 
Step III     
 Age  .00 -0.49 -.06 .626 
 Gender .01 0.08 .01 .937 
 Disability pre-intervention .00 0.07 .01 .942 
 Fear-avoidance pre-intervention .00 0.26 .03 .794 
 Fear-avoidance post-intervention .02* 2.03 .25 .048 
 Pain self-efficacy pre-intervention .00 0.12 .02 .332 
 Pain self-efficacy post-intervention .01 1.41 .17 .165 
 Depression pre-intervention .01 0.98 .12 .332 
 Depression post-intervention -.04* -2.33 -.28 .024 
 Anxiety pre-intervention -.02 -1.87 -.23 .068 
 Anxiety post-intervention .04 1.93 .23 .060 
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worsened by post-intervention. In contrast, individuals with low levels of anxiety who 
experienced improvements in anxiety during the intervention phase were slightly less likely 
to adhere to their post-intervention treatment plan.  
The interaction between pre-intervention depression and change in depressive 
symptoms from pre- to post-intervention (b = .00, p = .47, R2 = .02), pre-intervention self-
efficacy and change in self-efficacy (b = .00, p = .70, R2 = .00), and pre-intervention fear-
avoidance and change in fear avoidance (b = .00, p = .18, R2 = .03) were all non-significant 
predictors of adherence. 
A similar pattern was found when post-intervention variables were used. That is, the 
interaction between post-intervention depression and change in depressive symptoms from 
pre- to post-intervention (b = .00, p = .53, R2 = .00), post-intervention anxiety and change in 
anxiety (b = .00, p = .29, R2 = .02), post-intervention pain self-efficacy and change in pain 
self-efficacy (b = .00, p = .16, R2 = .03), and post-intervention fear avoidance and change in 
fear avoidance (b = .00, p = .81, R2 = .00) were all non-significant predictors of post-
intervention treatment adherence. 
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Figure 7. Graph of the moderating effect of anxiety improvement during treatment for the 
relationship between pre-treatment anxiety (AnxietyT1) and level of treatment adherence. 
Scores on anxiety at pre-treatment are centered at the mean 
5.4 Discussion 
Despite considerable exploration of the influence of psychological factors on 
prognosis in chronic pain contexts, few studies have explored the impact of these factors on 
treatment adherence, particularly in the post-treatment maintenance phase (Thompson et al., 
2016). The present longitudinal study sought to remedy this by testing the predictive value of 
four previously identified psychological risk factors (fear-avoidance, pain self-efficacy, 
depression, and anxiety) for post-intervention treatment adherence following a pain 
management intervention. These risk factors were measured pre- and post-intervention to 
evaluate how timing of measurement and potential change in these risk factors may predict 
post-intervention treatment adherence. Overall, findings provided mixed support for 
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hypotheses about the role of these predictors, as measured at these time-points, in treatment 
adherence. 
When viewed at the bivariate level, pain self-efficacy (at pre- and post-intervention) 
was the only significant correlate of post-intervention treatment adherence. This finding is 
consistent with other research (Brus van de Laar, Taal, Rasker & Wiegman, 1999; Medina-
Mirapeix et al., 2009; Thompson et al., 2016), which has also found a link between pain self-
efficacy and post-intervention treatment adherence. Notably, the adherence and pain self-
efficacy correlation was only marginally larger for post-treatment than pre-treatment self-
efficacy despite observed improvements in pain self-efficacy by post-intervention. Given the 
low correspondence between self-efficacy scores at these two time-points, it is possible that 
these different measurements of self-efficacy may be associated with treatment adherence in 
different ways. For instance, whereas some individuals may be motivated to adhere post-
intervention due to noticeable gains in self-efficacy during treatment, others may persist in 
spite of lack of gains (or even deterioration in pain self-efficacy). Further research that 
incorporates patient motivation may allow for direct testing of this proposition. 
Non-significant associations between treatment adherence and depression, anxiety, 
and fear-avoidance may be explained in several ways. Firstly, the pattern of findings may 
reflect the impact of time of assessment. That is, some variables such as fear avoidance may 
be important earlier in a chronic pain episode, while confidence in one’s ability to manage 
despite the pain may be important overall (Denison, Asenlof, & Lindberg, 2004). As such, 
the small correlations obtained for these variables may be an accurate reflection of their 
impact at the time-points they were measured, but miss their larger, true effect that perhaps 
occurs earlier in the treatment cycle. Alternatively, the true effects of these variables on 
adherence may be masked by confounds, such as individual differences in self-efficacy that 
were not controlled for in these bivariate analyses. For example, depression could be 
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moderated by pain self-efficacy rather than being a strong primary predictor of post-
intervention treatment adherence (Jerant Kravitz, Moore-Hill, & Franks, 2008). Or there 
could simply be no relationship; the intervention does not affect these variables. 
Testing combinations of these proposed predictors provided several additional 
insights. First, in combination, the proposed risk factors predicted over one-quarter of the 
variance in treatment adherence, with more of this explained variance attributable to the post-
intervention grouping of predictors. The amount of unexplained variance in this model 
suggests that psychological factors alone may be insufficient to explain individual differences 
in post-treatment adherence. Thus, although the intention in the present study was to test a 
plausible and parsimonious model of predictors, a more complex model may be needed to 
more fully understand the factors that drive treatment adherence. Second, within this 
multivariable context, only post-treatment fear avoidance and depression were uniquely 
predictive of adherence, which is counter to the pattern of bivariate correlations. The non-
significance of self-efficacy in this model despite it having the strongest bivariate 
associations with adherence may be attributable to self-efficacy being broadly related to the 
other psychological constructs in the model. As such, the variance it has to contribute to 
adherence overlaps with these other predictors. 
Finally, moderation analyses revealed that change in anxiety was the only variable to 
moderate the main effects of a proposed risk factor on treatment adherence. Individuals who 
had low levels of anxiety at pre-intervention exhibited greatest adherence to post-discharge 
treatment plans if they experienced a substantial increase in anxiety during the treatment 
phase. In contrast, those with low level symptoms at pre-intervention who experienced 
reductions in their symptoms tended to have lower adherence to the post-discharge treatment 
plan. As the present study explored anxiety specifically in relation to pain symptoms, it is 
possible that these findings indicate that the change in anxiety that the patient felt about their 
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symptoms may have motivated stronger adherence for patients whose anxiety worsened, but 
led to a more relaxed attitude to their treatment plan for those who experienced reduced 
anxiety over their symptoms.  
For the psychological variables, the lack of moderation effects may be due to the fact 
that more than half of the participants in the present study remained clinically depressed (i.e., 
moderate to extremely severe symptoms) post-intervention. Similarly, the majority of 
participants in the present study maintained moderate levels of fear-avoidance post-
intervention. 
5.4.1 Limitations 
Despite the use of a clinical sample and longitudinal design, present findings should 
be viewed within the context of study limitations. Although proposed predictors were 
measured at traditional time-points (pre-intervention and post-intervention), it is possible that 
the true effects of these variables were missed due to failing to measure at their appropriate 
time of impact (Timmons & Preacher, 2015). More detailed measurement within and beyond 
the treatment phase may help to clarify whether null findings are attributable to issues of 
measurement timing or rather reflect the true nature of their influence on adherence. Related 
to this, some imprecision in estimation of the effects of these predictors on post-treatment 
adherence may have arisen due to individual differences in when they filled out the adherence 
measure. If adherence systematically reduces over time, then adherence levels may be 
expected to be lower for individuals who returned their adherence survey at 6 months than for 
those who completed it at the time they received it (i.e., 3-months post-discharge).  
Further, it is possible that the relationships between post-intervention treatment 
adherence and the investigated predictors may have been diminished due to self-report biases. 
That is, the subjective recall of adherence and the potential desire of patients to pose in a 
positive light may have led many participants to report high levels of adherence regardless of 
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actual behaviour, thus, reducing variance among predictors. Finally, it is worth considering 
the impact of the adherence measure on present findings. The present study instead utilised a 
tailor-made measure to assess adherence to various activities that are recommended at the 
clinic these patients were recruited from. This approach has face validity (as it was created in 
consultation with employees at this pain clinic, and the measure covers activities that the 
patients are likely to be recommended), and the items were shown to be internally consistent. 
Nevertheless, it is possible that the low correlations between psychological factors and 
adherence in the present study may be attributable to the way adherence was measured. 
5.4.2 Implications and future directions 
Despite design limitations, present findings offer re-affirmation for the notion that 
psychological factors may be markers for likely adherence to post-treatment instructions for 
chronic pain sufferers. This recommendation of monitoring of known correlates of treatment 
success is in line with best practice procedures carried out among pain management program 
providers; that is, to measure change in pain-related variables pre- and post-intervention (Hill 
et al., 2011). However, as highlighted in the literature, often measures administered post-
program are aimed at identifying treatment efficacy as opposed to highlighting predictors of 
future adherence levels (McCracken, MacKichan & Eccleston, 2007). By utilising current 
research to promote a greater focus on post-intervention predictors of poor post-discharge 
adherence to treatment maintenance plans, patients at greater risk can be appropriately 
flagged and finite resources may be prioritised to these individuals, thereby enabling for 
increased post-program support and reduced re-admission rates. 
Even so, conclusions based on present findings should be tempered by the size of 
obtained effects, and remaining uncertainty about the most appropriate time to measure these 
constructs. While null findings from the present study may indicate that the chosen predictors 
are weakly or not related to treatment adherence post-intervention, it is also possible that 
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failure to model these associations at the appropriate time-points in the treatment cycle may 
have led to under-estimated effects. Moreover, the finding that change in anxiety moderated 
effects of this variable on treatment adherence provides some evidence to suggest that static 
assessments of psychological functioning may be an insufficient basis for determining level 
of adherence to a patient’s given treatment plan. Further evaluation with an increased number 
of assessments during and beyond the intervention, as well as consideration of how best to 
model these predictor-outcome associations is necessary.   
In summary, present findings offer some support for the notion that psychological 
constructs may be relevant to prediction of treatment adherence post-intervention for chronic 
pain patients. However, these effects tended to be small. Given the considerable variability in 
treatment adherence levels identified in the present study, further investigation into the 
factors that might identify treatment adherence vs non-adherence is clearly warranted. 
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Chapter 6  
 
General Discussion 
 
6.1 Overview of studies conducted 
The aim of this thesis was three-fold: the first aim was to review the current literature 
in order to gain a greater understanding of the associations between cognitions and treatment 
adherence among chronic pain patients attending multidisciplinary treatment programs.  The 
second aim was to examine the interrelationships among specific psychological variables and 
pain symptoms in individuals presenting for chronic pain management. Finally, the third aim 
was to explore the combined and relative predictive value of previously identified cognitive 
(pain self-efficacy and fear-avoidance) and psychological (depression and anxiety) predictors 
of post-treatment adherence as well as the most appropriate time to measure their predictive 
value. To address these three specific aims, three studies were conducted. Study one was a 
review of the literature examining pain-related beliefs in relation to treatment adherence 
(Thompson, Broadbent, Bertino & Staiger, 2016). Study Two was a cross-sectional study 
testing the interrelationships between various cognitive and psychological factors known to 
impact pain symptoms (Thompson, Broadbent, Fuller-Tyszkiewicz, Bertino & Staiger, under 
review). Finally, Study Three was a longitudinal study investigating the predictive value of 
various psychological factors and their measurement timing on post-treatment adherence 
(Thompson, Broadbent, Fuller-Tyszkiewicz, Bertino & Staiger, under review). 
6.1.1 Study One 
Study One was a systematic review of the literature examining psychological 
correlates of multidisciplinary treatment adherence (Thompson et al., 2016). The review 
found that from the years 2000 to 2014, there were 10 published articles which specifically 
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examined pain-related beliefs and multidisciplinary treatment adherence among the chronic 
pain population (Coppack, Kristensen & Karaheorghis, 2012; Robinson et al., 2004; Mannion 
et al., 2009; Nicholas et al., 2012; Dobkin et al., 2005; Dobkin et al., 2010; Glombiewski et 
al., 2010; Heapy et al., 2005; Curran et al., 2009; Engstrӧm & Ӧberg, 2005). These studies 
highlighted that pain-related beliefs such as pain self-efficacy (Coppack, Kristensen & 
Karaheorghis, 2012; Mannion et al., 2009; Nicholas et al., 2012., Dobkin et al., 2005; Dobkin 
et al., 2010; Heapy et al., 2005; Curran et al., 2009), perceived disability (Dobkin et al., 2005; 
Dobkin et al., 2010; Glombiewski et al., 2010), catastrophizing (Mannion et al., 2009; 
Nicholas et al., 2012; Curran et al., 2009), control beliefs (Robinson et al., 2004; Mannion et 
al., 2009; Engstrӧm & Ӧberg, 2005), fear-avoidance beliefs (Mannion et al., 2009; Nicholas 
et al., 2012), perceived benefits of treatment recommendations (Robinson et al., 2004; 
Dobkin et al., 2005; Engstrӧm & Ӧberg, 2005) and perceived barriers of treatment 
recommendations (Dobkin et al., 2005; Engstrӧm & Ӧberg, 2005) contribute to chronic pain 
patient’s ability to adhere to prescribed treatment regimens and post-treatment self-
management.  
The findings of the systematic review revealed that pain self-efficacy is the most 
commonly researched pain-related belief in relation to treatment adherence. Whereas, general 
self-efficacy refers to one’s belief in their ability to perform certain tasks (Bandura, 1977), 
pain self-efficacy specifically refers to one’s belief in their ability to perform certain tasks, 
despite the experience of pain (Nicholas, 1989). Seven of the ten studies examined the effect 
of pain self-efficacy on treatment adherence (at pre-program, mid-program and/or post-
program), with five of those studies showing that low pain self-efficacy is predictive of 
reduced treatment adherence (Coppack, Kristensen & Karaheorghis, 2012; Mannion et al., 
2009; Nicholas et al., 2012; Dobkin et al., 2010; Curran et al., 2009). Further, the results of 
one study (Mannion et al., 2009) highlighted that increases in pain self-efficacy over the 
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course of treatment predicted increased adherence. The findings also suggest that treatment 
adherence is determined by a combination of other pain-related beliefs (perceived disability, 
catastrophizing, fear-avoidance beliefs, and perceived benefits and barriers), either supporting 
or inhibiting the ability of chronic pain patients to adhere to treatment recommendations over 
time. That is, despite pain self-efficacy being the most commonly researched, various other 
pain-related beliefs were found to be important factors in determining treatment adherence. 
The implications and key findings of the review provided the impetus for the two main 
studies of this thesis. For this reason, a key and unique question to be addressed in the present 
research was based on clarifying the predictive nature of various known psychological factors 
and their interrelationships on multidisciplinary post-treatment adherence. 
6.1.2 Study Two 
Study Two consisted of a cross-sectional investigation of the interrelationships 
between key pain-related cognitions and psychological factors known to impact pain 
symptoms. The variables examined were drawn from the systematic review and clinical 
expertise. A secondary aim involved utilising an innovative analytic technique (network 
analysis) to gain further insights into the interrelationships among psychological constructs 
and pain symptoms. Network analysis examines the pattern of relationships between causal 
factors and a focal event, providing a model of the perceived causal structure between 
variables (Reser & Muncer, 2004). That is, the perceived causal structure for co-morbid 
affective disorders and pain symptoms (focal event) were examined in relation to various 
putative cognitive causes.  
 One hundred and sixty nine individuals attending a multidisciplinary chronic pain 
program participated in the study. Variables were collected at intake to the program which 
consisted of depression, anxiety, and pain-related cognitions such as pain self-efficacy, fear-
avoidance beliefs, perceived control and perceived disability. Findings from Study Two 
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indicated some interrelations among all of the psychological factors investigated, albeit the 
nature and magnitude of these associations differed. Some variables, such as pain self-
efficacy, tended to have direct associations with each variable (even after partialling out 
variance of all remaining variables). Other variables, such as fear avoidance, perceived 
control, and perceived disability, were shown to serve more as links between other variables, 
especially for relationships involving the mental health variables (depression and anxiety). 
For instance, depression and pain symptoms were linked indirectly via perceived control, and 
avoidance connected disability with depression. Finally, although anxiety had a moderate 
strength value in the model (suggesting reasonable magnitude relationships), this was driven 
primarily by its link with depression as anxiety was unrelated to any other variables in the 
model. Once anxiety was removed from the model, the centrality of self-efficacy in directly 
linking to as well as bridging between other modelled variables was made clear. Perceived 
disability was second strongest in this revised model. In summary then, this pattern of 
findings is consistent with the notion that enhancing self-efficacy and reducing perceptions of 
pain may enable change in both perceptions of disability and experiences of mental illness in 
clinical pain populations.  
6.1.3 Study Three 
Study Three was a longitudinal cohort study which aimed to examine the predictive 
psychological factors related to adherence to multidisciplinary recommendations post-
treatment (i.e., between discharge and a 3-6 month follow-up session). This study measured 
pain self-efficacy, fear-avoidance beliefs and pre-intervention perceived disability (informed 
by Study One and Two) as well as depression and anxiety (informed by Study Two) and their 
importance to post-intervention adherence. As an extension of Study One and Two, Study 
Three sought to evaluate how the measurement timing and change in these psychological risk 
factors over time predict adherence post-treatment. Chronic pain patients attending a 
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multidisciplinary clinic completed questionnaires at three time points: assessment, discharge 
and three-to-six months post-program (based on their scheduled follow-up appointment).  
In line with findings from the systematic review, Study Three found pain self-efficacy 
to be a predictor variable shown to positively correlate with adherence post-treatment; in fact, 
the results indicated pain self-efficacy to be the only significant correlate (albeit small) of 
post-treatment adherence. Moderation analyses showed change in anxiety to be the only 
variable to moderate the main effects of a proposed risk factor on treatment adherence. For 
example, individuals with lower levels of anxiety at pre-intervention who then experienced a 
worsening of anxiety symptoms were found to be more adherent to their post-discharge 
treatment plan. Conversely, individuals with higher levels of anxiety at pre-intervention who 
then experienced improvements of anxiety symptoms were found to be less adherent post-
program. The latter finding demonstrating the impact that awareness of rising anxiety levels 
seen post-program, may have on patients’ motivation to maintain prescribed treatment.  
 
6.2 Findings for the psychological factors examined 
The following sections are an integrated discussion of the three present studies with 
respect to the key psychological variables examined. 
6.2.1 Pain self-efficacy 
The findings from this thesis provide some support in line with previous literature 
highlighting the importance of pain self-efficacy for treatment adherence (Nicholas et al., 
2012; Coppack, Kristensen & Karaheorghis, 2012; Dobkin et al., 2010). That is, Study One 
found pain self-efficacy to be the most commonly researched pain-related belief in relation to 
treatment adherence. In addition, Study Three found pain self-efficacy (at pre- and post-
intervention to be the only variable significantly correlated with post-treatment adherence. 
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Despite its bivariate correlation with adherence, pain self-efficacy was not shown to be 
uniquely predictive of treatment adherence within a multivariate context. This may be due to 
pain self-efficacy being broadly related to the other psychological constructs in the model; 
whereby, the variance it has to contribute to adherence overlaps with these other predictors.  
Pain self-efficacy was also hypothesised to be an important risk factor for other pain 
associated outcomes such as co-morbid mental health conditions. This is based on the 
premise that factors that influence one’s ability to adhere to treatment may also impact on 
mental health and vice versa. Numerous studies (Börsbo, Gerdle & Peolsson, 2010; Sardá Jr., 
Nicholas, Asghari & Pimenta, 2009; Asghari, Julaeiha & Godarsi, 2008) have found pain 
self-efficacy to be significantly and negatively associated with depressive symptoms. The 
lack of belief in one’s own ability to manage persistent pain has been shown to be a 
significant predictor of the extent to which individuals with chronic pain become depressed 
and/or anxious. Understandably, patients at pre-treatment who have not yet had an 
opportunity to experience success in performing treatment techniques appear more likely to 
display depressive symptoms such as low mood and hopelessness in response. In addition to 
previous research examining this relationship (meta-analytic review; Jackson et al., 2014) 
results from Study Two also show support for the relationships between pain self-efficacy 
and co-morbid mental health problems with some sizable direct associations found between 
these variables, even after controlling for other cognitive predictors. These findings support 
the influence of pain self-efficacy on co-morbid mental health problems. Interestingly, in 
contrast, results from Study Three showed pain self-efficacy to have no significant influence 
on psychological coping. Study Three indirectly assessed the relationship between these 
factors at pre- and post-treatment, however, no significant associations were found. Given the 
conflicting findings of past and current research, further investigation clarifying the direct 
and mediating effects of pain self-efficacy on mental health problems is warranted.  
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6.2.2 Anxiety 
Study Two identified a connection between depressive and anxiety symptoms in 
relation to one’s pain experience. However, anxiety was not found to directly relate to any 
other psychological constructs in the network model examined. This may be partially 
explained by the strong correlation found between anxiety and depressive symptoms. 
However, it should also be noted that the relationships with psychological factors and pain 
experience were consistently weaker for anxiety than for depressive symptoms. One possible 
explanation for this is the DASS-21 anxiety measure may be more heavily 
influenced/confounded with co-morbid medical conditions and medication side effects than 
the depression measure (i.e. 4 of the 7 items including dry mouth, breathing difficulty, racing 
heart and trembling hands). The lack of direct connection between anxiety and other 
cognitive constructs included in Study Two is surprising given the vast literature in support of 
such connections. For example, significant interrelationships between anxiety and fear-
avoidance beliefs have been extensively documented (Lucchetti, Oliveira, Mercante & Peres, 
2012; Bailey, Carleton, Vlaeyen, & Asmundson, 2010; McCracken & Keogh, 2009). As 
such, replication of Study Two findings is important. Results from Study Three did not reveal 
a bivariate association between anxiety and treatment adherence. This is likely attributed to 
the real-world confounding effects between uncontrolled variables (e.g., the relationship 
between pain self-efficacy and depression). However, moderation analyses revealed change 
in anxiety to be the only variable to moderate the main effects of a proposed risk factor on 
treatment adherence. That is, individuals who presented with low levels of anxiety at pre-
intervention exhibited greatest adherence to post-discharge treatment plans if they 
experienced a substantial increase in anxiety during the treatment phase. In contrast, those 
with low level symptoms at pre-intervention who experienced reductions in their symptoms 
tended to have lower adherence to the post-discharge treatment plan. It is possible that these 
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findings indicate that the change in anxiety that the patient felt about their symptoms may 
have motivated stronger adherence for patients whose anxiety worsened, but led to a more 
relaxed attitude to their treatment plan for those who experienced reduced anxiety over their 
symptoms. Based on this finding, treatment aimed at improving anxiety may not be as 
important or effective for chronic pain self-management as previously thought (Nicklas, 
Dunbar & Wild, 2010; Jack, McLean, Moffett & Gardiner, 2010). Research further exploring 
how change in anxiety symptoms impacts on treatment adherence specifically is warranted to 
clarify the value of identifying anxious chronic pain patients during intervention. 
6.2.3 Depression 
Study Two found depression to present with the highest strength value in the network 
model. Moreover, depression revealed relatively high levels of betweenness, serving as the 
shortest (and only) path to anxiety compared to the other variables in the model. As 
mentioned in the previous section (i.e., 6.2.2), this may be partly attributable to a strong 
association with anxiety. Study Two findings also showed depressive symptoms to directly 
link to various cognitive constructs included in the network model. That is, depression 
presented with a moderate closeness value, reflecting close proximity to fear-avoidance, 
perceived control, and pain self-efficacy. Thus, it appears that when assessing for and treating 
depression among chronic pain patients, consideration and further exploration of potentially 
underlying cognitive factors (particularly, fear-avoidance, perceived control, and pain self-
efficacy) and their impact on psychological coping is warranted. When viewed at the 
bivariate level, depressive symptoms were not found to significantly correlate with post-
treatment adherence in Study Three. This is contrary to literature examining this relationship 
(Nicholas et al., 2012; Blashill, Perry & Safren, 2011; Jack et al., 2010). An explanation for 
this finding may be that depression is moderated by other variables such as pain self-efficacy 
rather than being a strong primary predictor of post-intervention treatment adherence. There 
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is considerable support for this mediational effect as seen throughout the broader literature. 
For example, Maeda et al.’s (2013) study found self-efficacy to mediate the contribution of 
depression to treatment adherence among a large sample (N=252) of heart failure outpatients. 
Further research exploring this relationship, specifically among chronic pain patients, would 
be beneficial. Despite the lack of a bivariate association, multivariate analyses identified post-
intervention depression to be a unique predictor of adherence to post-discharge treatment 
plans. In this respect, identifying chronic pain patients who are struggling with symptoms of 
depression after a pain management program may be a key factor for improving post-
program self-management. A better understanding of the pathways in question will prompt 
more refined methodology for treating chronic pain and subsequently improve pain-related 
outcomes such as comorbidity and treatment adherence. 
6.2.4 Fear-avoidance beliefs 
The findings of Study Two identified fear-avoidance beliefs as being significantly 
implicated in pain and affective disorder symptoms. That is, chronic pain patients with higher 
fear-avoidance beliefs are at greater risk of displaying elevated symptoms of pain intensity as 
well as depression and anxiety. The importance of high fear-avoidance as a risk factor for 
anxiety is well documented throughout the literature (Lucchetti et al., 2012; Bailey, Carleton, 
Vlaeyen, & Asmundson, 2010; McCracken & Keogh, 2009). Longitudinally, no significant 
bivariate relationship was found between fear-avoidance beliefs and depression or anxiety. 
Nor was change in fear-avoidance beliefs shown to have any moderating effect. Interestingly, 
fear-avoidance scores remained moderately high for most pain patients at program 
completion which may have impacted on the lack of moderation effects. Similarly, Study 
One found limited support for the relationship between fear-avoidance beliefs and treatment 
adherence. That is, only two of the ten papers included in the study examined this 
relationship. Of these two studies, only one indicated higher degrees of adherence to 
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treatment recommendations to be predictive of greater pre-post treatment changes in fear-
avoidance beliefs. However, similar to the pattern of relationships identified for depression, 
longitudinal multivariate analyses identified post-intervention depression to be a unique 
predictor of adherence. Therefore, chronic pain patients presenting with heightened fear-
avoidance at the completion of pain management may also be an important target for 
improved post-program adherence. Overall, these findings provide some evidence for the 
importance of identifying chronic pain patients with high fear-avoidance beliefs for treatment 
adherence, particularly in the post-intervention phase, however, the relevance of fear-
avoidance for depression and anxiety remains somewhat unclear. Again, further research 
aimed at replicating these findings is needed in order to enhance understanding of the 
predictive value of fear-avoidance beliefs for pain and affective symptomatology.  
6.2.5 Perceived disability and control 
In Study One, three of the ten studies included examined the effect of perceived 
disability on treatment adherence. Perceived control was also examined by three studies in 
the systematic review. Whereas, two studies found moderate to strong negative associations 
between perceived disability and treatment adherence, all three studies found no relationship 
between perceived control and treatment adherence. Study Two findings also revealed limited 
support for perceived control. Despite perceived control displaying direct links (to fear-
avoidance beliefs and depressive symptoms) within the examined network, its bridging 
effects to other variables appeared weaker than those identified for other linked variables. 
That is, results from Study Two showed perceived disability to also have direct effects on 
other variables (pain self-efficacy and pain intensity), however, these effects appeared much 
stronger than those identified for perceived control. In light of these findings, both perceived 
disability and perceived control appear to have an influence (direct or as a mediator) on other 
modelled constructs, albeit, perceived disability may serve as a more important mediator and 
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risk factor for the development and maintenance of chronic pain outcomes. For this reason, 
perceived disability was given preference for inclusion as a baseline measure in Study Three. 
Results showed perceived disability at pre-intervention to not indicate a significant predictor 
of treatment adherence. Future research would benefit from including discharge levels of 
perceived disability to examine its effect in relation to post-treatment adherence from a 
longitudinal perspective.  
 
6.3 Novel investigations and findings  
Study One is the only review that provides a systematic review of the research to-date 
examining pain-related beliefs and treatment adherence. This review highlighted the 
importance of pain self-efficacy in predicting chronic pain treatment adherence. It also 
revealed several other pain-related beliefs to be important for self-management during and 
after pain management intervention.  
Study Two utilised an innovative analytic technique (network analysis) to gain further 
insights into the interrelationships among psychological variables and pain symptoms in a 
group of individuals seeking treatment for chronic pain. In addition, to the authors 
knowledge, no prior studies have examined the specific combination of cognitive factors as 
predictors of affective disorder symptoms or the pain experience within the same conceptual 
model.  
Despite considerable exploration of the influence of psychological risk factors 
(anxiety, depression, fear avoidance, and self-efficacy) on prognosis in chronic pain contexts, 
fewer studies have explored the impact of these factors concurrently on treatment adherence, 
particularly in the post-treatment maintenance phase. This reflects the novel contribution of 
Study Three. Considerable research is focused on examining program effectiveness at 
discharge and the relative improvement of symptoms pre- and post-program. However, few 
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studies have identified or explored the most appropriate time to measure the predictive value 
of various specific psychological factors on post-treatment adherence. The present 
longitudinal study sought to remedy this by testing the predictive value of four previously 
identified psychological risk factors (pain self-efficacy, fear-avoidance beliefs, depression, 
and anxiety) for post-intervention treatment adherence following a pain management 
program. These risk factors were measured pre- and post-intervention to evaluate how timing 
of measurement and potential change in these risk factors may predict post-intervention 
treatment adherence.  
Examination of the importance of measurement timing (pre- and post-intervention) 
for these risk factors and treatment adherence is a methodology that had not been explored 
previously. By testing these variables together and at different stages of intervention, Study 
Three pinpointed depression and fear-avoidance (both at post-intervention) as the strongest 
unique predictors of treatment adherence following a pain management program. These 
findings confirm that post-intervention levels of specific psychological constructs are better 
predictors (than pre-intervention levels) of post-discharge treatment adherence. This research 
also provided a better understanding of how change in anxiety predicts post-intervention 
adherence; with improvement of anxiety symptoms shown to conversely impact pain 
patients’ ability to maintain self-management behaviours.  
 
6.4 Treatment implications 
The findings of this thesis have highlighted the importance of psychological factors 
for effective post-treatment adherence and self-management behaviour. Treating clinicians of 
chronic pain patients need to be aware of the impact that factors such as depression, fear-
avoidance beliefs and anxiety have on post-treatment adherence outcomes. The findings of 
this thesis support previous research, which suggest that depression and fear-avoidance are 
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important to identify prior to discharge from pain management programs to intervene and 
improve adherence behaviour. The findings here extended on the knowledge of this 
relationship by highlighting the need to prioritise post-intervention predictors of adherence to 
self-management plans post-discharge. This is important as measures administered post-
program are often aimed at identifying treatment effectiveness as opposed to highlighting 
predictors of poor adherence. With a refined focus, patients at greater risk can be 
appropriately flagged and scheduled for follow-up, thus enabling for increased post-program 
support and reduced likelihood of re-admission.   
Depression and fear-avoidance have both previously been identified as modifiable 
psychological factors (George, Valencia & Beneciuk, 2010; Smeeding, Bradshaw, Kumpfer, 
Trevithick & Stoddard, 2010), which can be reduced with appropriate intervention to improve 
treatment adherence outcomes. However, as pain management programmes generally run for 
a finite period of time (i.e., weeks to months), severe psychological presentations can be 
difficult to overcome completely. As such, pain management clinicians should be encouraged 
to dedicate ample time to the re-assessment of client’s level of depression and fear-avoidance 
post-program (i.e., discharge and follow-up), regardless of assessment results at intake. 
Integrative re-assessment aimed at identifying at-risk individuals by highlighting predictors 
of poor treatment adherence would help to target those in need of ongoing support and 
community referral. By improving continuity of care, at-risk individuals can receive 
intervention and monitoring beyond their involvement in pain management. Subsequently, 
enabling better implementation and maintenance of learned self-management strategies, 
therefore, reducing the likelihood of relapse into passive coping mechanisms.  
It is important that clinicians working with chronic pain patients, understand the 
relationship between fear-avoidance beliefs and mental health issues. Based on the current 
findings, it is recommended that clinicians focus on identifying pain patients with high fear-
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avoidance beliefs and behaviours as this may indicate a risk factor for co-morbid mental 
health problems and heightened pain intensity. There are many practical ways to reduce fear-
avoidance beliefs. For example, providing clinicians with adequate resources to expand on 
patients’ understanding of the inherent cognitive, emotional and behavioural components 
involved in the pain experience. This may help to alleviate common misconceptions; for 
example, that fear-avoidance beliefs occur as a reaction to the physical sensation of pain 
rather than it being a contributing factor to prolonged pain. Knowledge such as this may also 
help to educate patients about the importance of physical movement in pain rehabilitation and 
the disabling consequences of activity avoidance. A greater understanding and exploration 
into the mechanisms of individual fear-avoidance will better enable patients to take proactive 
steps against such unhelpful beliefs.   
The present research provided an interesting insight into the relationship between 
anxiety and treatment adherence. Although, change in anxiety symptoms over the course of 
pain management is important to monitor, it appears that relying on self-report measures of 
anxiety symptoms alone may not be sufficient to identify at-risk individuals. This was evident 
in the present research which revealed heightened anxiety to improve self-management 
behaviour, contrary to previous findings examining this relationship (Nicklas et al., 2010; 
Jack et al., 2010). As such, clinicians are encouraged to dedicate time to conducting more in-
depth assessment of anxiety, in particular, via semi-structured interview. This may help to 
distinguish between patients who are motivated by their anxiety to self-manage pain versus 
patients whose anxiety serves as a risk factor for treatment non-adherence. This knowledge 
can be used to tailor intervention in a way that more appropriately targets individual 
requirements for effective chronic pain self-management. 
  190 
 
 
 
6.5 Limitations 
Within Study Two and Study Three there were some limitations that were specific to 
the design and some limitations that are more inherent in chronic pain research.  
The main limitations of the present research are methodological in nature. In addition 
to the cross-sectional design of Study Two preventing any causal inferences to be made, the 
majority of participants in Studies Two and Three were female and presented with chronic 
pain that was musculoskeletal in nature. Subsequently, results from these studies may lack 
generalizability to the broader pain population, including various other pain localisations, and 
warrant cautious interpretation. The issue of generalizability may be of particular concern if 
certain beliefs are found to be more common among individuals with specific pain 
localisations (e.g., fear-avoidance beliefs among chronic low back pain sufferers, Brox et al., 
2005). Therefore, interpretation of the relationships supported in Studies Two and Three may 
be limited to similar samples of female predominant patients with chronic musculoskeletal 
pain presentations. 
There are also several limitations specific to Study Three. Firstly, there was a 
significant participant attrition rate of approximately sixty four percent, despite efforts by the 
research team to follow up participants. This involved contacting participants via telephone 
with reminders if their questionnaires weren’t received. High attrition rates are a common 
problem of longitudinal research and are well documented in samples of chronic pain patients 
(Chiesa & Serretti, 2011; Solberg, Roach & Segerstrom, 2009). This is likely due to the 
experience of chronic pain often being reported as persistently challenging, both physically 
and emotionally. Replication of the present longitudinal study with a larger sample size is 
warranted. However, careful consideration and planning of strategies to reduce attrition rates 
at the outset are needed to curtail excessive study drop-out.   
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Secondly, the wide variety of treatment approaches recommended to participants in 
Study Three resulted in considerable heterogeneity when it came to comparing post-treatment 
adherence. For example, adherence to physical exercise recommendations and to mood 
management techniques would appear to be very different things. The finding that higher 
pain-related self-efficacy and lower anxiety were general predictors of adherence to all these 
different potential self-management behaviours leaves many unanswered questions.  Future 
research which disseminates these different potential pain management behaviours is crucial 
to clarify the relative and specific importance of predictors of post-treatment adherence, in 
particular, pain self-efficacy and anxiety. Considerable variation in the methods of assessing 
other core constructs such as pain self-efficacy was also highlighted in Study 1 (e.g., Pain 
Self-Efficacy Questionnaire, Arthritis Self-Efficacy Scale, Exercise Self-Efficacy 
Questionnaire). This may have partly accounted for the differences among studies examining 
the impact of pain self-efficacy on treatment adherence. Therefore, research aimed at 
enhancing the consistency and comparability of research by intentionally utilising similar 
methods of measurement would be beneficial. 
Thirdly, the proposed predictors of post-treatment adherence included in Study Three 
were measured at traditional time-points (pre- and post-intervention). It is possible that the 
true effects of these variables were missed due to failing to measure at their appropriate time 
of impact. To rectify this limitation for future research, more detailed measurement within 
and beyond the treatment phase may help to clarify whether null findings are attributable to 
issues of measurement timing or rather reflect the true nature of their influence on post-
treatment adherence. 
A further limitation of the chronic pain literature in general is the self-report nature 
that nearly all studies adopt. Although self-report is considered the gold standard of pain 
measurement given its consistency with the ‘subjective’ definition of pain, limitations are 
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inherent in the subjectivity of self-reported measures, such as ability to discern and 
effectively communicate one’s pain state (Schiavenato & Kenneth, 2010). This brings a 
fourth limitation of Study Three to light - the Treatment Maintenance Questionnaire (TMQ) 
developed by the researchers of this study to measure post-treatment adherence. In addition to 
the subjectiveness inherent in this self-report measure, it is also possible that the responses to 
questions about adherence to treatment recommendations reflect social desirability biases 
(van de Mortel, 2008). Subsequently, for a range of reasons (e.g., compensation, desire to be 
perceived in a positive light), participants may be led to alter their true level of adherence to 
impress their treating clinicians and/or stage improvements of pain characteristics and 
associated outcomes. To mediate the limitations of self-report measures, inclusion of 
professional assessment and interpretation of presenting psychological factors is 
recommended. Another limitation of the TMQ relates to its scoring system. That is, patients 
were instructed to score a zero on an item if they had not been recommended to use a 
particular strategy (i.e., ‘0 – I was not recommended to use this strategy’). This led to 
inherent challenges (in the form of time expenditure) in calculating an accurate total TMQ 
score. To address the limitations of the TMQ, inclusion of more precise (e.g., ‘not 
applicable’) and reverse-scored items assessing post-treatment adherence would be 
beneficial. This may help to overcome time consuming scoring challenges in addition to 
further reducing the likelihood of self-report biases; thus, improving the comparative validity 
and reliability of this outcome measure. 
 
6.6 Conclusions and future research 
The overall aim of this thesis was to explore the associations between pain-related 
beliefs, psychological presentations and treatment adherence in individuals experiencing 
chronic pain. All three studies in this thesis have highlighted the importance of psychological 
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factors on chronic pain outcomes and the need for future participants to be more thoroughly 
screened for at-risk levels of these factors pre- and post-intervention. This is crucial in order 
to improve and maintain treatment outcomes and thus, reduce the likelihood of relapse and 
re-admission into Australian pain management programmes.  
Findings for the three studies demonstrated the importance of several psychological 
factors. Whereas, Study One showed pain self-efficacy to be the pain-related belief most 
reliably implicated in treatment adherence outcomes, Study Two highlighted the importance 
of pain self-efficacy for pain and affective disorder symptoms. Fear-avoidance beliefs and 
perceived disability were also considered to be important constructs in Study Two. Study 
Three indicated depression and fear-avoidance post-treatment to be important risk factors for 
patient’s ability to adhere to treatment recommendations. Interestingly, Study Three also 
found change in anxiety symptoms from pre-to post-intervention was found to conversely 
predict post-intervention adherence. These findings are quite promising as pain self-efficacy, 
depression, fear-avoidance beliefs, perceived disability as well as anxiety are all modifiable 
and have been shown empirically to independently improve chronic pain outcomes when 
modified through appropriate interventions (Börsbo, Gerdle & Peolsson, 2010; George et al., 
2010; Gockel, Lindholm, Niemistö & Hurri, 2008; Smeeding et al., 2010).  
Collectively, the series of studies included in this thesis endeavoured to examine the 
relationships between various psychological and cognitive factors on chronic pain outcomes, 
in particular, post-treatment adherence. Specifically, Study Three contributed to the chronic 
pain literature by highlighting which of these specific psychological factors, and at what 
time-points, are most predictive of effective self-management post-treatment. This is 
particularly important to enable clinicians to identify which specific variables to target and 
when; thereby, increasing the likelihood of effective long-term self-management and, thus, 
reducing rates of relapse and re-admission to chronic pain programmes. This research helps 
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to justify the usefulness of PMPs whilst advocating for adequate economic support for future 
programmes. However, to further assimilate the resource use and cost of such programmes, 
future research in this field would benefit from the inclusion of a health economist. Future 
longitudinal research might also consider the use of a mixed methods approach (e.g., in-depth 
interviews, questionnaires) to provide insight into process data, thus, adding more value to 
any quantitative findings. Similarly, clinicians should exercise caution in administering 
'standard' assessments, instead, utilising mixed methods to achieve more accurate 
formulations and subsequent treatment plans. This is important to uphold best practice and 
patient-centred intervention. By ensuring thorough assessments of the subjective features of 
chronic pain (e.g., understanding unique barriers and facilitators), treatment can be better 
tailored to suit individual needs. Finally, future research is needed to expand on the findings 
of this thesis, to improve upon the methodological limitations of the present research design 
and further investigate the role that modifiable cognitive and psychological factors have on 
post-treatment adherence and self-management behaviour.  
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Appendix D: Plain Language Statement for Study Two 
 
                                                                                                                  
TITLE OF THE STUDY:   
“A retrospective analysis of pain characteristics, demographics, functioning, & mental health 
symptoms in adults who have attended the Pain Management Clinic at The Victorian 
Rehabilitation Centre” 
PURPOSE OF THE STUDY:  
Research findings from overseas (especially the U.S. and U.K.) have led to the current 
best practice clinical guidelines for the treatment of Chronic Pain which are now used in 
Australia. These guidelines recommend that healthcare professionals should look out for 
‘risk factors’ which might make management of Chronic Pain more difficult for sufferers 
(including biological, psychological and social issues). They also recommend that part of the 
treatment for people with Chronic Pain should be to try to help sufferers recognise and 
change some of these risk factors if it is possible (e.g. helping to change negative perceptions 
of disability, fears about movement, low self confidence in managing pain, and emotional 
distress).   
However, there has been very little research done in this area specifically with 
Australian sufferers, presenting at a service such as the Pain Management Clinic at The 
Victorian Rehabilitation Centre. Although there are many similarities between Australian and 
U.S. and U.K. populations, there are also some differences - particularly regarding the 
medical and legal systems.  
The purpose of this study is to discover whether the same risk factors are important for 
an Australian population of Chronic Pain sufferers, which would assist us in 
determining whether the current best practice guidelines are appropriate. 
METHODS USED IN THE STUDY: 
Should you choose to participate in this project the researchers will enter your 
information from your hospital file into a secure database. You do not need to complete 
any new information.  
However, in order for us to be able to use your information, you must sign and return the 
attached consent form using the enclosed reply paid envelope. This information will then 
be used to write publications for scientific journals or conferences.  
The information that is entered into the secure database will be ‘de-identified’, meaning that 
instead of including names and addresses, the data will be attached to a code and names will 
be removed prior to the research team accessing the data. We are coding the data, in case we 
need to add any follow up information that we may collect from you at a later date. The 
coded data will be kept in a secure, locked location at The Victorian Rehabilitation Centre, in 
a similar way to which patient’s hospital files are stored, and will be kept for a minimum of 
10 years before being securely destroyed.  
The computer database will only be accessible to members of the research team, including 
Dr. M. Bertino, Ms. R. Kovacevic, Ms. M. Sandilands, Ms. D. Zammit, Ms. A. Newbigin, 
Ms. E. Ahmet, Dr. J. Broadbent, Ms E. Thompson and supervised, trained research assistants. 
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The information that will be accessed and entered into the secure database will include: 
your demographics (age, gender, insurer, referral source) completed at the time of 
assessment, questionnaires that you completed when attending the centre (relating to mental 
health, functioning, pain attitudes beliefs and responses, medications, and services received), 
and information from the initial assessment interview form that was completed by the 
clinicians during your assessment interview (relating to primary concerns at the time, pain 
severity rating, mental health symptoms, mental health history and diagnoses, work history, 
social supports, and coping strategies).  
Names, addresses or contact details will NOT be entered into the research database. In 
writing any publications from the data, the research team will only use participant’s data 
in a combined form with other participant’s data, so that individual identities cannot be 
determined by the readers of the publications.  
DEMANDS OF THE STUDY: 
To complete and return the attached consent form using the enclosed reply paid 
envelope, should you wish to participate in this project. This will allow the researchers to 
access the information specified above from your medical file, under the above conditions. If 
you change your mind, you may withdraw your consent to participate at any time prior to 
publication of the results by contacting the researchers (Phone 0395018785). 
COMPLAINTS: 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact: The 
Manager, Research Integrity, Deakin University, 221 Burwood Highway, Burwood Victoria 
3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-ethics@deakin.edu.au. 
Please quote project number: 2012-147. 
 
 
 
 
 
 
 
 
 
 
 
 
  206 
 
 
 
Appendix E: Consent form Study Two 
 
                                                     
 
CONSENT FORM 
FOR INVOLVEMENT OF PARTICIPANTS IN MEDICAL RESEARCH 
at The Victorian Rehabilitation Centre 
Approved by The Melbourne Clinic Research Ethics Committee 
I agree to participate in a research project entitled “A retrospective analysis of pain 
characteristics, demographics, functioning, and mental health symptoms in adults who have 
attended the Pain Management Clinic at the Victorian Rehabilitation Centre” 
This research is being conducted by Dr. Melanie Bertino, Ms. Rachel Kovacevic, Ms. Mary 
Sandilands, Ms. Denise Zammitt, Ms. Emel Ahmet, and Ms. Amanda Newbigin, psychologists 
at the Victorian Rehabilitation Centre, in collaboration with researchers at Deakin University, 
Dr. Jaclyn Broadbent (lecturer) and Ms. Emma Thompson (Doctor of Health Psychology 
Student).  
1. My agreement is based on the understanding that: 
My involvement entails me posting back this signed consent form using the reply-paid 
envelope. This will allow the researchers to access de-identified information from my 
hospital record and enter it into a computer database (de-identified meaning that instead 
of using my name, my data will be attached to a code to protect my privacy). The computer 
database will only be accessible to members of the research team, including the above-named 
psychologists and supervised, trained research assistants.  
My information that will be entered will include: demographics (age, gender, insurer, referral 
source), questionnaires (mental health, functioning, pain attitudes beliefs and responses, 
medications, services received), and the initial assessment interview form from my assessment 
interview (primary concerns, pain severity rating, mental health symptoms, mental health 
history and diagnoses, work history, social supports, and coping strategies).  
My name, address or contact details will NOT be entered into the research database. In writing 
any publications from the data, the research team will only use my data in a combined form 
with other participants’ data, so that my identity cannot be determined by the audience of the 
publication.  
2. The following risks, discomforts and inconveniences have been explained to me:  
No adverse outcomes are expected from your participation in this project. Should you have any 
concerns regarding this project, please contact Dr. Melanie Bertino in the first instance on: 
(03)95018785. Alternatively, please contact the Melbourne Clinic Research Ethics Committee 
Research Manager (Professorial Unit), Deidre Smith, on: (03)94209353. 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:  The 
Manager, Research Integrity, Deakin University, 221 Burwood Highway, Burwood Victoria 
3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-ethics@deakin.edu.au. 
Please quote project number: 2012-147 
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3. I have read the attached “Information Sheet” and understand the general purposes, methods 
and demands of the project. 
4. I understand that the project may not be of direct benefit to me.  
5. I can withdraw my data from the project at any time prior to the results being published. In 
order to withdraw my consent I should contact Dr Melanie Bertino on (03)95662939. This will 
not affect any further therapy or relationships with staff at The Victorian Rehabilitation Centre 
in any way.  
6. I am satisfied with the explanation given in relation to the project in so far as it affects me. 
7. My consent to participate in this project is given freely. 
8. I have been informed that the information I provide will be confidential. 
 
..................................................................................................................................... 
(Name of participant) 
 
SIGNED ..................................................................... DATE ................................... 
(Participant) 
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Appendix F: Network map without anxiety symptoms for Study Two 
 
 
Once anxiety is excluded from the model, depression drops from the node (variable) with the 
highest strength value to third highest. Its betweenness value also dropped as it was no longer 
bridging other variables with anxiety. Depressive symptoms retained direct links with 
control, avoidance, and self-efficacy, as per the original model. In this revised model, there is 
still no direct link between pain intensity and depression, ruling out the possibility that the 
lack of direct association in the original model was due to heavy overlap between depression 
and anxiety symptoms. 
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Appendix H: Plain Language Statement for Study Three 
 
                                                                                                                        
TITLE OF THE STUDY:   
“A retrospective analysis of pain characteristics, demographics, functioning, & mental health 
symptoms in adults who have attended the Pain Management Clinic at The Victorian 
Rehabilitation Centre” 
PURPOSE OF THE STUDY:  
The researchers of this study are interested in obtaining follow-up information about the 
effectiveness of Chronic Pain treatment interventions on patient outcomes over time.   
Research findings from overseas (especially the U.S. and U.K.) have led to the current best 
practice clinical guidelines for the treatment of Chronic Pain which are now used in 
Australia. These guidelines recommend that healthcare professionals should look out for ‘risk 
factors’ which might make management of Chronic Pain more difficult for sufferers (including 
biological, psychological and social issues). They also recommend that part of the treatment for 
people with Chronic Pain should be to try to help sufferers recognise and change some of these 
risk factors if it is possible (e.g. helping to change negative perceptions of disability, fears about 
movement, low self confidence in managing pain, and emotional distress).   
However, there has been very little research done in this area specifically with Australian 
sufferers, presenting at a service such as the Pain Management Clinic at The Victorian 
Rehabilitation Centre. Although there are many similarities between Australian and U.S. and 
U.K. populations, there are also some differences - particularly regarding the medical and legal 
systems.  
The purpose of this study is to discover whether the same risk factors are important for an 
Australian population of Chronic Pain sufferers, which would assist us in determining 
whether the current best practice guidelines are appropriate. 
METHODS USED IN THE STUDY: 
Should you choose to participate in this study, you need to complete and return the 
questionnaire booklet enclosed.  This questionnaire booklet contains the same battery of 
measures that you completed at the beginning of treatment and one additional measure 
entitled ‘Treatment Maintenance Questionnaire’.  
However, in order for us to be able to use your information from the questionnaire booklet, you 
must sign and return the attached consent form using the reply-paid envelope provided. 
This information will then be used to write publications for scientific journals or conferences.  
The information that is entered into the secure database will be ‘de-identified’, meaning that 
instead of including names and addresses, the data will be attached to a code and names will be 
removed prior to the research team accessing the data. We are coding the data, in case we need to 
add any follow up information that we may collect from you at a later date. The coded data will 
be kept in a secure, locked location at The Victorian Rehabilitation Centre, in a similar way to 
which patient’s hospital files are stored, and will be kept for a minimum of 10 years before being 
securely destroyed.  
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The computer database will only be accessible to members of the research team, including Dr. 
M. Bertino, Ms. R. Kovacevic, Ms. M. Sandilands, Ms. D. Zammit, Ms. A. Newbigin, Ms. E. 
Ahmet, Dr. J. Broadbent, Ms E. Thompson and supervised, trained research assistants. The new 
information that will be entered into the secure database will include your responses in the 
questionnaire booklet.  
Names, addresses or contact details will NOT be entered into the research database. In writing 
any publications from the data, the research team will only use participant’s data in a 
combined form with other participant’s data, so that individual identities cannot be 
determined by the readers of the publications.  
DEMANDS OF THE STUDY: 
To complete and return the attached consent form and questionnaire booklet using the 
enclosed reply paid envelope, should you wish to participate in this project. This will allow 
the researchers to include the information specified above, under the above conditions. If you 
change your mind, you may withdraw your consent to participate at any time prior to publication 
of the results by contacting the researchers (Phone 03 9566 2777). 
COMPLAINTS: 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact: The 
Manager, Research Integrity, Deakin University, 221 Burwood Highway, Burwood Victoria 
3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-ethics@deakin.edu.au. 
Please quote project number: 2012-147. 
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Appendix I: Consent form for Study 3 
 
 
                                                                                                                                        
                                                 
 
CONSENT FORM 
FOR INVOLVEMENT OF PARTICIPANTS IN MEDICAL RESEARCH 
at The Victorian Rehabilitation Centre 
Approved by The Melbourne Clinic Research Ethics Committee 
I agree to participate in a follow-up study for the research project entitled “A retrospective analysis 
of pain characteristics, demographics, functioning, and mental health symptoms in adults who 
have attended the Pain Management Clinic at the Victorian Rehabilitation Centre” 
This research is being conducted by Melanie Bertino, Rachel Kovacevic, Mary Sandilands, Denise 
Zammitt, Emel Ahmet, and Amanda Newbigin, psychologists at the Victorian Rehabilitation 
Centre, in collaboration with researchers at Deakin University, Jaclyn Broadbent (lecturer) and 
Emma Thompson (Doctor of Health Psychology Student).  
3. My agreement is based on the understanding that: 
My involvement entails me posting back this signed consent form and questionnaire booklet 
using the reply-paid envelope. This questionnaire booklet will not contain any identifying 
information other than a code used to match this data to your previous data. This is known 
as de-identified data (de-identified meaning that instead of using my name, my data will be 
attached to a code to protect my privacy). The computer database will only be accessible to 
members of the research team, including the above-named psychologists and supervised, trained 
research assistants.  
My name, address or contact details will NOT be entered into the research database. In writing any 
publications from the data, the research team will only use my data in a combined form with other 
participants’ data, so that my identity cannot be determined by the audience of the publication.  
4. The following risks, discomforts and inconveniences have been explained to me:  
No adverse outcomes are expected from your participation in this project. Should you have any 
concerns regarding this project, please contact Dr. Melanie Bertino in the first instance on: 
95018785.  If you are distressed in any way by the research procedures used in this project, please 
contact Dr. Simone Fisher on: 95018791, a clinician who is not a member of the research team. 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:  The Chair of 
the Melbourne Clinic Research Ethics Committee, Dr Harry Derham, Telephone: 9420 9350.  
Or the Manager, Research Integrity, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-
ethics@deakin.edu.au. Please quote project number: 2012-147 
3. I have read the attached “Information Sheet” and understand the general purposes, methods 
and demands of the project. 
4. I understand that the project may not be of direct benefit to me.  
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5. I can withdraw my data from the project at any time prior to the results being published. In 
order to withdraw my consent, I should contact Melanie Bertino on 95018785. This will 
not affect any further therapy or relationships with staff at The Victorian Rehabilitation 
Centre in any way.  
6. I am satisfied with the explanation given in relation to the project in so far as it affects me. 
7. My consent to participate in this project is given freely. 
8. I have been informed that the information I provide will be confidential. 
 
NAME ..................................................................................................................................... 
 
 
SIGNED ..................................................................... DATE ................................... 
(Participant) 
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Appendix J: Battery of questionnaires for Studies Two and Three 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PSYCHOLOGICAL QUESTIONNAIRES FOR PAIN MANAGEMENT 
 
 
 
 
 
Name 
 
 
 
Date 
 
 
 
 
 
Everyone who attends for pain assessment at The Victorian Rehabilitation Centre is 
asked to complete these questionnaires as a standard part of the assessment and 
programme. 
 
Your responses to these questionnaires provide information about your pain and how 
it impacts on your life. 
 
Please complete the questionnaires in this booklet by yourself, and answer every 
question. 
 
There are no “trick questions”, and no answers are either “wrong” or “right”. 
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DASS-21 
Lovibond & Lovibond (1995) 
Please read each statement and circle a number – 0, 1, 2 or 3 – which indicates how 
much the statement applied to you over the past week.  There are no right or wrong 
answers.  Do not spend too much time on any statement. 
 
 
The rating scale is as follows: 
 
0 Did not apply to me at all 
1 Applied to me to some degree, or some of the time 
2 Applied to me to a considerable degree, or a good part of time 
3 Applied to me very much, or most of the time 
  
 
1. I found it hard to wind down 0      1      2      3 
 
2. I was aware of dryness of my mouth 0      1     2      3 
 
3. I couldn’t seem to experience any positive feeling at all 0      1     2      3 
  
4. I experienced breathing difficulty (eg: excessively rapid breathing, 0      1     2      3 
  breathlessness in the absence of physical exertion)  
 
5. I found it difficult to work up the initiative to do things 0      1     2      3 
 
6. I tended to over-react to situations  0      1     2      3 
 
7. I experienced trembling (eg: in the hands)    0      1     2      3 
 
8. I felt that I was using a lot of nervous energy    0      1     2      3 
 
9. I was worried about situations in which I might panic    0      1     2      3 
 and make a fool of myself 
 
10. I felt that I had nothing to look forward to       0      1     2      3 
 
11. I found myself getting agitated       0      1     2      3 
 
12. I found it difficult to relax    0      1     2      3 
 
13.  I felt down-hearted and blue    0      1     2      3 
 
14. I was intolerant of anything that kept me from getting on   0      1     2      3 
 with what I was doing 
 
15. I felt I was close to panic    0      1     2      3 
  
16. I was unable to become enthusiastic about anything    0      1     2      3 
 
17. I felt I wasn’t worth much as a person    0      1     2      3 
 
18. I felt I was rather touchy    0      1     2      3 
 
19. I was aware of the action of my heart in the absence of physical   0      1      2      3 
 exertion (eg: sense of heart rate increase, heart missing a beat) 
 
20. I felt scared without any good reason    0      1     2      3 
 
21. I felt that life was meaningless    0      1     2      3 
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PSEQ 
Nicholas (1988) 
Please rate how confident you are that you can do the following things at present 
despite the pain.  To indicate your answer circle one of the numbers on the scale 
under each item, where 0 = not at all confident and 6 = completely confident.  
Remember, this questionnaire is not asking whether or not you have been doing 
these things, but rather how confident you are that you can do them at present, 
despite the pain. 
 
 1. I can enjoy things, despite the pain. 
 
  0 1 2 3 4 5 6 
 Not at all confident     Completely confident 
 
 2. I can do most of the household chores (eg: tidying-up, washing dishes) despite the pain. 
  
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
 
 3. I can socialise with my friends or family as often as I used to do, despite the pain. 
   
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
 
 4. I can cope with my pain in most situations. 
    
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
 
5. I can do some form of work, despite the pain. (housework, paid and unpaid work). 
   
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
6. I can still do many of the things I enjoy doing (hobbies or leisure), despite the pain. 
 
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
 7. I can cope with my pain without medication. 
 
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
     
 8. I can still accomplish most of my goals in life, despite the pain. 
 
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
     
 9. I can live a normal lifestyle, despite the pain. 
     
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident 
 
10. I can gradually become more active, despite the pain. 
 
  0 1 2 3 4  5 6 
 Not at all confident     Completely confident
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PDI 
The rating scales below are designed to measure the degree to which several 
aspects of your life are presently disrupted by chronic pain.  In other words, we would 
like to know how much your pain is preventing you from doing what you would 
normally do, or from doing it as well as you normally would.   
Respond to each category by indicating the overall impact of pain in your life, not just 
when the pain is at its worst.   
For each of the 6 categories of life activity listed, please circle the number on the 
scale which describes the level of disability you typically experience.   
A score of 0 means no disability at all, and a score of 10 signifies that all of the 
activities in which you would normally be involved have been totally disrupted or 
prevented by your pain. 
Family / Home Responsibilities 
This category refers to activities related to the home or family.  It includes chores or 
duties performed around the house (eg: yard work) and errands or favours for other 
family members (eg: driving the children to school). 
0 1 2 3 4 5 6 7 8 9 10 
No disability Worst disability 
 
Recreation 
This category includes hobbies, sports, and other similar leisure time activities. 
 
0 1 2 3 4 5 6 7 8 9 10 
No disability Worst disability 
 
Social Activity 
This category refers to activities that involve participation with friends and 
acquaintances other than family members.  It includes parties, theatre, concerts, 
dining out, and other social functions. 
0 1 2 3 4 5 6 7 8 9 10 
No disability Worst disability 
 
Occupation 
This category refers to activities that are a part of or directly related to one’s job.  This 
includes non-paying jobs as well, such as that of a housewife or volunteer worker. 
0 1 2 3 4 5 6 7 8 9 10 
No disability Worst disability 
 
Sexual Behaviour 
This category refers to the frequency and quality of one’s sex life. 
 
0 1 2 3 4 5 6 7 8 9 10 
No disability Worst disability 
 
Life Support Activity 
This category refers to basic life-supporting behaviours such as eating, sleeping and 
breathing. 
0 1 2 3 4 5 6 7 8 9 10 
No disability Worst disability 
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THE TAMPA SCALE 
Miller, Kori & Todd (1991) 
In these days of high-tech medicine, one of the most important sources of information about you 
is often missing from your medical records: your own feelings or intuitions about what is 
happening with your body.  We hope that the following information will help to fill that gap. 
Please answer the following questions according to the scale on the right.  Please answer 
according to your true feelings, not according to what others think you should believe.  This is 
not a test of medical knowledge; we want to know how you see it. 
Circle the number next to each question that best corresponds to how you feel. 
 
The rating scale is as follows:  1. Strongly disagree 
2. Somewhat disagree 
3. Somewhat agree 
4. Strongly agree 
 
1. I’m afraid that I might injure myself if I exercise 1      2      3      4 
 
2. If I were to try to overcome it, my pain would increase 1      2      3      4 
 
3. My body is telling me I have something dangerously wrong 1     2      3      4 
 
4. My pain would probably be relieved if I were to exercise 1     2      3      4 
 
5. People aren’t taking my medical condition seriously enough 1     2      3      4 
 
7. My accident has put my body at risk for the rest of my life  1     2      3      4 
 
7. Pain always means I have injured by body    1     2      3      4 
 
8. Just because something aggravates my pain does not mean   1     2      3      4 
 it is dangerous 
 
9. I am afraid that I might injure myself accidentally   1     2      3      4 
 
10. Simply being careful that I do not make any unnecessary movements 1     2      3      4 
 is the safest thing I can do to prevent my pain from worsening 
 
11. I wouldn’t have this much pain if there weren’t something 1     2      3      4 
 potentially dangerous going on in my body 
 
12. Although my condition is painful, I would be better off if I were 1     2      3      4 
 physically active 
 
13.  Pain lets me know when to stop exercising so that I don’t injure 1     2      3      4 
 myself 
 
14. It’s really not safe for a person with a condition like mine to be 1     2      3      4 
 physically active 
 
15. I can’t do all the things normal people do because it’s too easy 1     2      3      4 
 for me to get injured 
  
16. Even though something is causing me a lot of pain, I don’t think 1     2      3     4 
 it’s actually dangerous 
 
17. No one should have to exercise when s/he is in pain 1     2      3     4 
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Survey of Pain Attitudes – Revised (SOPA-R) 
 
Please indicate how much you agree with each of the following statements about your 
pain problem by using the response key below. 
 
Response Key : 0 = This is very untrue for me 
1 = This is somewhat untrue for me 
2 = This is neither true nor untrue for me (or it does not apply 
to me) 
3 = This is somewhat true for me 
4 = This is very true for me 
 
 1. The pain I feel is a sign that damage is being done                                0    1    2    3    4 
  
 2. I will probably always have to take pain medications    0    1    2    3    4 
 
 3. When I hurt, I want my family to treat me better   0    1    2    3    4 
 
 4. If my pain continues at this present level, I will be unable to work 0    1    2    3    4 
 
 5. The amount of pain I feel is out of my control 0    1    2    3    4 
 
6. I do not expect a medical cure for my pain 0    1    2    3    4 
 
7. Pain does not have to mean that my body is being harmed 0    1    2    3    4 
 
8. I have had the most relief from pain with the use of medications 0    1    2    3    4 
 
9. Anxiety increases the pain I feel 0    1    2    3    4 
 
10. There is little that I can do to ease my pain 0    1    2    3    4 
 
11. When I am hurting, I deserve to be treated with care and concern 0    1    2    3    4 
 
12. I pay doctors so they will cure me of my pain 0    1    2    3    4 
 
13. My pain problem does not need to interfere with my activity level 0    1    2    3    4 
 
14. It is the responsibility of my family to help me when I feel pain 0    1    2    3    4 
 
15. Stress in my life increases the pain I feel 0    1    2    3    4 
 
16. Exercise and movement are good for my pain problem 0    1    2    3    4 
 
17. Medicine is one of the best treatments for chronic pain 0    1    2    3    4 
 
18. My family needs to learn how to take better care of me when I am 
in pain 
0    1    2    3    4 
 
 
19. Depression increases the pain I feel 0    1    2    3    4 
 
20. If I exercise, I could make my pain problem much worse 0    1    2    3    4 
 
21. I can control my pain by changing my thoughts 0    1    2    3    4 
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22. I need more tender loving care than I am now getting when I am in 
pain 
0    1    2    3    4 
 
 
23. I consider myself to be disabled 0    1    2    3    4 
 
24. I have learned to control my pain 0    1    2    3    4 
 
25. I trust that doctors can cure my pain 0    1    2    3    4 
 
26. My pain does not stop me from leading a physically active life 0    1    2    3    4 
 
27. My physical pain will never be cured 0    1    2    3    4 
 
28. There is a strong connection between my emotions and my pain 
level 
0    1    2    3    4 
 
 
29. I am not in control of my pain 0    1    2    3    4 
 
30. No matter how I feel emotionally, my pain stays the same 0    1    2    3    4 
 
31. When I find the right doctor, he or she will know how to reduce my 
pain 
0    1    2    3    4 
 
 
32. If my doctor prescribed pain medications for me, I would throw 
them away 
0    1    2    3    4 
 
 
33. I will never take pain medications again 0    1    2    3    4 
 
34. Exercise can decrease the amount of pain I experience 0    1    2    3    4 
 
35. My pain would stop anyone from leading an active life 0    1    2    3    4 
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Appendix K: Treatment Maintenance Questionnaire for Study Three  
 
 
Treatment Maintenance Questionnaire 
 
From our records, you attended a pain program at [Name of clinic omitted to maintain 
anonymity during review process] in                 .  During this program, you may have received 
physiotherapy/exercise physiology, psychology, occupational therapy and/or hydrotherapy.  
Please place a tick in the boxes next to the treatment that you received. You may answer 
more than once.   
   
           
 Physiotherapy/Exercise Physiology 
 Psychology 
 Occupational Therapy 
 Hydrotherapy 
 
 
When you attended this program it may have been recommended that you continue to 
perform certain strategies to manage your pain symptoms after treatment.  Please read the 
following list of strategies and circle a number 0, 1, 2, 3, or 4 which indicates how often you 
currently perform them.  There are no right or wrong answers.  
 
 
The rating scale is as follows:  0 I was not recommended to use this strategy 
        1 I do not use this strategy 
        2 I use this strategy some of the time 
      3 I use this strategy most of the time 
        4 I use this strategy all of the time 
 
 
1. Regular exercise   
a) Stretching           
        0 1 2 3 4 
b) Walking               
        0 1 2 3 4 
c) Resistance           
        0 1 2 3 4 
 
2. Biomechanics  
a) Moving correctly              0 1 2 3 4 
b) Lifting correctly          0 1 2 3 4 
c) Sitting/standing postures     0 1 2 3 4 
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3. Relaxation techniques  
a) Breathing                             0 1 2 3 4 
b) Mindfulness                             0 1 2 3 4 
c) Progressive/deep muscle relaxation    0 1 2 3 4 
 
4. Activity pacing  
a) Breaking up tasks      0 1 2 3 4 
b) Taking rest breaks      0 1 2 3 4 
c) Planning ahead      0 1 2 3 4 
 
5. Stress and mood management  
a) Identifying stressors                 0 1 2 3 4 
b) Problem solving                 0 1 2 3 4 
c) Challenge unhelpful thoughts     0 1 2 3 4 
d) Pleasant activity scheduling     0 1 2 3 4 
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Appendix L: Glossary of definitions 
 
Anxiety   Feelings of worry, nervousness, or unease about something  
  with an uncertain outcome 
Catastrophising  The tendency to exaggerate and ruminate negative cognitions 
  and emotions during actual or perceived painful stimulation 
Depression   Feelings of severe despondency and dejection 
Fear-avoidance   An irrational and debilitating fear of physical movement and 
    activity resulting from a feeling of vulnerability to painful  
    (re)injury 
Pain intensity    The sensation of physical hurt or discomfort  
Pain self-efficacy   Confidence in one’s ability to perform a range of activities  
    while in pain 
Perceived control   The belief that one can control their own pain experience 
Perceived disability   The impact that pain has on the ability of a person to participate 
    in essential life activities 
Treatment maintenance Adherence behaviour to post-intervention recommendations 
 
 
 
 
 
 
